Word,Tag
#15702478
Mutation,B-DNA_Mutation
analysis,O
of,O
p53,B-Gene_protein
,,I-Gene_protein
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
,,I-Gene_protein
and,O
BRAF,B-Gene_protein
genes,O
in,O
colorectal,O
cancer,O
progression,O
.,O
 , 


,O
Gene,O
mutations,B-DNA_Mutation
in,O
APC,B-Gene_protein
,,I-Gene_protein
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
,,I-Gene_protein
and,O
p53,B-Gene_protein
are,O
thought,O
to,O
be,O
essential,O
events,O
for,O
colorectal,O
cancer,O
development,O
.,O
 , 
Recent,O
data,O
seem,O
to,O
indicate,O
that,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
and,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
rarely,O
co,O
-,O
exist,O
in,O
the,O
same,O
tumor,O
,,O
indicating,O
that,O
these,O
alterations,O
do,O
not,O
represent,O
a,O
synergistic,O
evolutionary,O
pathway,O
.,O
 , 
Moreover,O
,,O
an,O
inverse,O
relation,O
between,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
activation,B-DNA_modification
and,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
has,O
been,O
demonstrated,O
,,O
suggesting,O
alternative,O
pathways,O
for,O
colorectal,O
cancer,O
transformation,O
.,O
 , 
To,O
reconstruct,O
the,O
chronological,O
modulation,O
of,O
these,O
gene,O
mutations,B-DNA_Mutation
during,O
cell,O
transformation,O
and,O
colorectal,O
cancer,O
progression,O
,,O
mutations,B-DNA_Mutation
of,O
p53,B-Gene_protein
,,I-Gene_protein
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
,,I-Gene_protein
and,O
BRAF,B-Gene_protein
genes,O
were,O
analyzed,O
by,O
Single,O
Strand,O
Conformation,O
Polymorphism,O
(,O
SSCP,O
),O
or,O
sequencing,O
analysis,O
in,O
100,O
colorectal,O
cancer,O
samples,O
,,O
evenly,O
distributed,O
among,O
different,O
Dukes,O
',O
stages,O
.,O
 , 
We,O
found,O
mutations,B-DNA_Mutation
in,O
p53,B-Gene_protein
,,I-Gene_protein
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
,,I-Gene_protein
and,O
BRAF,B-Gene_protein
genes,O
in,O
35,O
%,O
,,O
30,O
%,O
,,O
and,O
4,O
%,O
of,O
tumors,O
,,O
respectively,O
,,O
and,O
observed,O
a,O
minimal,O
or,O
no,O
co,O
-,O
presence,O
of,O
these,O
gene,O
alterations,O
.,O
 , 
Moreover,O
,,O
the,O
frequency,O
of,O
molecular,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
increased,O
as,O
tumor,O
stage,O
increased,O
,,O
suggesting,O
an,O
important,O
role,O
for,O
this,O
gene,O
in,O
the,O
progression,O
of,O
colorectal,O
cancer,O
.,O
 , 
Conversely,O
,,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
or,O
BRAF,B-Gene_protein
genes,O
were,O
not,O
related,O
to,O
tumor,O
stage,O
or,O
location,O
.,O
 , 
These,O
data,O
seem,O
to,O
indicate,O
the,O
absence,O
of,O
a,O
co,O
-,O
presence,O
of,O
the,O
genes,O
,,O
highlighting,O
the,O
possibility,O
of,O
multiple,O
pathways,O
for,O
colorectal,O
tumor,O
progression,O
.,O
 , 
Moreover,O
,,O
mutations,B-DNA_Mutation
in,O
p53,B-Gene_protein
,,I-Gene_protein
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
,,I-Gene_protein
and,O
BRAF,B-Gene_protein
are,O
not,O
present,O
in,O
about,O
one,O
-,O
third,O
of,O
colorectal,O
cancers,O
and,O
therefore,O
other,O
gene,O
mutations,B-DNA_Mutation
need,O
to,O
be,O
investigated,O
to,O
better,O
understand,O
molecular,O
mechanisms,O
at,O
the,O
basis,O
of,O
cell,O
transformation,O
and,O
the,O
progression,O
of,O
colorectal,O
cancer,O
.,O
 , 

,O
 , 
#12530077
Amplified,B-DNA_modification
Muc1,B-Gene_protein
-,I-Gene_protein
specific,O
gene,O
expression,O
in,O
colon,O
cancer,O
cells,O
utilizing,O
a,O
binary,O
system,O
in,O
adenoviral,O
vectors,O
.,O
 , 


,B-Gene_protein
Mucin-1,I-Gene_protein
is,O
expressed,O
in,O
a,O
variety,O
of,O
colon,O
carcinomas,O
and,O
Muc-1,B-Gene_protein
/,B-Gene_protein
DF3,I-Gene_protein
promoters,O
have,O
been,O
utilized,O
to,O
reduce,O
systemic,O
toxicity,O
through,O
specific,O
gene,O
expression,O
.,O
 , 
To,O
overcome,O
weak,O
expression,O
,,O
which,O
is,O
much,O
lower,O
than,O
the,O
widely,O
used,O
cytomegalovirus,O
-,O
promoter,O
(,O
CMV,O
),O
,,O
new,O
adenoviral,O
vectors,O
containing,O
a,O
binary,O
system,O
of,O
transgene,O
amplification,O
have,O
been,O
developed,O
.,O
 , 
The,O
Muc-1,B-Gene_protein
/,B-Gene_protein
DF3,I-Gene_protein
promoter,O
was,O
used,O
to,O
control,O
the,O
expression,O
of,O
a,O
Gal4VP16,B-Gene_protein
fusion,O
protein,O
.,O
 , 
This,O
vector,O
also,O
contained,O
Gal4,B-Gene_protein
binding,O
sites,O
enabling,O
the,O
fusion,O
protein,O
to,O
act,O
as,O
a,O
transactivator,O
,,O
inducing,O
transgene,O
expression,O
within,O
the,O
same,O
construct,O
.,O
 , 
Mucin-1,B-Gene_protein
expression,O
was,O
analyzed,O
in,O
a,O
variety,O
of,O
colon,O
cancer,O
cell,O
lines,O
.,O
 , 
After,O
infection,O
with,O
recombinant,O
adenoviruses,O
,,O
transgene,O
expression,O
was,O
quantified,O
using,O
the,O
luciferase,O
system,O
.,O
 , 
Integration,O
of,O
the,O
Gal4VP16,B-Gene_protein
-,I-Gene_protein
binary,O
resulted,O
in,O
an,O
up,O
to,O
250,O
-,O
fold,O
increase,O
of,O
Muc-1,B-Gene_protein
/,I-Gene_protein
DF3,I-Gene_protein
-,I-Gene_protein
specific,O
gene,O
expression,O
.,O
 , 
In,O
mucin,B-Gene_protein
-,I-Gene_protein
positive,O
cell,O
lines,O
utilizing,O
this,O
amplified,O
Muc-1,B-Gene_protein
/,B-Gene_protein
DF3,I-Gene_protein
promoter,O
,,O
expression,O
was,O
up,O
to,O
590,O
-,O
fold,O
higher,O
as,O
compared,O
to,O
the,O
CMV,O
-,O
promoter,O
.,O
 , 
Western,O
blot,O
detected,O
the,O
presence,O
of,O
Gal4VP16,B-Gene_protein
in,O
infected,O
muc-1,B-Gene_protein
-,I-Gene_protein
positive,O
but,O
not,O
-,O
negative,O
cell,O
lines,O
.,O
 , 
These,O
new,O
adenoviral,O
vectors,O
combing,O
highly,O
efficient,O
and,O
specific,O
transgene,O
expression,O
and,O
will,O
contribute,O
to,O
the,O
safety,O
and,O
efficacy,O
of,O
experimental,O
approaches,O
in,O
cancer,O
gene,O
therapy,O
.,O
 , 

,O
 , 
#3399825
Increased,O
in,O
vitro,O
tetraploidy,O
and,O
mandibular,O
osteomas,O
in,O
patients,O
with,O
and,O
without,O
colorectal,O
diseases,O
.,O
 , 


,O
One,O
hundred,O
and,O
seventy,O
-,O
six,O
individuals,O
with,O
various,O
colorectal,O
diseases,O
were,O
investigated,O
simultaneously,O
for,O
increased,O
in,O
vitro,O
tetraploidy,O
in,O
dermal,O
fibroblast,O
cultures,O
and,O
for,O
occult,O
mandibular,O
osteomas,O
.,O
 , 
In,O
only,O
10,O
of,O
the,O
176,O
persons,O
were,O
both,O
presumed,O
markers,O
of,O
colorectal,O
genetic,O
predisposition,O
present,O
in,O
the,O
same,O
individual,O
.,O
 , 
No,O
evidence,O
was,O
found,O
that,O
these,O
traits,O
are,O
causally,O
associated,O
.,O
 , 
A,O
combination,O
of,O
the,O
two,O
presumed,O
markers,O
showed,O
a,O
tendency,O
towards,O
occurrence,O
in,O
individuals,O
with,O
a,O
positive,O
family,O
history,O
of,O
colorectal,O
cancer,O
among,O
first,O
-,O
degree,O
relatives,O
.,O
 , 

,O
 , 
#24576032
Summary,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
test,O
results,O
from,O
laboratories,O
participating,O
in,O
proficiency,O
surveys,O
:,O
proficiency,O
survey,O
results,O
from,O
2005,O
to,O
2012,O
.,O
 , 



,O
#,O
#,O
CONTEXT,O

,O
The,O
College,O
of,O
American,O
Pathologists,O
surveys,O
are,O
the,O
largest,O
laboratory,O
peer,O
comparison,O
programs,O
in,O
the,O
world,O
.,O
 , 
These,O
programs,O
allow,O
laboratories,O
to,O
regularly,O
evaluate,O
their,O
performance,O
and,O
improve,O
the,O
accuracy,O
of,O
the,O
patient,O
test,O
results,O
they,O
provide,O
.,O
 , 
Proficiency,O
testing,O
is,O
offered,O
twice,O
a,O
year,O
to,O
laboratories,O
performing,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
testing,O
.,O
 , 
These,O
surveys,O
are,O
designed,O
to,O
emulate,O
clinical,O
practice,O
,,O
and,O
some,O
surveys,O
have,O
more,O
challenging,O
cases,O
to,O
encourage,O
the,O
refinement,O
of,O
laboratory,O
practices,O
.,O
 , 


,O
#,O
#,O
OBJECTIVE,O

,O
This,O
report,O
summarizes,O
the,O
results,O
and,O
trends,O
in,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
proficiency,O
testing,O
from,O
participating,O
laboratories,O
from,O
the,O
inception,O
of,O
the,O
program,O
in,O
2005,O
through,O
2012,O
.,O
 , 


,O
#,O
#,O
DESIGN,O

,O
We,O
compiled,O
and,O
analyzed,O
data,O
for,O
16,O
surveys,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
proficiency,O
testing,O
during,O
2005,O
to,O
2012,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
number,O
of,O
laboratories,O
participating,O
in,O
the,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
survey,O
has,O
more,O
than,O
doubled,O
from,O
42,O
to,O
104,O
during,O
the,O
8,O
years,O
analyzed,O
.,O
 , 
An,O
average,O
of,O
95.4,O
%,O
of,O
the,O
laboratories,O
correctly,O
classified,O
each,O
of,O
the,O
survey,O
test,O
samples,O
from,O
the,O
2005A,O
through,O
2012B,O
proficiency,O
challenges,O
.,O
 , 
In,O
the,O
2011B,O
survey,O
,,O
a,O
lower,O
percentage,O
of,O
laboratories,O
(,O
78.4,O
%,O
),O
correctly,O
classified,O
the,O
specimen,O
,,O
possibly,O
because,O
of,O
overlooking,O
subtle,O
changes,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
and/or,O
failing,O
to,O
enrich,O
the,O
tumor,O
content,O
of,O
the,O
specimen,O
to,O
meet,O
the,O
limit,O
of,O
detection,O
of,O
their,O
assay,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
 , 
In,O
general,O
,,O
laboratories,O
performed,O
well,O
in,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
testing,O
.,O
 , 
This,O
testing,O
will,O
continue,O
to,O
be,O
important,O
in,O
screening,O
patients,O
with,O
colorectal,O
and,O
other,O
cancers,O
for,O
Lynch,O
syndrome,O
and,O
guiding,O
the,O
management,O
of,O
patients,O
with,O
sporadic,O
colorectal,O
cancer,O
.,O
 , 

,O
 , 
#17350669
Fatty,B-Gene_protein
acid,I-Gene_protein
synthase,I-Gene_protein
overexpression,O
in,O
colorectal,O
cancer,O
is,O
associated,O
with,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
,,I-DNA_Mutation
independent,O
of,O
CpG,B-locus
island,I-locus
methylator,B-DNA_modification
phenotype,O
.,O
 , 


,O
Overexpression,O
of,O
fatty,B-Gene_protein
acid,I-Gene_protein
synthase,I-Gene_protein
(,B-Gene_protein
FASN,I-Gene_protein
),I-Gene_protein
,,O
a,O
key,O
enzyme,O
for,O
de,O
novo,O
lipogenesis,O
,,O
is,O
observed,O
in,O
many,O
cancers,O
including,O
colorectal,O
cancer,O
and,O
is,O
associated,O
with,O
poor,O
clinical,O
outcomes,O
.,O
 , 
Cellular,O
FASN,B-Gene_protein
expression,O
is,O
physiologically,O
upregulated,O
in,O
a,O
state,O
of,O
energy,O
excess,O
.,O
 , 
Obesity,O
and,O
excess,O
energy,O
balance,O
have,O
been,O
known,O
to,O
be,O
risk,O
factors,O
for,O
colorectal,O
cancer,O
.,O
 , 
High,O
degree,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
-,I-DNA_Mutation
H,O
),O
is,O
a,O
distinct,O
phenotype,O
in,O
colorectal,O
cancer,O
,,O
associated,O
with,O
CpG,B-locus
island,I-locus
methylator,B-DNA_modification
phenotype,O
(,O
CIMP,O
),O
.,O
 , 
Previous,O
data,O
suggest,O
that,O
obesity,O
or,O
altered,O
energy,O
balance,O
may,O
potentially,O
modify,O
risks,O
for,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,O
cancers,O
and,O
microsatellite,O
stable,O
(,O
MSS,O
),O
cancers,O
differently,O
.,O
 , 
However,O
,,O
the,O
relationship,O
between,O
MSI,B-DNA_Mutation
and,O
FASN,B-Gene_protein
overexpression,O
has,O
not,O
been,O
investigated,O
.,O
 , 
Using,O
976,O
cases,O
of,O
population,O
-,O
based,O
colorectal,O
cancer,O
samples,O
from,O
2,O
large,O
prospective,O
cohort,O
studies,O
,,O
we,O
correlated,O
FASN,B-Gene_protein
expression,O
(,O
by,O
immunohistochemistry,O
),O
with,O
MSI,B-DNA_Mutation
,,I-DNA_Mutation
KRAS,B-Gene_protein
and,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
,,I-DNA_Mutation
p53,B-Gene_protein
expression,O
(,O
by,O
immunohistochemistry,O
),O
,,O
and,O
CIMP,O
status,O
[,O
determined,O
by,O
MethyLight,O
for,O
8,O
CIMP,O
-,O
specific,O
gene,O
promoters,O
including,O
CACNA1,B-Gene_protein
G,I-Gene_protein
,,I-Gene_protein
CDKN2A,B-Gene_protein
(,O
p16,O
),O
,,O
CRABP1,B-Gene_protein
,,I-Gene_protein
IGF2,B-Gene_protein
,,I-Gene_protein
MLH1,B-Gene_protein
,,I-Gene_protein
NEUROG1,B-Gene_protein
,,I-Gene_protein
RUNX3,B-Gene_protein
,,I-Gene_protein
and,O
SOCS1,B-Gene_protein
],I-Gene_protein
.,O
 , 
Marked,O
(,O
2,O
+,O
),O
FASN,B-Gene_protein
overexpression,O
was,O
observed,O
in,O
110,O
(,O
11,O
%,O
),O
of,O
the,O
976,O
tumors,O
and,O
was,O
significantly,O
more,O
common,O
in,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,O
tumors,O
(,O
21,O
%,O
[,O
28/135,O
],O
),O
than,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
low,O
(,O
5.6,O
%,O
[,O
4/72,O
],O
,,O
P,O
=,O
.004,O
),O
and,O
MSS,O
tumors,O
(,O
11,O
%,O
[,O
72/678,O
],O
,,O
P,O
=,O
.001,O
),O
.,O
 , 
The,O
association,O
between,O
FASN,B-Gene_protein
overexpression,O
and,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,O
persisted,O
even,O
after,O
stratification,O
by,O
CIMP,O
status,O
.,O
 , 
In,O
contrast,O
,,O
FASN,B-Gene_protein
overexpression,O
was,O
not,O
correlated,O
with,O
CIMP,O
after,O
stratification,O
by,O
MSI,B-DNA_Mutation
status,O
.,O
 , 
Fatty,B-Gene_protein
acid,I-Gene_protein
synthase,I-Gene_protein
overexpression,O
was,O
not,O
significantly,O
correlated,O
with,O
sex,O
,,O
tumor,O
location,O
,,O
p53,B-Gene_protein
,,I-Gene_protein
or,O
KRAS,B-Gene_protein
/,B-Gene_protein
BRAF,I-Gene_protein
status,O
.,O
 , 
In,O
conclusion,O
,,O
FASN,B-Gene_protein
overexpression,O
in,O
colorectal,O
cancer,O
is,O
associated,O
with,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,O
,,O
independent,O
of,O
CIMP,O
status,O
.,O
 , 

,O
 , 
#9841584
Benefits,O
of,O
colonoscopic,O
surveillance,O
and,O
prophylactic,O
colectomy,O
in,O
patients,O
with,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
mutations,B-Mutation
.,I-Mutation
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Predisposition,O
genetic,O
testing,O
is,O
now,O
possible,O
for,O
many,O
hereditary,O
cancer,O
syndromes,O
,,O
including,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
.,O
 , 
The,O
optimal,O
management,O
of,O
the,O
elevated,O
risk,O
for,O
cancer,O
in,O
carriers,O
of,O
mutations,B-Mutation
for,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
is,O
unclear,O
.,O
 , 


,O
#,O
#,O
OBJECTIVE,O

,O
To,O
assess,O
the,O
life,O
expectancy,O
and,O
quality,O
-,O
adjusted,O
life,O
expectancy,O
benefits,O
derived,O
from,O
endoscopic,O
surveillance,O
and,O
prophylactic,O
colectomy,O
for,O
persons,O
who,O
carry,O
a,O
mutation,B-Mutation
associated,O
with,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
.,O
 , 


,O
#,O
#,O
DESIGN,O

,O
Decision,O
analysis,O
model,O
.,O
 , 
Lifetime,O
risk,O
for,O
colorectal,O
cancer,O
,,O
efficacy,O
of,O
surveillance,O
and,O
colectomy,O
,,O
stage,O
-,O
specific,O
colorectal,O
cancer,O
mortality,O
,,O
and,O
quality,O
of,O
life,O
were,O
included,O
in,O
the,O
model,O
.,O
 , 


,O
#,O
#,O
SETTING,O

,O
Decision,O
about,O
a,O
cancer,O
prevention,O
strategy,O
at,O
the,O
time,O
of,O
a,O
positive,O
result,O
on,O
genetic,O
testing,O
.,O
 , 


,O
#,O
#,O
PATIENTS,O

,O
Carriers,O
of,O
a,O
mutation,B-Mutation
for,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
who,O
were,O
25,O
years,O
of,O
age,O
.,O
 , 


,O
#,O
#,O
INTERVENTIONS,O

,O
Immediate,O
prophylactic,O
colectomy,O
;,O
delayed,O
colectomy,O
on,O
the,O
basis,O
of,O
age,O
,,O
adenoma,O
,,O
or,O
diagnosis,O
of,O
colorectal,O
cancer,O
;,O
and,O
endoscopic,O
surveillance,O
.,O
 , 
Prophylactic,O
surgical,O
options,O
were,O
proctocolectomy,O
with,O
ileoanal,O
anastomosis,O
and,O
subtotal,O
colectomy,O
with,O
ileorectal,O
anastomosis,O
.,O
 , 


,O
#,O
#,O
MEASUREMENTS,O

,O
Life,O
expectancy,O
and,O
quality,O
-,O
adjusted,O
life,O
expectancy,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
All,O
risk,O
-,O
reduction,O
strategies,O
led,O
to,O
large,O
gains,O
in,O
life,O
expectancy,O
for,O
carriers,O
of,O
a,O
mutation,B-Mutation
for,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
,,O
with,O
benefits,O
ranging,O
from,O
13.5,O
years,O
for,O
surveillance,O
to,O
15.6,O
years,O
for,O
prophylactic,O
proctocolectomy,O
at,O
25,O
years,O
of,O
age,O
compared,O
with,O
no,O
intervention,O
.,O
 , 
The,O
benefits,O
of,O
colectomy,O
compared,O
with,O
surveillance,O
decreased,O
with,O
increasing,O
age,O
and,O
were,O
minimal,O
if,O
colectomy,O
was,O
performed,O
at,O
the,O
time,O
of,O
colorectal,O
cancer,O
diagnosis,O
.,O
 , 
When,O
health,O
-,O
related,O
quality,O
of,O
life,O
was,O
considered,O
,,O
surveillance,O
led,O
to,O
the,O
greatest,O
quality,O
-,O
adjusted,O
life,O
expectancy,O
benefit,O
(,O
3.1,O
years,O
compared,O
with,O
proctocolectomy,O
and,O
0.3,O
years,O
compared,O
with,O
subtotal,O
colectomy,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Colonoscopic,O
surveillance,O
is,O
an,O
effective,O
method,O
of,O
reducing,O
risk,O
for,O
cancer,O
in,O
carriers,O
of,O
a,O
mutation,B-Mutation
for,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
.,O
 , 
The,O
individual,O
patient,O
's,O
choice,O
between,O
prophylactic,O
surgery,O
and,O
surveillance,O
is,O
a,O
complex,O
decision,O
in,O
which,O
personal,O
preferences,O
weigh,O
heavily,O
.,O

,O
 , 
#8431846
Multiple,O
polyps,O
of,O
esophagus,O
,,O
stomach,O
,,O
colon,O
,,O
and,O
rectum,O
accompanying,O
rectal,O
cancer,O
in,O
a,O
patient,O
with,O
constitutional,O
chromosomal,O
inversion,B-DNA_Mutation
.,I-DNA_Mutation
 , 



,O
#,O
#,O
BACKGROUND,O

,O
It,O
has,O
been,O
reported,O
that,O
colorectal,O
carcinomas,O
are,O
caused,O
by,O
a,O
multistage,O
process,O
.,O
 , 
In,O
patients,O
with,O
familial,O
adenomatous,O
polyposis,O
,,O
carcinoma,O
of,O
the,O
colorectum,O
frequently,O
develops,O
and,O
occasionally,O
polyps,O
develop,O
in,O
the,O
upper,O
gastrointestinal,O
tract,O
.,O
 , 
Chromosomal,O
deletion,B-DNA_Mutation
often,O
is,O
found,O
for,O
chromosomes,B-locus
5,I-locus
,,I-locus
17,B-locus
,,I-locus
and,O
18,B-locus
,,I-locus
on,O
which,O
tumor,O
suppressor,O
genes,O
are,O
located,O
.,O
 , 
Furthermore,O
,,O
loss,B-DNA_Mutation
of,O
the,O
alleles,O
of,O
loci,O
on,O
chromosome,B-locus
3,I-locus
has,O
been,O
reported,O
in,O
renal,O
cell,O
carcinoma,O
,,O
small,O
cell,O
lung,O
carcinoma,O
,,O
and,O
mixed,O
salivary,O
gland,O
tumor,O
in,O
hereditary,O
and,O
sporadic,O
cases,O
.,O
 , 
These,O
data,O
support,O
the,O
concept,O
of,O
a,O
recessive,O
mechanism,O
for,O
the,O
development,O
of,O
human,O
tumors,O
.,O
 , 


,O
#,O
#,O
PATIENTS,O
AND,O
RESULTS,O

,O
 , 
The,O
authors,O
report,O
the,O
case,O
of,O
a,O
48,O
-,O
year,O
-,O
old,O
woman,O
with,O
rectal,O
cancer,O
accompanied,O
by,O
multiple,O
polyps,O
in,O
the,O
esophagus,O
,,O
stomach,O
,,O
and,O
colorectum,O
.,O
 , 
Histologically,O
,,O
the,O
polypoid,O
lesions,O
in,O
the,O
esophagus,O
,,O
stomach,O
,,O
and,O
colorectum,O
showed,O
a,O
thickened,O
mucosa,O
,,O
hyperplastic,O
polyps,O
,,O
and,O
mixed,O
hyperplastic,O
adenomatous,O
polyps,O
,,O
respectively,O
.,O
 , 
Karyotype,O
analysis,O
showed,O
46,O
,,O
xx,O
,,O
inv(3)(p12.2q25.3,B-DNA_Mutation
),I-locus
in,O
all,O
20,O
inspected,O
peripheral,O
lymphocytes,O
.,O
 , 
By,O
Southern,O
blot,O
with,O
a,O
c,B-Gene_protein
-,I-Gene_protein
raf,I-Gene_protein
probe,O
,,O
one,O
allele,O
of,O
the,O
c,B-Gene_protein
-,I-Gene_protein
raf-1,I-Gene_protein
gene,O
,,O
which,O
has,O
been,O
mapped,O
on,O
chromosome,B-locus
3p25,I-locus
,,I-locus
was,O
deleted,B-DNA_Mutation
from,O
the,O
rearranged,B-DNA_Mutation
chromosome,B-locus
3,I-locus
in,O
the,O
peripheral,O
lymphocytes,O
,,O
intact,O
colonic,O
mucosa,O
,,O
and,O
cancer,O
tissue,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
These,O
results,O
suggest,O
that,O
the,O
development,O
of,O
hyperplastic,O
polyps,O
and,O
carcinoma,O
of,O
the,O
rectum,O
results,O
from,O
the,O
allelic,O
loss,B-DNA_Mutation
in,O
chromosome,B-locus
3p,I-locus
,,I-locus
as,O
has,O
been,O
reported,O
for,O
solid,O
tumors,O
at,O
other,O
sites,O
.,O
 , 

,O
 , 
#18345036
Deregulation,B-DNA_modification
of,O
Cdk2,B-Gene_protein
causes,O
Bim,B-Gene_protein
-,I-Gene_protein
mediated,O
apoptosis,O
in,O
p53,B-Gene_protein
-,I-Gene_protein
deficient,O
tumors,O
following,O
actin,B-Gene_protein
damage,O
.,O
 , 


,O
We,O
previously,O
reported,O
that,O
actin,B-Gene_protein
damage,O
by,O
treatment,O
with,O
an,O
actin,B-Gene_protein
-,I-Gene_protein
depolymerizing,O
agent,O
including,O
pectenotoxin-2,O
induces,O
Bim,B-Gene_protein
-,I-Gene_protein
mediated,O
apoptosis,O
in,O
p53,B-Gene_protein
-,I-Gene_protein
deficient,O
human,O
tumors,O
.,O
 , 
In,O
this,O
study,O
,,O
we,O
investigated,O
a,O
molecular,O
mechanism,O
underlying,O
Bim,B-Gene_protein
-,I-Gene_protein
mediated,O
apoptosis,O
of,O
p53,B-Gene_protein
-,I-Gene_protein
deficient,O
tumor,O
cells,O
following,O
actin,B-Gene_protein
damage,O
.,O
 , 
We,O
found,O
that,O
actin,B-Gene_protein
inhibitors,O
increased,O
the,O
protein,O
levels,O
of,O
p53,B-Gene_protein
and,O
p21,B-Gene_protein
and,O
thereby,O
inactivated,O
both,O
Cdk2,B-Gene_protein
and,O
Cdc2,B-Gene_protein
kinases,O
.,O
 , 
However,O
,,O
p53-,B-Gene_protein
or,O
p21,B-Gene_protein
-,I-Gene_protein
knockout,O
cells,O
fail,O
to,O
induce,O
p21,B-Gene_protein
and,O
hence,O
kept,O
both,O
Cdk2,B-Gene_protein
and,O
Cdc2,B-Gene_protein
kinases,O
active,O
even,O
after,O
treatment,O
with,O
actin,B-Gene_protein
inhibitor,O
.,O
 , 
The,O
p53-,B-Gene_protein
or,O
p21,B-Gene_protein
-,I-Gene_protein
knockout,O
cells,O
became,O
multinucleate,O
and,O
polyploidy,O
in,O
association,O
with,O
induction,O
of,O
apoptosis,O
.,O
 , 
Expression,O
of,O
Bcl,B-Gene_protein
-,I-Gene_protein
x(L,I-Gene_protein
),I-Gene_protein
resulted,O
in,O
accumulation,O
of,O
polyploid,O
cells,O
in,O
association,O
with,O
inhibition,O
of,O
apoptosis,O
.,O
 , 
However,O
,,O
expression,O
of,O
a,O
dominant,B-DNA_Mutation
negative,I-DNA_Mutation
mutant,I-DNA_Mutation
(,B-Gene_protein
Cdk2dn,I-Gene_protein
),O
and,O
treatment,O
with,O
chemical,O
inhibitors,O
for,O
Cdk2,B-Gene_protein
suppressed,O
not,O
only,O
accumulation,O
of,O
multinucleated,O
cells,O
,,O
but,O
also,O
induction,O
of,O
Bim,B-Gene_protein
expression,O
and,O
apoptosis,O
.,O
 , 
Therefore,O
,,O
these,O
results,O
suggest,O
that,O
Bim,B-Gene_protein
-,I-Gene_protein
mediated,O
apoptosis,O
following,O
actin,B-Gene_protein
damage,O
due,O
to,O
deregulation,O
of,O
Cdk2,B-Gene_protein
and,O
the,O
cell,O
cycle,O
by,O
the,O
absence,O
of,O
functional,O
p53,B-Gene_protein
.,I-Gene_protein
 , 

,O
 , 
#1319833
Loss,B-DNA_Mutation
of,O
expression,O
of,O
the,O
DCC,B-Gene_protein
gene,O
during,O
progression,O
of,O
colorectal,O
carcinomas,O
in,O
familial,O
adenomatous,O
polyposis,O
and,O
non,O
-,O
familial,O
adenomatous,O
polyposis,O
patients,O
.,O
 , 


,O
We,O
have,O
previously,O
observed,O
that,O
the,O
frequency,O
of,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
(,B-DNA_Mutation
LOH,I-DNA_Mutation
),I-DNA_Mutation
on,O
chromosome,B-locus
18q,I-locus
was,O
low,O
in,O
adenomas,O
and,O
intramucosal,O
carcinomas,O
,,O
whereas,O
invasive,O
carcinomas,O
exhibited,O
a,O
high,O
frequency,O
in,O
familial,O
adenomatous,O
polyposis,O
patients,O
(,O
M.,O
Miyaki,O
et,O
al,O
.,O
,,O
Cancer,O
Res,O
.,O
,,O
50,O
:,O
7166,O
-,O
7173,O
,,O
1990,O
),O
.,O
 , 
In,O
the,O
present,O
study,O
,,O
LOH,B-DNA_Mutation
at,O
the,O
DCC,B-Gene_protein
locus,O
on,O
chromosome,B-locus
18q,I-locus
and,O
the,O
expression,O
of,O
DCC,B-Gene_protein
gene,O
into,O
mRNA,O
were,O
analyzed,O
in,O
colorectal,O
tumors,O
with,O
distinct,O
histopathological,O
types,O
.,O
 , 
The,O
carcinomas,O
that,O
showed,O
18q,B-locus
LOH,B-DNA_Mutation
also,O
lost,O
the,O
DCC,B-Gene_protein
locus,O
.,O
 , 
The,O
expression,O
of,O
DCC,B-Gene_protein
gene,O
into,O
mRNA,O
was,O
examined,O
at,O
the,O
level,O
of,O
233,O
-,O
base,O
pair,O
fragments,O
of,O
nucleotide,B-locus
986,I-locus
-,I-locus
1218,I-locus
in,O
DCC,B-Gene_protein
complementary,O
DNA,O
.,O
 , 
In,O
a,O
moderate,O
-,O
to,O
-,O
severe,O
adenoma,O
,,O
5,O
carcinoma,O
-,O
in,O
-,O
adenomas,O
,,O
and,O
4,O
intramucosal,O
carcinomas,O
,,O
the,O
level,O
of,O
expression,O
was,O
as,O
high,O
as,O
in,O
normal,O
colorectal,O
mucosa,O
,,O
whereas,O
it,O
was,O
greatly,O
reduced,O
or,O
not,O
detectable,O
in,O
most,O
(,O
13,O
of,O
16,O
),O
invasive,O
carcinomas,O
.,O
 , 
Among,O
these,O
invasive,O
carcinomas,O
,,O
7,O
of,O
11,O
showed,O
18q,B-locus
LOH,B-DNA_Mutation
,,I-DNA_Mutation
but,O
4,O
showed,O
no,O
LOH,B-DNA_Mutation
.,I-DNA_Mutation
 , 
These,O
results,O
suggest,O
that,O
the,O
DCC,B-Gene_protein
gene,O
is,O
included,O
in,O
the,O
allelic,O
deletion,B-DNA_Mutation
on,O
chromosome,B-locus
18q,I-locus
,,I-locus
and,O
that,O
the,O
progression,O
of,O
colorectal,O
carcinoma,O
from,O
early,O
stage,O
to,O
advanced,O
stage,O
accompanies,O
the,O
inactivation,B-DNA_modification
of,O
the,O
DCC,B-Gene_protein
gene,O
through,O
LOH,B-DNA_Mutation
and,O
other,O
mechanisms,O
.,O
 , 

,O
 , 
#19140394
[,O
Peculiarities,O
of,O
regulation,O
of,O
tumour,O
cell,O
apoptosis,O
],O
.,O
 , 


,O
Studies,O
of,O
expression,O
of,O
BCL-2,B-Gene_protein
gene,O
family,O
revealed,O
abnormal,O
regulation,O
of,O
biosynthesis,O
of,O
apoptosis,O
-,O
related,O
proteins,O
in,O
tumour,O
cells,O
involved,O
in,O
the,O
development,O
and,O
progress,O
of,O
neoplastic,O
diseases,O
.,O
 , 
Expression,O
of,O
BCL-2,B-Gene_protein
proteins,O
in,O
highly,O
differentiated,O
gastric,O
and,O
colonic,O
tumours,O
was,O
roughly,O
1.2,O
times,O
lower,O
than,O
in,O
the,O
normal,O
cells,O
.,O
 , 
A,O
3.5,O
-,O
fold,O
rise,O
in,O
BCL-2,B-Gene_protein
expression,O
was,O
documented,O
in,O
a,O
group,O
of,O
moderately,O
differentiated,O
adenocarcinomas,O
and,O
undifferentiated,O
tumours,O
.,O
 , 
The,O
most,O
striking,O
(,O
9,O
-,O
fold,O
),O
difference,O
between,O
BCL,B-Gene_protein
expression,O
in,O
untransformed,O
and,O
atypical,O
cells,O
was,O
recorded,O
in,O
moderately,O
differentiated,O
metastatic,O
colonic,O
adenocarcinoma,O
.,O
 , 
Immunohistochemical,O
studies,O
of,O
BAX,B-Gene_protein
expression,O
in,O
untransformed,O
and,O
atypical,O
gastric,O
and,O
colonic,O
cells,O
demonstrated,O
activation,O
of,O
apoptosis,O
-,O
inducing,O
mechanisms,O
in,O
the,O
pathologically,O
changed,O
tissue,O
.,O
 , 
Investigations,O
with,O
the,O
use,O
of,O
SSCP,O
showed,O
that,O
20,O
%,O
of,O
the,O
patients,O
had,O
BAX,B-Gene_protein
gene,O
mutations,B-DNA_Mutation
affecting,O
codons,B-locus
38,I-locus
to,I-locus
41,I-locus
of,O
exone,B-locus
3,I-locus
.,I-locus
 , 
This,O
region,O
was,O
found,O
to,O
contain,O
octadeoxyguanosine,O
G8,O
sequence,O
.,O
 , 
The,O
mutations,B-DNA_Mutation
were,O
caused,O
by,O
deletion,B-DNA_Mutation
of,O
G7,O
or,O
insertion,B-DNA_Mutation
of,O
G9,O
.,O
 , 

,O
 , 
#24120286
[,O
Indications,O
for,O
prophylactic,O
hysterectomy,O
],O
.,O
 , 


,O
Endometrial,O
cancer,O
is,O
the,O
most,O
common,O
gynecologic,O
cancer,O
in,O
France,O
with,O
an,O
incidence,O
in,O
France,O
in,O
2010,O
,,O
of,O
6560,O
new,O
cases,O
and,O
1900,O
deaths,O
secondary,O
to,O
endometrial,O
cancer,O
.,O
 , 
The,O
main,O
risk,O
factors,O
are,O
age,O
,,O
hyperoestrogenic,O
factors,O
and,O
hereditary,O
syndroms,O
.,O
 , 
Prophylactic,O
hysterectomy,O
could,O
prevent,O
endometrial,O
cancer,O
in,O
case,O
of,O
risk,O
factors,O
such,O
as,O
genetic,O
syndroms,O
.,O
 , 
Actually,O
,,O
only,O
Lynch,O
syndrome,O
is,O
a,O
validate,O
indication,O
and,O
should,O
be,O
discussed,O
in,O
patients,O
older,O
than,O
40,O
-,O
45,O
years,O
.,O
 , 
Prophylactic,O
hysterectomy,O
does,O
not,O
seem,O
a,O
reasonable,O
option,O
to,O
patients,O
carrying,O
BRCA,B-Gene_protein
1,I-Gene_protein
or,I-Gene_protein
2,I-Gene_protein
mutation,B-Mutation
.,I-Mutation
 , 

,O
 , 
#21261604
Childhood,O
brain,O
tumours,O
due,O
to,O
germline,O
bi,O
-,O
allelic,O
mismatch,O
repair,O
gene,O
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
Childhood,O
brain,O
tumours,O
may,O
be,O
due,O
to,O
germline,O
bi,O
-,O
allelic,O
mismatch,O
repair,O
(,O
MMR,O
),O
gene,O
mutations,B-DNA_Mutation
in,O
MLH1,B-Gene_protein
,,I-Gene_protein
MSH2,B-Gene_protein
,,I-Gene_protein
MSH6,B-Gene_protein
or,O
PMS2,B-Gene_protein
.,I-Gene_protein
 , 
These,O
mutations,B-DNA_Mutation
can,O
also,O
lead,O
to,O
colorectal,O
neoplasia,O
and,O
haematological,O
malignancies,O
.,O
 , 
Here,O
,,O
we,O
review,O
this,O
syndrome,O
and,O
present,O
siblings,O
with,O
early,O
-,O
onset,O
rectal,O
adenoma,O
and,O
papillary,O
glioneural,O
brain,O
tumour,O
,,O
respectively,O
,,O
due,O
to,O
novel,O
germline,O
bi,O
-,O
allelic,O
PMS2,B-Gene_protein
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Identification,O
of,O
MMR,O
protein,O
defects,O
can,O
lead,O
to,O
early,O
diagnosis,O
of,O
this,O
condition,O
.,O
 , 
In,O
addition,O
,,O
assays,O
for,O
these,O
defects,O
may,O
help,O
to,O
classify,O
brain,O
tumours,O
for,O
research,O
protocols,O
aimed,O
at,O
targeted,O
therapies,O
.,O
 , 

,O
 , 
#17234021
Cost,O
-,O
effectiveness,O
of,O
surveillance,O
programs,O
for,O
families,O
at,O
high,O
and,O
moderate,O
risk,O
of,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
OBJECTIVES,O

,O
Surveillance,O
programs,O
are,O
recommended,O
to,O
both,O
families,O
at,O
high,O
risk,O
(,O
Amsterdam,O
-,O
positive,O
families,O
with,O
known-,O
and,O
unknown,O
mutation,B-Mutation
),I-Mutation
and,O
moderate,O
risk,O
(,O
families,O
not,O
fulfilling,O
all,O
Amsterdam,O
criteria,O
),O
of,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
Cost,O
-,O
effectiveness,O
has,O
so,O
far,O
only,O
been,O
estimated,O
for,O
the,O
group,O
at,O
high,O
risk,O
.,O
 , 
The,O
aim,O
of,O
the,O
present,O
study,O
is,O
to,O
determine,O
cost,O
-,O
effectiveness,O
of,O
surveillance,O
programs,O
where,O
families,O
at,O
both,O
high,O
and,O
moderate,O
risk,O
of,O
HNPCC,O
participate,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
A,O
decision,O
analytic,O
model,O
(,O
Markov,O
model,O
),O
is,O
developed,O
to,O
assess,O
surveillance,O
programs,O
where,O
families,O
at,O
high,O
and,O
moderate,O
risk,O
of,O
HNPCC,O
are,O
offered,O
surveillance,O
from,O
age,O
25,O
and,O
age,O
45,O
,,O
respectively,O
.,O
 , 
The,O
model,O
includes,O
costs,O
for,O
all,O
families,O
referred,O
to,O
genetic,O
counseling,O
,,O
including,O
genetic,O
risk,O
assessment,O
,,O
mutation,B-Mutation
analysis,O
,,O
and,O
surveillance,O
in,O
relevant,O
families,O
with,O
or,O
without,O
known,O
mutation,B-Mutation
,,I-Mutation
plus,O
the,O
costs,O
related,O
to,O
any,O
surgical,O
treatment,O
.,O
 , 
The,O
risk,O
of,O
metachronous,O
CRC,O
is,O
also,O
modeled,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Incremental,O
costs,O
per,O
life,O
year,O
gained,O
are,O
estimated,O
to,O
be,O
euro,O
980,O
when,O
families,O
at,O
both,O
high,O
and,O
moderate,O
risk,O
of,O
HNPCC,O
undergo,O
surveillance,O
(,O
euro,O
508,O
for,O
high,O
risk,O
and,O
euro,O
1600,O
for,O
moderate,O
risk,O
),O
and,O
euro,O
1947,O
when,O
the,O
moderate,O
risk,O
group,O
is,O
evaluated,O
genetically,O
but,O
not,O
offered,O
surveillance,O
.,O
 , 
Sensitivity,O
analysis,O
showed,O
these,O
findings,O
to,O
be,O
robust,O
,,O
although,O
cost,O
-,O
effectiveness,O
can,O
be,O
improved,O
in,O
cases,O
of,O
more,O
conservative,O
referrals,O
to,O
genetic,O
counseling,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
The,O
result,O
for,O
high,O
risk,O
families,O
confirms,O
the,O
findings,O
in,O
similar,O
studies,O
.,O
 , 
Somewhat,O
surprisingly,O
,,O
cost,O
-,O
effectiveness,O
improves,O
when,O
surveillance,O
of,O
the,O
moderate,O
risk,O
groups,O
are,O
included,O
in,O
the,O
decision,O
model,O
.,O
 , 

,O
 , 
#7669575
Microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
in,O
human,O
testicular,O
germ,O
cell,O
tumours,O
.,O
 , 


,O
DNA,O
samples,O
obtained,O
from,O
29,O
testicular,O
germ,O
cell,O
tumours,O
have,O
been,O
screened,O
for,O
instability,B-DNA_Mutation
at,O
nine,O
different,O
microsatellite,B-locus
sequences,O
consisting,O
of,O
dinucleotide,O
,,O
trinucleotide,O
and,O
tetranucleotide,O
loci,O
.,O
 , 
Overall,O
,,O
in,O
tumours,O
from,O
six,O
(,O
21,O
%,O
),O
patients,O
we,O
found,O
abnormalities,O
in,O
at,O
least,O
one,O
of,O
the,O
loci,O
examined,O
.,O
 , 
Mutation,B-DNA_Mutation
was,O
most,O
frequently,O
found,O
in,O
tetranucleotide,O
and,O
trinucleotide,O
repeats,O
with,O
only,O
a,O
low,O
proportion,O
of,O
alterations,B-DNA_modification
in,O
dinucleotide,O
repeats,O
.,O
 , 
This,O
pattern,O
of,O
instability,B-DNA_Mutation
is,O
distinct,O
from,O
that,O
reported,O
in,O
colorectal,O
cancer,O
and,O
other,O
cancers,O
that,O
have,O
a,O
high,O
level,O
of,O
alterations,B-DNA_modification
in,O
dinucleotide,O
repeats,O
.,O
 , 

,O
 , 
#22545919
Polymorphisms,B-DNA_Mutation
in,O
the,O
mitochondrial,O
oxidative,O
phosphorylation,O
chain,O
genes,O
as,O
prognostic,O
markers,O
for,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
 , 
Currently,O
,,O
the,O
TNM,O
classification,O
of,O
malignant,O
tumours,O
based,O
on,O
clinicopathological,O
staging,O
remains,O
the,O
standard,O
for,O
colorectal,O
cancer,O
(,O
CRC,O
),O
prognostication,O
.,O
 , 
Recently,O
,,O
we,O
identified,O
the,O
mitochondrial,O
oxidative,O
phosphorylation,O
chain,O
as,O
a,O
consistently,O
overrepresented,O
category,O
in,O
the,O
published,O
gene,O
expression,O
profiling,O
(,O
GEP,O
),O
studies,O
on,O
CRC,O
prognosis,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
We,O
evaluated,O
associations,O
of,O
putative,O
regulatory,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNPs,I-DNA_Mutation
),I-DNA_Mutation
in,O
genes,O
from,O
the,O
oxidative,O
phosphorylation,O
chain,O
with,O
survival,O
and,O
disease,O
prognosis,O
in,O
613,O
CRC,O
patients,O
from,O
Northern,O
Germany,O
(,O
PopGen,O
cohort,O
),O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Two,O
SNPs,B-DNA_Mutation
in,O
the,O
3,B-locus
',I-locus
untranslated,I-locus
region,I-locus
of,O
UQCRB,B-Gene_protein
(,B-Gene_protein
complex,I-Gene_protein
III,I-Gene_protein
),I-Gene_protein
,,O
rs7836698,B-dbSNP
and,O
rs10504961,B-dbSNP
,,I-dbSNP
were,O
associated,O
with,O
overall,O
survival,O
(,O
HR,O
=,O
0.52,O
,,O
95,O
%,O
CI,O
0.32,O
-,O
0.85,O
and,O
HR,O
=,O
0.64,O
,,O
95,O
%,O
CI,O
0.42,O
-,O
0.99,O
,,O
for,O
TT,O
carriers,O
),O
.,O
 , 
These,O
associations,O
were,O
restricted,O
to,O
the,O
group,O
of,O
patients,O
with,O
cancer,O
located,O
in,O
the,O
colon,O
(,O
HR,O
=,O
0.42,O
,,O
95,O
%,O
CI,O
0.22,O
-,O
0.82,O
and,O
HR,O
=,O
0.46,O
,,O
95,O
%,O
CI,O
0.25,O
-,O
0.83,O
),O
.,O
 , 
Multivariate,O
analysis,O
indicated,O
that,O
both,O
markers,O
might,O
act,O
as,O
independent,O
prognostic,O
markers,O
.,O
 , 
Additionally,O
,,O
the,O
TT,O
carriers,O
were,O
~2,O
times,O
more,O
likely,O
to,O
develop,O
tumours,O
in,O
the,O
colon,O
than,O
in,O
the,O
rectum,O
.,O
 , 
Two,O
SNPs,B-DNA_Mutation
in,O
COX6B1,B-Gene_protein
(,B-Gene_protein
complex,I-Gene_protein
IV,I-Gene_protein
),I-Gene_protein
were,O
associated,O
with,O
lymph,O
node,O
metastasis,O
in,O
a,O
dominant,O
model,O
(,B-dbSNP
rs6510502,I-dbSNP
,,I-dbSNP
OR,O
=,O
1.75,O
,,O
95,O
%,O
CI,O
1.20,O
-,O
2.57,O
;,O
rs10420252,B-dbSNP
,,I-dbSNP
OR,O
=,O
1.68,O
,,O
95,O
%,O
CI,O
1.11,O
-,O
2.53,O
),O
;,O
rs6510502,B-dbSNP
was,O
associated,O
also,O
with,O
distant,O
metastasis,O
(,O
OR,O
=,O
1.67,O
,,O
95,O
%,O
CI,O
1.09,O
-,O
2.56,O
in,O
a,O
dominant,O
model,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
 , 
This,O
is,O
the,O
first,O
report,O
suggesting,O
that,O
markers,O
in,O
genes,O
from,O
the,O
mitochondrial,O
oxidative,O
chain,O
might,O
be,O
prognostic,O
factors,O
for,O
CRC,O
.,O
 , 
Additional,O
studies,O
replicating,O
the,O
presented,O
findings,O
are,O
needed,O
.,O
 , 

,O
 , 
#22615057
Phase,O
I,O
pharmacokinetic,O
and,O
pharmacodynamic,O
study,O
of,O
cetuximab,O
,,O
irinotecan,O
and,O
sorafenib,O
in,O
advanced,O
colorectal,O
cancer,O
.,O
 , 


,O
Background,O
This,O
phase,O
Ib,O
study,O
was,O
designed,O
to,O
determine,O
the,O
maximum,O
tolerated,O
doses,O
(,O
MTD,O
),O
and,O
dose,O
limiting,O
toxicities,O
(,O
DLTs,O
),O
of,O
irinotecan,O
and,O
cetuximab,O
with,O
sorafenib,O
.,O
 , 
Secondary,O
objectives,O
included,O
characterizing,O
the,O
pharmacokinetics,O
and,O
pharmacodynamics,O
and,O
evaluating,O
preliminary,O
antitumor,O
activity,O
in,O
patients,O
with,O
advanced,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
Methods,O
Patients,O
with,O
metastatic,O
,,O
pretreated,O
CRC,O
were,O
treated,O
at,O
five,O
dose,O
levels,O
.,O
 , 
Results,O
Eighteen,O
patients,O
were,O
recruited,O
with,O
median,O
age,O
56.5,O
 ,O
years,O
.,O
 , 
In,O
the,O
first,O
five,O
patients,O
treated,O
,,O
2,O
irinotecan,O
related,O
DLTs,O
were,O
observed,O
.,O
 , 
With,O
reduced,O
dose,O
intensity,O
irinotecan,O
,,O
there,O
were,O
no,O
further,O
DLTs,O
.,O
 , 
The,O
most,O
common,O
toxicities,O
were,O
diarrhea,O
,,O
nausea,O
/,O
vomiting,O
,,O
fatigue,O
,,O
anorexia,O
and,O
rash,O
.,O
 , 
DLTs,O
included,O
neutropenia,O
and,O
thrombocytopenia,O
.,O
 , 
Two,O
patients,O
had,O
partial,O
responses,O
(,O
one,O
with,O
a,O
KRAS,B-Gene_protein
mutation,B-DNA_Mutation
),I-DNA_Mutation
and,O
8,O
had,O
stable,O
disease,O
(,O
8,O
-,O
36,O
 ,O
weeks,O
),O
.,O
 , 
The,O
median,O
progression,O
free,O
survival,O
(,O
PFS,O
),O
and,O
overall,O
survival,O
(,O
OS,O
),O
were,O
2.5,O
and,O
4.7,O
 ,O
months,O
respectively,O
.,O
 , 
Pharmacokinetic,O
analyses,O
suggest,O
sorafenib,O
and,O
metabolite,O
exposure,O
correlate,O
with,O
OS,O
and,O
DLTs,O
.,O
 , 
Conclusions,O
 , 
The,O
recommended,O
phase,O
II,O
dose,O
(,O
RP2D,O
),O
is,O
irinotecan,O
100,O
 ,O
mg,O
/,O
m(2,O
),O
i.v,O
.,O
days,O
1,O
,,O
8,O
;,O
cetuximab,O
400,O
 ,O
mg,O
/,O
m(2,O
),O
i.v,O
.,O
days,O
1,O
and,O
250,O
 ,O
mg,O
/,O
m(2,O
),O
i.v,O
.,O
weekly,O
;,O
and,O
sorafenib,O
400,O
 ,O
mg,O
orally,O
twice,O
daily,O
in,O
advanced,O
,,O
pretreated,O
CRC,O
.,O
 , 
The,O
combination,O
resulted,O
in,O
a,O
modest,O
response,O
rate,O
.,O
 , 

,O
 , 
#10822375
Somatic,O
mutation,B-DNA_Mutation
of,O
hPMS2,B-Gene_protein
as,O
a,O
possible,O
cause,O
of,O
sporadic,O
human,O
colon,O
cancer,O
with,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 


,B-DNA_modification
Inactivation,I-DNA_modification
of,O
DNA,O
-,O
mismatch,O
repair,O
underlies,O
the,O
genesis,O
of,O
microsatellite,B-DNA_Mutation
unstable,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
colon,O
cancers,O
.,O
 , 
hPMS2,B-Gene_protein
is,O
one,O
of,O
several,O
genes,O
encoding,O
components,O
of,O
the,O
DNA,O
-,O
mismatch,O
repair,O
complex,O
,,O
and,O
germline,O
hPMS2,B-Gene_protein
mutations,B-DNA_Mutation
have,O
been,O
found,O
in,O
a,O
few,O
kindreds,O
with,O
hereditary,O
nonpolyposis,O
colorectal,O
carcinoma,O
(,O
HNPCC,O
),O
,,O
in,O
whom,O
hereditary,O
MSI,B-DNA_Mutation
colon,O
cancers,O
develop,O
.,O
 , 
However,O
,,O
mice,O
bearing,O
null,O
hPMS2,B-Gene_protein
genes,O
do,O
not,O
develop,O
colon,O
cancers,O
and,O
hPMS2,B-Gene_protein
mutations,B-DNA_Mutation
in,O
sporadic,O
human,O
colon,O
cancers,O
have,O
not,O
been,O
described,O
.,O
 , 
Here,O
we,O
report,O
that,O
in,O
Vaco481,O
colon,O
cancer,O
the,O
hPMS2,B-Gene_protein
gene,O
is,O
inactivated,B-DNA_Mutation
by,O
somatic,O
mutations,B-DNA_Mutation
of,O
both,O
hPMS2,B-Gene_protein
alleles,O
.,O
 , 
The,O
cell,O
line,O
derived,O
from,O
this,O
tumor,O
is,O
functionally,O
deficient,O
in,O
DNA,O
mismatch,O
repair,O
.,O
 , 
This,O
deficiency,O
can,O
be,O
biochemically,O
complemented,O
by,O
addition,O
of,O
a,O
purified,O
hMLH1,B-Gene_protein
-,B-Gene_protein
hPMS2,I-Gene_protein
(,B-Gene_protein
hMutLalpha,I-Gene_protein
),I-Gene_protein
complex,O
.,O
 , 
The,O
hPMS2,B-Gene_protein
deficient,O
Vaco481,O
cancer,O
cell,O
line,O
demonstrates,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
,,I-DNA_Mutation
an,O
elevated,O
HPRT,B-Gene_protein
gene,O
mutation,B-DNA_Mutation
rate,O
,,O
and,O
resistance,O
to,O
the,O
cytotoxicity,O
of,O
the,O
alkylator,O
MNNG,O
.,O
 , 
We,O
conclude,O
that,O
somatic,O
inactivation,B-DNA_modification
of,O
hPMS2,B-Gene_protein
can,O
play,O
a,O
role,O
in,O
development,O
of,O
sporadic,O
MSI,B-DNA_Mutation
colon,O
cancer,O
expressing,O
the,O
full,O
range,O
of,O
cancer,O
phenotypes,O
associated,O
with,O
inactivation,B-DNA_modification
of,O
the,O
mismatch,O
repair,O
system,O
.,O
 , 

,O
 , 
#9439149
Microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
in,O
Korean,O
patients,O
with,O
gastric,O
adenocarcinoma,O
.,O
 , 



,O
#,O
#,O
OBJECTIVES,O

,O
 , 
Microsatellites,O
are,O
short,O
repeated,O
oligonucleotide,O
sequences,O
found,O
throughout,O
the,O
human,O
genome,O
.,O
 , 
High,O
mutation,B-DNA_Mutation
rates,O
in,O
microsatellite,O
sequences,O
have,O
been,O
found,O
in,O
tumors,O
from,O
patients,O
with,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
carcinoma,O
and,O
some,O
sporadic,O
carcinomas,O
.,O
 , 
However,O
,,O
little,O
information,O
is,O
available,O
regarding,O
RER,O
-,O
positive,O
phenotype,O
in,O
gastric,O
carcinomas,O
,,O
particularly,O
in,O
terms,O
of,O
age,O
of,O
onset,O
and,O
other,O
pathologic,O
features,O
,,O
such,O
as,O
histologic,O
types,O
,,O
degree,O
of,O
differentiation,O
,,O
location,O
or,O
stage,O
of,O
the,O
carcinoma,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
To,O
obtain,O
a,O
better,O
understanding,O
of,O
the,O
molecular,O
mechanism,O
of,O
gastric,O
carcinogenesis,O
,,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
was,O
examined,O
at,O
6,O
gene,O
loci,O
(,B-locus
D2S71,I-locus
,,I-locus
D2S119,B-locus
,,I-locus
D3S1067,B-locus
,,I-locus
D6S87,B-locus
,,I-locus
D8S87,B-locus
,,I-locus
D11S905,B-locus
),I-locus
in,O
77,O
gastric,O
carcinomas,O
(,O
40,O
cases,O
of,O
young,O
patients,O
and,O
37,O
cases,O
of,O
elderly,O
patients,O
),O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
RER,O
-,O
positive,O
phenotypes,O
were,O
found,O
in,O
17,O
(,O
22.1,O
%,O
),O
of,O
77,O
cases,O
.,O
 , 
In,O
young,O
patients,O
(,O
under,O
40,O
years,O
),O
 , 
RER,O
-,O
positive,O
phenotype,O
was,O
found,O
in,O
9,O
(,O
22.5,O
%,O
),O
of,O
40,O
cases,O
,,O
and,O
in,O
elderly,O
patients,O
8,O
(,O
21.6,O
%,O
),O
of,O
37,O
cases,O
.,O
 , 
Moderately,O
differentiated,O
carcinoma,O
revealed,O
a,O
significantly,O
high,O
frequency,O
of,O
RER,O
-,O
positive,O
phenotype,O
than,O
well,O
differentiated,O
carcinoma(p,O
<,O
0.001,O
),O
.,O
 , 
Tumors,O
arising,O
from,O
the,O
middle,O
third,O
(,O
p,O
<,O
0.001,O
),O
or,O
lower,O
third,O
(,O
p,O
<,O
0.001,O
),O
revealed,O
higher,O
frequency,O
of,O
RER,O
-,O
positive,O
phenotype,O
than,O
the,O
tumors,O
arising,O
from,O
the,O
upper,O
third,O
of,O
the,O
stomach,O
.,O
 , 
The,O
RER,O
-,O
positive,O
phenotype,O
was,O
not,O
significantly,O
affected,O
by,O
the,O
sex,O
,,O
histologic,O
type,O
or,O
stage,O
of,O
carcinoma,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
RER,O
-,O
positive,O
phenotype,O
occurs,O
frequently,O
in,O
gastric,O
carcinoma,O
,,O
although,O
the,O
frequency,O
of,O
RER,O
-,O
positive,O
phenotype,O
between,O
young,O
and,O
elderly,O
patient,O
was,O
not,O
significantly,O
different,O
.,O
 , 
Thus,O
,,O
the,O
acquisition,O
of,O
RER,O
-,O
positive,O
phenotype,O
might,O
be,O
an,O
early,O
event,O
in,O
gastric,O
carcinogenesis,O
.,O
 , 

,O
 , 
#23497483
Mutation,B-Mutation
spectrum,O
in,O
human,O
colorectal,O
cancers,O
and,O
potential,O
functional,O
relevance,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Somatic,O
variants,B-Mutation
,,I-Mutation
which,O
occur,O
in,O
the,O
genome,O
of,O
all,O
cells,O
,,O
are,O
well,O
accepted,O
to,O
play,O
a,O
critical,O
role,O
in,O
cancer,O
development,O
,,O
as,O
their,O
accumulation,O
in,O
genes,O
could,O
affect,O
cell,O
proliferations,O
and,O
cell,O
cycle,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
In,O
order,O
to,O
understand,O
the,O
role,O
of,O
somatic,O
mutations,B-Mutation
in,O
human,O
colorectal,O
cancers,O
,,O
we,O
characterized,O
the,O
mutation,B-Mutation
spectrum,O
in,O
two,O
colorectal,O
tumor,O
tissues,O
and,O
their,O
matched,O
normal,O
tissues,O
,,O
by,O
analyzing,O
deep,O
-,O
sequenced,O
transcriptome,O
data,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
We,O
found,O
a,O
higher,O
mutation,B-Mutation
rate,O
of,O
somatic,O
variants,B-Mutation
in,O
tumor,O
tissues,O
in,O
comparison,O
with,O
normal,O
tissues,O
,,O
but,O
no,O
trend,O
was,O
observed,O
for,O
mutation,B-Mutation
properties,O
.,O
 , 
By,O
applying,O
a,O
series,O
of,O
stringent,O
filters,O
,,O
we,O
identified,O
418,O
genes,O
with,O
tumor,O
specific,O
disruptive,O
somatic,O
variants,B-Mutation
.,I-Mutation
 , 
Of,O
these,O
genes,O
,,O
three,O
genes,O
in,O
mucin,O
protein,O
family,O
(,B-Gene_protein
MUC2,I-Gene_protein
,,I-Gene_protein
MUC4,B-Gene_protein
,,I-Gene_protein
and,O
MU12,B-Gene_protein
),I-Gene_protein
are,O
of,O
particular,O
interests,O
.,O
 , 
It,O
has,O
been,O
reported,O
that,O
the,O
expression,O
of,O
mucin,O
proteins,O
was,O
correlated,O
with,O
the,O
progression,O
of,O
colorectal,O
cancer,O
therefore,O
somatic,O
variants,B-Mutation
within,O
those,O
genes,O
can,O
interrupt,O
their,O
normal,O
expression,O
and,O
thus,O
contribute,O
to,O
the,O
tumorigenesis,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Our,O
findings,O
provide,O
evidence,O
of,O
the,O
utility,O
of,O
RNA,O
-,O
Seq,O
in,O
mutation,B-Mutation
screening,O
in,O
cancer,O
studies,O
,,O
and,O
suggest,O
a,O
list,O
of,O
candidate,O
genes,O
for,O
future,O
colorectal,O
cancer,O
diagnosis,O
and,O
treatment,O
.,O
 , 

,O
 , 
#17454882
Prevention,O
of,O
colorectal,O
cancer,O
by,O
colonoscopic,O
surveillance,O
in,O
families,O
with,O
hereditary,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
OBJECTIVE,O

,O
 , 
In,O
recent,O
years,O
persons,O
at,O
risk,O
for,O
colorectal,O
cancers,O
(,O
CRC,O
),O
have,O
been,O
subjected,O
to,O
follow,O
-,O
up,O
with,O
colonoscopy,O
in,O
many,O
centres,O
.,O
 , 
There,O
is,O
,,O
however,O
,,O
limited,O
knowledge,O
about,O
the,O
effect,O
of,O
such,O
interventions,O
.,O
 , 
The,O
objective,O
of,O
this,O
study,O
was,O
to,O
report,O
the,O
results,O
of,O
our,O
observations,O
during,O
the,O
past,O
15,O
years,O
.,O
 , 


,O
#,O
#,O
MATERIAL,O
AND,O
METHODS,O

,O
Healthy,O
persons,O
were,O
included,O
in,O
the,O
study,O
according,O
to,O
their,O
family,O
history,O
of,O
CRCs,O
,,O
and,O
prospectively,O
followed,O
with,O
colonoscopies,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Altogether,O
,,O
1133,O
individuals,O
were,O
included,O
and,O
observed,O
for,O
a,O
total,O
of,O
3474,O
follow,O
-,O
up,O
years,O
from,O
the,O
first,O
to,O
the,O
last,O
colonoscopy,O
initiated,O
by,O
our,O
activity,O
.,O
 , 
Mismatch,O
repair,O
(,O
MMR,O
),O
mutations,B-Mutation
were,O
detected,O
in,O
6.5,O
%,O
of,O
cases,O
.,O
 , 
A,O
total,O
of,O
1383,O
polyps,O
were,O
removed,O
,,O
72,O
%,O
were,O
less,O
than,O
5,O
mm,O
in,O
diameter,O
.,O
 , 
Findings,O
were,O
scored,O
as,O
hyperplastic,O
polyps,O
(,O
n=887,O
),O
,,O
adenomas,O
with,O
mild,O
to,O
moderate,O
dysplasia,O
(,O
n=460,O
),O
,,O
adenomas,O
with,O
high,O
-,O
grade,O
dysplasia,O
(,O
n=30,O
),O
and,O
cancers,O
(,O
n=6,O
),O
.,O
 , 
Two,O
cancers,O
were,O
observed,O
after,O
the,O
first,O
colonoscopy,O
,,O
compared,O
with,O
2.6,O
expected,O
by,O
chance,O
and,O
more,O
than,O
20,O
expected,O
under,O
the,O
hypothesis,O
of,O
predominant,O
inherited,O
diseases,O
in,O
the,O
families,O
.,O
 , 
Observed,O
annual,O
incidence,O
rates,O
for,O
adenomas,O
were,O
similar,O
in,O
all,O
groups,O
,,O
while,O
in,O
the,O
mutation,B-Mutation
carriers,O
there,O
was,O
a,O
higher,O
frequency,O
of,O
progression,O
to,O
severe,O
dysplasia,O
or,O
infiltrating,O
cancer,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
 , 
A,O
simple,O
explanation,O
for,O
the,O
combined,O
findings,O
may,O
be,O
that,O
all,O
selected,O
families,O
had,O
a,O
similar,O
tendency,O
to,O
produce,O
adenomas,O
,,O
while,O
mutation,B-Mutation
carriers,O
more,O
frequently,O
demonstrated,O
dysplasia,O
/,O
cancer,O
in,O
the,O
adenomas,O
.,O
 , 
The,O
low,O
annual,O
incidence,O
rates,O
for,O
CRC,O
indicated,O
that,O
the,O
removal,O
of,O
adenomas,O
may,O
have,O
prevented,O
cancers,O
.,O
 , 

,O
 , 
#26416897
Variations,B-DNA_Mutation
in,O
genes,O
regulating,O
tumor,O
-,O
associated,O
macrophages,O
(,O
TAMs,O
),O
to,O
predict,O
outcomes,O
of,O
bevacizumab,O
-,O
based,O
treatment,O
in,O
patients,O
with,O
metastatic,O
colorectal,O
cancer,O
:,O
results,O
from,O
TRIBE,O
and,O
FIRE3,O
trials,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Tumor,O
-,O
associated,O
macrophages,O
(,O
TAMs,O
),O
with,O
the,O
M2,O
-,O
like,O
phenotype,O
are,O
regulated,O
by,O
mainly,O
NF,O
-,O
kB,O
pathway,O
including,O
TBK1,B-Gene_protein
,,I-Gene_protein
which,O
can,O
influence,O
tumor,O
progression,O
by,O
secretion,O
of,O
proangiogenic,O
factors,O
such,O
as,O
vascular,O
endothelial,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
.,I-Gene_protein
 , 
The,O
CCL2,B-Gene_protein
/,B-Gene_protein
CCR2,I-Gene_protein
axis,O
,,O
histidine,B-Gene_protein
-,I-Gene_protein
rich,I-Gene_protein
glycoprotein,I-Gene_protein
(,B-Gene_protein
HRG,I-Gene_protein
),I-Gene_protein
,,O
and,O
placenta,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
(,B-Gene_protein
PIGF,I-Gene_protein
),I-Gene_protein
play,O
a,O
critical,O
role,O
in,O
the,O
polarization,O
of,O
M1,O
/,O
M2,O
phenotypes,O
and,O
the,O
recruitment,O
of,O
TAMs,O
to,O
tumor,O
microenvironment,O
.,O
 , 
We,O
therefore,O
hypothesized,O
that,O
variations,B-DNA_Mutation
in,O
genes,O
involved,O
in,O
regulating,O
TAMs,O
may,O
predict,O
clinical,O
outcomes,O
of,O
bevacizumab,O
treatment,O
in,O
patients,O
with,O
metastatic,O
colorectal,O
cancer,O
(,O
mCRC,O
),O
.,O
 , 


,O
#,O
#,O
PATIENTS,O
AND,O
METHODS,O

,O
 , 
We,O
analyzed,O
genomic,O
DNA,O
extracted,O
from,O
samples,O
of,O
patients,O
receiving,O
bevacizumab,O
plus,O
FOLFIRI,O
as,O
a,O
first,O
-,O
line,O
treatment,O
using,O
PCR,O
-,O
based,O
direct,O
sequencing,O
.,O
 , 
Twelve,O
functional,O
single,B-DNA_Mutation
-,I-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
in,O
eight,O
genes,O
(,B-Gene_protein
CCL2,I-Gene_protein
,,I-Gene_protein
CCR2,B-Gene_protein
,,I-Gene_protein
HRG,B-Gene_protein
,,I-Gene_protein
PIGF,B-Gene_protein
,,I-Gene_protein
NFKB1,B-Gene_protein
,,I-Gene_protein
TBK1,B-Gene_protein
,,I-Gene_protein
CCL18,B-Gene_protein
,,I-Gene_protein
and,O
IRF3,B-Gene_protein
),I-Gene_protein
were,O
tested,O
for,O
associations,O
with,O
clinical,O
outcomes,O
in,O
a,O
discovery,O
cohort,O
of,O
228,O
participants,O
in,O
TRIBE,O
trial,O
(,O
NCT00719797,O
),O
,,O
then,O
validated,O
in,O
248,O
KRAS,B-Gene_protein
exon2,B-locus
(,B-Gene_protein
KRAS,I-Gene_protein
),I-Gene_protein
wild,O
-,O
type,O
participants,O
in,O
FIRE3,O
trial,O
(,O
NCT00433927,O
),O
.,O
 , 
FIRE3,O
-,O
cetuximab,O
cohort,O
served,O
as,O
a,O
negative,O
control,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,B-Gene_protein
TBK1,I-Gene_protein
rs7486100,B-dbSNP
was,O
significantly,O
associated,O
with,O
overall,O
survival,O
in,O
95,O
KRAS,B-Gene_protein
wild,O
-,O
type,O
patients,O
of,O
TRIBE,O
cohort,O
in,O
univariate,O
analysis,O
and,O
had,O
a,O
strong,O
trend,O
in,O
multivariable,O
analysis,O
;,O
furthermore,O
,,O
the,O
association,O
of,O
the,O
T,O
allele,O
was,O
observed,O
for,O
progression,O
-,O
free,O
survival,O
(,O
PFS,O
),O
in,O
both,O
univariate,O
and,O
multivariable,O
analyses,O
in,O
FIRE3,O
-,O
bevacizumab,O
but,O
not,O
cetuximab,O
cohort,O
.,O
 , 
CCL2,B-Gene_protein
rs4586,B-dbSNP
,,I-dbSNP
CCL18,B-Gene_protein
rs14304,B-dbSNP
,,I-dbSNP
and,O
IRF3,B-Gene_protein
rs2304205,B-dbSNP
had,O
univariate,O
and,O
multivariable,O
correlations,O
with,O
PFS,O
in,O
KRAS,B-Gene_protein
mutant,B-DNA_Mutation
patients,O
of,O
the,O
TRIBE,O
cohort,O
,,O
whereas,O
they,O
had,O
no,O
correlations,O
in,O
KRAS,B-Gene_protein
wild,O
-,O
type,O
patients,O
of,O
the,O
TRIBE,O
cohort,O
.,O
 , 
No,O
association,O
was,O
seen,O
in,O
control,O
cohort,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Our,O
study,O
demonstrates,O
for,O
the,O
first,O
time,O
that,O
variations,B-DNA_Mutation
in,O
genes,O
regulating,O
TAMs,O
-,O
related,O
functions,O
are,O
significantly,O
associated,O
with,O
clinical,O
outcomes,O
in,O
mCRC,O
patients,O
treated,O
with,O
bevacizumab,O
-,O
containing,O
chemotherapy,O
.,O
 , 
These,O
results,O
also,O
suggest,O
that,O
some,O
TAM,O
-,O
related,O
gene,O
variations,B-DNA_Mutation
may,O
predict,O
outcomes,O
of,O
bevacizumab,O
treatment,O
in,O
KRAS,B-Gene_protein
status,O
-,O
dependent,O
manner,O
.,O
 , 

,O
 , 
#18268114
Large,O
-,O
scale,O
evaluation,O
of,O
genetic,O
variants,B-DNA_Mutation
in,O
candidate,O
genes,O
for,O
colorectal,O
cancer,O
risk,O
in,O
the,O
Nurses,O
',O
Health,O
Study,O
and,O
the,O
Health,O
Professionals,O
',O
Follow,O
-,O
up,O
Study,O
.,O
 , 


,O
Advances,O
in,O
genomics,O
offer,O
new,O
strategies,O
for,O
assessing,O
the,O
association,O
of,O
common,O
genetic,O
variations,B-DNA_Mutation
at,O
multiple,O
loci,O
and,O
risk,O
of,O
many,O
diseases,O
,,O
including,O
colorectal,O
cancer,O
.,O
 , 
Low,O
-,O
penetrance,O
alleles,O
of,O
genes,O
in,O
many,O
biological,O
pathways,O
,,O
such,O
as,O
DNA,O
repair,O
,,O
metabolism,O
,,O
inflammation,O
,,O
cell,O
cycle,O
,,O
apoptosis,O
,,O
and,O
Wnt,O
signaling,O
,,O
may,O
influence,O
the,O
risk,O
of,O
nonfamilial,O
colorectal,O
cancer,O
.,O
 , 
To,O
identify,O
susceptibility,O
genes,O
for,O
colorectal,O
cancer,O
,,O
we,O
designed,O
a,O
large,O
-,O
scale,O
case,O
-,O
control,O
association,O
study,O
nested,O
within,O
the,O
Nurses,O
',O
Health,O
Study,O
(,O
190,O
cases,O
and,O
190,O
controls,O
),O
and,O
the,O
Health,O
Professionals,O
',O
Follow,O
-,O
up,O
Study,O
(,O
168,O
cases,O
and,O
168,O
controls,O
),O
.,O
 , 
We,O
used,O
a,O
custom,O
GoldenGate,O
(,O
Illumina,O
),O
oligonucleotide,O
pool,O
assay,O
including,O
1,536,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNP,I-DNA_Mutation
),I-DNA_Mutation
selected,O
in,O
candidate,O
genes,O
from,O
cancer,O
-,O
related,O
pathways,O
,,O
which,O
have,O
been,O
sequenced,O
and,O
genotyped,O
in,O
the,O
SNP500Cancer,B-DNA_Mutation
project,O
;,O
1,412,O
of,O
the,O
1,536,O
(,O
92,O
%,O
),O
of,O
the,O
SNPs,B-DNA_Mutation
were,O
genotyped,O
successfully,O
within,O
388,O
genes,O
.,O
 , 
SNPs,B-DNA_Mutation
in,O
high,O
linkage,O
disequilibrium,O
(,O
r(2,O
),O
>,O
/=,O
0.90,O
),O
with,O
another,O
assayed,O
SNP,B-DNA_Mutation
were,O
excluded,O
from,O
further,O
analyses,O
.,O
 , 
As,O
expected,O
by,O
chance,O
(,O
and,O
not,O
significant,O
compared,O
with,O
a,O
corrected,O
Bonferroni,O
P,O
=,O
0.00004,O
),O
,,O
in,O
the,O
additive,O
model,O
,,O
11,O
of,O
1,253,O
(,O
0.9,O
%,O
),O
SNPs,B-DNA_Mutation
had,O
a,O
P(trend,O
),O
<,O
0.01,O
and,O
38,O
of,O
1,253,O
(,O
3.0,O
%,O
),O
SNPs,B-DNA_Mutation
had,O
a,O
P(trend,O
),O
 , 
>,O
/=,O
0.01,O
and,O
P(trend,O
),O
<,O
0.05,O
.,O
 , 
Of,O
note,O
,,O
the,O
MGMT,B-Gene_protein
Lys(178)Arg,B-Protein_Mutation
(,B-dbSNP
rs2308237,I-dbSNP
),I-dbSNP
SNP,B-DNA_Mutation
,,I-DNA_Mutation
in,O
linkage,O
disequilibrium,O
with,O
the,O
previously,O
reported,O
MGMT,B-Gene_protein
Ile(143)Val,B-Protein_Mutation
SNP,B-DNA_Mutation
,,I-DNA_Mutation
had,O
an,O
inverse,O
association,O
with,O
colorectal,O
cancer,O
risk,O
(,B-Gene_protein
MGMT,I-Gene_protein
Lys(178)Arg,B-Protein_Mutation
:,I-Protein_Mutation
odds,O
ratio,O
,,O
0.52,O
;,O
95,O
%,O
confidence,O
interval,O
,,O
0.35,O
-,O
0.78,O
;,O
unadjusted,O
P(trend,O
),O
 , 
=,O
0.0003,O
for,O
the,O
additive,O
model,O
;,O
gene,O
-,O
based,O
test,O
global,O
P,O
=,O
0.00003,O
),O
.,O
 , 
The,O
SNP500Cancer,B-DNA_Mutation
database,O
and,O
the,O
Illumina,O
GoldenGate,O
Assay,O
allowed,O
us,O
to,O
test,O
a,O
larger,O
number,O
of,O
SNPs,B-DNA_Mutation
than,O
previously,O
possible,O
.,O
 , 
We,O
identified,O
several,O
SNPs,B-DNA_Mutation
worthy,O
of,O
investigation,O
in,O
larger,O
studies,O
.,O

,O
 , 
#19276868
Identification,O
and,O
characterization,O
of,O
a,O
novel,O
anticancer,O
agent,O
with,O
selectivity,O
against,O
deleted,B-Gene_protein
in,I-Gene_protein
pancreatic,I-Gene_protein
cancer,I-Gene_protein
locus,I-Gene_protein
4,I-Gene_protein
(,B-Gene_protein
DPC4)-deficient,I-Gene_protein
pancreatic,O
and,O
colon,O
cancer,O
cells,O
.,O
 , 



,O
#,O
#,O
OBJECTIVES,O

,O
 , 
The,O
deleted,B-Gene_protein
in,I-Gene_protein
pancreatic,I-Gene_protein
cancer,I-Gene_protein
locus,I-Gene_protein
4,I-Gene_protein
(,B-Gene_protein
DPC4)/SMAD4,B-Gene_protein
tumor,O
suppressor,O
gene,O
is,O
frequently,O
inactivated,B-DNA_modification
in,O
pancreatic,O
(,O
approximately,O
55,O
%,O
),O
and,O
colorectal,O
cancers,O
(,O
approximately,O
30,O
%,O
),O
.,O
 , 
Like,O
other,O
tumor,O
suppressor,O
genes,O
,,O
the,O
loss,B-DNA_Mutation
-,I-DNA_Mutation
of,I-DNA_Mutation
-,I-DNA_Mutation
function,I-DNA_Mutation
mutations,I-DNA_Mutation
found,O
in,O
the,O
DPC4,B-Gene_protein
gene,O
are,O
specific,O
to,O
cancer,O
cells,O
.,O
 , 
This,O
provides,O
an,O
attractive,O
and,O
unique,O
opportunity,O
for,O
therapeutic,O
intervention,O
.,O
 , 
The,O
aim,O
of,O
this,O
study,O
was,O
to,O
identify,O
and,O
characterize,O
small,O
molecules,O
that,O
selectively,O
kill,O
DPC4,B-Gene_protein
-,I-Gene_protein
deficient,O
cancer,O
cells,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
An,O
unbiased,O
chemical,O
screening,O
using,O
isogenic,O
cell,O
lines,O
that,O
only,O
differ,O
in,O
the,O
DPC4,B-Gene_protein
gene,O
was,O
carried,O
out,O
to,O
identify,O
positive,O
hits,O
.,O
 , 
Selected,O
hits,O
were,O
further,O
verified,O
in,O
additional,O
isogenic,O
cell,O
lines,O
and,O
characterized,O
in,O
cancer,O
cells,O
using,O
several,O
different,O
cellular,O
assays,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
A,O
lead,O
molecule,O
,,O
UA62784,O
,,O
was,O
identified,O
to,O
be,O
selectively,O
cytotoxic,O
against,O
cancer,O
cells,O
with,O
deficient,O
DPC4,B-Gene_protein
.,I-Gene_protein
 , 
UA62784,O
preferentially,O
induces,O
cell,O
cycle,O
arrest,O
and,O
apoptosis,O
in,O
cells,O
with,O
deficient,O
DPC4,B-Gene_protein
.,I-Gene_protein
 , 
It,O
also,O
selectively,O
reduces,O
the,O
clonogenicity,O
of,O
DPC4,B-Gene_protein
-,I-Gene_protein
deficient,O
cells,O
on,O
soft,O
agar,O
when,O
compared,O
with,O
cells,O
with,O
wild,O
type,O
DPC4,B-Gene_protein
.,I-Gene_protein
 , 
We,O
further,O
demonstrate,O
that,O
UA62784,O
induces,O
CDC2,B-Gene_protein
kinase,O
activity,O
preferentially,O
in,O
DPC4,B-Gene_protein
-,I-Gene_protein
negative,O
cells,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
UA62784,O
is,O
a,O
small,O
molecule,O
that,O
selectively,O
kills,O
DPC4,B-Gene_protein
-,I-Gene_protein
deficient,O
cancer,O
cells,O
.,O
 , 
Its,O
potent,O
activity,O
and,O
relatively,O
low,O
molecular,O
weight,O
make,O
it,O
a,O
decent,O
candidate,O
for,O
further,O
lead,O
optimization,O
.,O
 , 

,O
 , 
#8495305
Expression,O
of,O
p53,B-Gene_protein
in,O
colorectal,O
cancer,O
and,O
dysplasia,O
complicating,O
ulcerative,O
colitis,O
.,O
 , 


,O
An,O
immunohistochemical,O
method,O
using,O
Pab1801,O
,,O
a,O
monoclonal,O
antibody,O
specific,O
to,O
the,O
human,O
p53,B-Gene_protein
protein,O
,,O
was,O
applied,O
to,O
detect,O
p53,B-Gene_protein
expression,O
in,O
colorectal,O
cancer,O
and,O
dysplasia,O
complicating,O
ulcerative,O
colitis,O
.,O
 , 
Of,O
20,O
tissue,O
samples,O
with,O
dysplasia,O
,,O
six,O
showed,O
positive,O
immunoreactivity,O
.,O
 , 
Archival,O
paraffin,O
-,O
embedded,O
tissue,O
blocks,O
from,O
21,O
colitic,O
cancers,O
were,O
analysed,O
;,O
11,O
showed,O
positive,O
immunoreactivity,O
,,O
compared,O
with,O
ten,O
of,O
21,O
samples,O
from,O
matched,O
sporadic,O
colorectal,O
cancers,O
(,O
P,O
not,O
significant,O
),O
.,O
 , 
Previous,O
data,O
suggesting,O
that,O
colorectal,O
carcinoma,O
complicating,O
ulcerative,O
colitis,O
has,O
a,O
reduced,O
frequency,O
of,O
c,B-Gene_protein
-,I-Gene_protein
Ki,I-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutation,B-Mutation
compared,O
with,O
sporadic,O
cancer,O
have,O
led,O
to,O
the,O
hypothesis,O
that,O
different,O
genetic,O
lesions,O
underlie,O
colitic,O
and,O
sporadic,O
colorectal,O
carcinoma,O
.,O
 , 
The,O
present,O
results,O
suggest,O
that,O
this,O
is,O
not,O
the,O
case,O
with,O
regard,O
to,O
p53,B-Gene_protein
gene,O
alterations,B-DNA_Mutation
.,I-DNA_Mutation

,O
 , 
#19706845
A,O
novel,O
polymorphism,B-DNA_Mutation
rs1329149,B-dbSNP
of,O
CYP2E1,B-Gene_protein
and,O
a,O
known,O
polymorphism,B-DNA_Mutation
rs671,B-dbSNP
of,O
ALDH2,B-Gene_protein
of,O
alcohol,O
metabolizing,O
enzymes,O
are,O
associated,O
with,O
colorectal,O
cancer,O
in,O
a,O
southwestern,O
Chinese,O
population,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
To,O
screen,O
for,O
tagging,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,O
tagSNP,B-DNA_Mutation
),I-DNA_Mutation
in,O
the,O
major,O
alcohol,O
metabolizing,O
enzymes,O
:,O
ADH1B,B-Gene_protein
,,I-Gene_protein
ALDH2,B-Gene_protein
,,I-Gene_protein
and,O
CYP2E1,B-Gene_protein
,,I-Gene_protein
and,O
to,O
evaluate,O
the,O
association,O
between,O
these,O
tagSNPs,B-DNA_Mutation
and,O
colorectal,O
cancer,O
(,O
CRC,O
),O
in,O
a,O
southwestern,O
Chinese,O
population,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
A,O
hospital,O
-,O
based,O
case,O
-,O
control,O
study,O
of,O
440,O
CRC,O
patients,O
and,O
800,O
cancer,O
-,O
free,O
controls,O
was,O
conducted,O
.,O
 , 
Personal,O
information,O
was,O
collected,O
by,O
a,O
Semi,O
-,O
Quantitative,O
Food,O
Frequency,O
Questionnaire,O
.,O
 , 
The,O
tagSNPs,B-DNA_Mutation
were,O
screened,O
in,O
the,O
HapMap,O
with,O
Haploview,O
by,O
setting,O
the,O
minor,O
allele,O
frequency,O
at,O
0.03,O
with,O
the,O
highest,O
score,O
of,O
r(2,O
),O
form,O
each,O
block,O
.,O
 , 
Genotypes,O
were,O
identified,O
by,O
using,O
the,O
SNPLex,B-DNA_Mutation
System,O
.,O
 , 
Both,O
crude,O
and,O
adjusted,O
odds,O
ratio,O
(,O
OR,O
),O
and,O
95,O
%,O
confidence,O
interval,O
(,O
CI,O
),O
were,O
used,O
to,O
evaluate,O
the,O
risk,O
of,O
each,O
SNP,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
#,O
#,O
RESULTS,O

,O
Sixteen,O
tagSNPs,B-DNA_Mutation
were,O
selected,O
,,O
and,O
13,O
were,O
successfully,O
genotyped,O
.,O
 , 
A,O
novel,O
CYP2E1,B-Gene_protein
locus,O
rs1329149,B-dbSNP
and,O
a,O
known,O
ALDH2,B-Gene_protein
locus,O
rs671,B-dbSNP
were,O
found,O
to,O
be,O
significantly,O
associated,O
with,O
CRC,O
risk,O
.,O
 , 
The,O
adjusted,O
OR,O
was,O
1.86,O
(,O
95,O
%,O
CI,O
,,O
1.12,O
-,O
3.09,O
),O
for,O
the,O
rs671,B-dbSNP
A,O
/,O
A,O
genotype,O
and,O
4.04,O
for,O
the,O
rs1329149,B-dbSNP
T,O
/,O
T,O
genotype,O
(,O
95,O
%,O
CI,O
,,O
2.44,O
-,O
6.70,O
),O
,,O
compared,O
with,O
their,O
common,O
homozygous,O
genotypes,O
.,O
 , 
Interaction,O
was,O
found,O
between,O
alcohol,O
consumption,O
and,O
gene,O
polymorphisms,B-DNA_Mutation
on,O
CRC,O
,,O
the,O
adjusted,O
OR,O
was,O
7.17,O
(,O
95,O
%,O
CI,O
,,O
2.01,O
-,O
25.53,O
),O
for,O
drinking,O
habits,O
combined,O
with,O
rs671,B-dbSNP
A,O
/,O
A,O
or,O
rs1329149,B-dbSNP
T,O
/,O
T,O
genotype,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
The,O
results,O
of,O
this,O
study,O
suggest,O
that,O
rs671,B-dbSNP
A,O
/,O
A,O
and,O
the,O
first,O
reported,O
locus,O
rs1329149,B-dbSNP
T,O
/,O
T,O
genotypes,O
increase,O
the,O
susceptibility,O
to,O
CRC,O
,,O
and,O
gene,O
-,O
environmental,O
interaction,O
between,O
the,O
two,O
loci,O
and,O
alcohol,O
use,O
existed,O
for,O
CRC,O
in,O
Southwestern,O
Chinese,O
.,O
 , 
Larger,O
studies,O
are,O
warranted,O
to,O
verify,O
our,O
findings,O
.,O
 , 

,O
 , 
#18554281
Colorectal,O
cancer,O
in,O
HNPCC,O
:,O
cumulative,O
lifetime,O
incidence,O
,,O
survival,O
and,O
tumour,O
distribution,O
.,O
 , 
A,O
report,O
of,O
121,O
families,O
with,O
proven,O
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
Hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
is,O
an,O
autosomal,O
dominant,O
condition,O
caused,O
by,O
inactivating,O
mutations,B-DNA_Mutation
of,O
DNA,O
mismatch,O
repair,O
(,O
MMR,O
),O
genes,O
.,O
 , 
An,O
accurate,O
estimation,O
of,O
colorectal,O
cancer,O
risk,O
for,O
mutation,B-DNA_Mutation
carriers,O
is,O
essential,O
for,O
counselling,O
and,O
rationalizing,O
screening,O
programmes,O
.,O
 , 
Families,O
were,O
referred,O
on,O
the,O
basis,O
of,O
clinical,O
criteria,O
.,O
 , 
Tumour,O
immunohistochemistry,O
and,O
microsatellite,O
testing,O
were,O
performed,O
.,O
 , 
Appropriate,O
patients,O
underwent,O
sequencing,O
of,O
all,O
relevant,O
exons,O
of,O
the,O
MMR,O
genes,O
.,O
 , 
Proven,O
and,O
obligate,O
mutation,B-DNA_Mutation
carriers,O
and,O
first,O
-,O
degree,O
relatives,O
(,O
FDRs,O
),O
with,O
an,O
HNPCC,O
spectrum,O
cancer,O
were,O
considered,O
mutation,B-DNA_Mutation
carriers,O
,,O
as,O
were,O
a,O
proportion,O
of,O
untested,O
,,O
unaffected,O
FDRs,O
based,O
on,O
the,O
proportion,O
of,O
unaffected,O
relatives,O
testing,O
positive,O
in,O
each,O
age,O
group,O
.,O
 , 
The,O
cumulative,O
lifetime,O
risk,O
was,O
calculated,O
by,O
Kaplan,O
-,O
Meier,O
analysis,O
.,O
 , 
Three,O
hundred,O
and,O
forty,O
-,O
one,O
colorectal,O
cancers,O
in,O
839,O
proven,O
,,O
obligate,O
,,O
or,O
assumed,O
mutation,B-DNA_Mutation
carriers,O
were,O
analysed,O
.,O
 , 
The,O
cumulative,O
risk,O
to,O
age,O
70,O
years,O
for,O
all,O
mutation,B-DNA_Mutation
carriers,O
combined,O
was,O
50.4,O
%,O
(,O
95,O
%,O
CI,O
47.8,O
-,O
52.9,O
),O
.,O
 , 
The,O
cumulative,O
risk,O
in,O
males,O
was,O
54.3,O
%,O
(,O
95,O
%,O
CI,O
50.7,O
-,O
57.8,O
),O
,,O
which,O
was,O
significantly,O
higher,O
than,O
in,O
females,O
(,O
log,O
rank,O
p,O
=,O
0.02,O
),O
who,O
had,O
a,O
risk,O
of,O
46.3,O
%,O
(,O
95,O
%,O
CI,O
42.8,O
-,O
49.9,O
),O
.,O
 , 
These,O
penetrance,O
estimates,O
from,O
HNPCC,O
families,O
attending,O
high,O
-,O
risk,O
clinics,O
have,O
been,O
corrected,O
for,O
ascertainment,O
bias,O
and,O
are,O
appropriate,O
risks,O
for,O
those,O
referred,O
to,O
a,O
high,O
-,O
risk,O
clinic,O
.,O
 , 
Current,O
colonoscopic,O
screening,O
guidelines,O
are,O
appropriate,O
.,O
 , 

,O
 , 
#21128281
Identification,O
of,O
candidate,O
predisposing,O
copy,B-DNA_Mutation
number,I-DNA_Mutation
variants,I-DNA_Mutation
in,O
familial,O
and,O
early,O
-,O
onset,O
colorectal,O
cancer,O
patients,O
.,O
 , 


,O
In,O
the,O
majority,O
of,O
colorectal,O
cancers,O
(,O
CRCs,O
),O
under,O
clinical,O
suspicion,O
for,O
a,O
hereditary,O
cause,O
,,O
the,O
disease,O
-,O
causing,O
genetic,O
factors,O
are,O
still,O
to,O
be,O
discovered,O
.,O
 , 
To,O
identify,O
such,O
genetic,O
factors,O
we,O
stringently,O
selected,O
a,O
discovery,O
cohort,O
of,O
41,O
CRC,O
index,O
patients,O
with,O
microsatellite,B-DNA_Mutation
-,I-DNA_Mutation
stable,I-DNA_Mutation
tumors,O
.,O
 , 
All,O
patients,O
were,O
below,O
40,O
years,O
of,O
age,O
at,O
diagnosis,O
and/or,O
exhibited,O
an,O
overt,O
family,O
history,O
.,O
 , 
We,O
employed,O
genome,O
-,O
wide,O
copy,O
number,O
profiling,O
using,O
high,O
-,O
resolution,O
SNP,B-DNA_Mutation
arrays,O
on,O
germline,O
DNA,O
,,O
which,O
resulted,O
in,O
the,O
identification,O
of,O
novel,O
copy,B-DNA_Mutation
number,I-DNA_Mutation
variants,I-DNA_Mutation
(,B-DNA_Mutation
CNVs,I-DNA_Mutation
),I-DNA_Mutation
in,O
six,O
patients,O
(,O
15,O
%,O
),O
encompassing,O
,,O
among,O
others,O
,,O
the,O
cadherin,O
gene,O
CDH18,B-Gene_protein
,,I-Gene_protein
the,O
bone,O
morphogenetic,O
protein,O
antagonist,O
family,O
gene,O
GREM1,B-Gene_protein
,,I-Gene_protein
and,O
the,O
breakpoint,O
cluster,O
region,O
gene,O
BCR,B-Gene_protein
.,I-Gene_protein
 , 
In,O
addition,O
,,O
two,O
genomic,O
deletions,B-DNA_Mutation
were,O
encountered,O
encompassing,O
two,O
microRNA,O
genes,O
,,O
hsa,B-RNA
-,I-RNA
mir-491,I-RNA
/,I-RNA
KIAA1797,I-RNA
and,O
hsa,B-RNA
-,I-RNA
mir-646,I-RNA
/,I-RNA
AK309218,I-RNA
.,I-RNA
 , 
None,O
of,O
these,O
CNVs,B-DNA_Mutation
has,O
previously,O
been,O
reported,O
in,O
relation,O
to,O
CRC,O
predisposition,O
in,O
humans,O
,,O
nor,O
were,O
they,O
encountered,O
in,O
large,O
control,O
cohorts,O
(,O
>,O
1,600,O
unaffected,O
individuals,O
),O
.,O
 , 
Since,O
several,O
of,O
these,O
newly,O
identified,O
candidate,O
genes,O
may,O
be,O
functionally,O
linked,O
to,O
CRC,O
development,O
,,O
our,O
results,O
illustrate,O
the,O
potential,O
of,O
this,O
approach,O
for,O
the,O
identification,O
of,O
novel,O
candidate,O
genes,O
involved,O
in,O
CRC,O
predisposition,O
.,O
 , 

,O
 , 
#9476377
[,O
Familial,O
adenomatous,B-Gene_protein
polyposis,I-Gene_protein
coli,I-Gene_protein
in,O
the,O
Czech,O
population,O
.,O
 , 
I.,O
Detection,O
of,O
an,O
additional,O
3,O
mutations,B-DNA_Mutation
out,O
of,O
a,O
total,O
of,O
7,O
in,O
exon,B-locus
15,I-locus
of,O
the,O
APC,B-Gene_protein
gene,O
],O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
is,O
an,O
autosomal,O
dominant,O
inherited,O
disease,O
characterized,O
by,O
multiple,O
adenomatous,O
polyps,O
in,O
the,O
colon,O
which,O
progress,O
to,O
carcinoma,O
.,O
 , 
FAP,O
is,O
caused,O
by,O
germ,O
-,O
line,O
mutation,B-Mutation
of,O
the,O
tumor,O
-,O
suppressor,O
adenomatous,B-Gene_protein
polyposis,I-Gene_protein
coli,I-Gene_protein
(,B-Gene_protein
APC,I-Gene_protein
),I-Gene_protein
gene,O
,,O
the,O
structure,O
and,O
coding,O
sequence,O
of,O
which,O
have,O
been,O
known,O
from,O
1991,O
.,O
 , 
The,O
diagnosis,O
of,O
FAP,O
has,O
classically,O
been,O
based,O
on,O
the,O
detection,O
of,O
multiple,O
colorectal,O
adenomas,O
,,O
often,O
after,O
carcinoma,O
development,O
.,O
 , 
Presymptomatic,O
genetic,O
testing,O
for,O
the,O
presence,O
of,O
an,O
allele,O
carrying,O
the,O
FAP,O
mutation,B-Mutation
is,O
now,O
possible,O
using,O
a,O
variety,O
of,O
techniques,O
.,O
 , 


,O
#,O
#,O
METHODS,O
AND,O
RESULTS,O

,O
 , 
The,O
present,O
paper,O
is,O
the,O
first,O
part,O
of,O
an,O
analysis,O
of,O
37,O
different,O
Czech,O
families,O
with,O
83,O
members,O
affected,O
by,O
FAP,O
.,O
 , 
Our,O
goal,O
is,O
to,O
identify,O
the,O
mutation,B-Mutation
characteristic,O
for,O
each,O
family,O
for,O
early,O
diagnosis,O
of,O
FAP,O
.,O
 , 
We,O
screened,O
clinically,O
manifest,O
representatives,O
of,O
nine,O
families,O
for,O
mutations,B-DNA_Mutation
in,O
exon,B-locus
15,I-locus
of,O
the,O
APC,B-Gene_protein
gene,O
.,O
 , 
First,O
,,O
we,O
searched,O
for,O
the,O
mutation,B-Mutation
hot,O
spots,O
(,B-locus
codons,I-locus
1061,I-locus
and,O
1309,B-locus
,,I-locus
respectively,O
),O
and,O
later,O
for,O
the,O
entire,O
exon,B-locus
15,I-locus
.,I-locus
 , 
Denatured,O
gradient,O
gel,O
electrophoresis,O
(,O
DGGE,O
),O
of,O
amplified,O
regions,O
ov,O
exon,B-locus
15,I-locus
has,O
been,O
used,O
to,O
identify,O
DNA,O
sequence,O
variations,B-DNA_Mutation
followed,O
by,O
sequencing,O
verification,O
.,O
 , 
In,O
seven,O
patients,O
,,O
seven,O
different,O
mutations,B-DNA_Mutation
in,O
exon,B-locus
15,I-locus
of,O
APC,B-Gene_protein
gene,O
,,O
four,O
deletion,B-DNA_Mutation
mutants,I-DNA_Mutation
(,O
5,O
-,O
base,O
deletions,B-DNA_Mutation
in,O
codons,B-locus
1061,I-locus
and,O
1309,B-locus
,,I-locus
1,O
-,O
base,O
deletion,B-DNA_Mutation
in,O
codons,B-locus
759,I-locus
and,O
7,O
-,O
base,O
deletion,B-DNA_Mutation
combined,O
with,O
a,O
2,O
-,O
base,O
insertion,B-DNA_Mutation
in,O
codon,B-locus
712,I-locus
),I-locus
,,O
one,O
insertion,B-DNA_Mutation
mutation,I-DNA_Mutation
(,O
1,O
-,O
base,O
/,O
A,O
/,B-DNA_Mutation
insertion,I-DNA_Mutation
in,O
codon,B-locus
1554,I-locus
),I-locus
and,O
two,O
point,B-DNA_Mutation
mutations,I-DNA_Mutation
(,B-DNA_Mutation
C,I-DNA_Mutation
to,I-DNA_Mutation
T,I-DNA_Mutation
and,O
C,B-DNA_Mutation
to,I-DNA_Mutation
A,I-DNA_Mutation
substitutions,B-DNA_Mutation
in,O
codons,B-locus
737,I-locus
and,O
935,B-locus
,,I-locus
respectively,O
,,O
in,O
both,O
cases,O
leading,O
to,O
formation,O
of,O
stop,O
codons,O
),O
have,O
been,O
found,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
From,O
seven,O
different,O
mutations,B-DNA_Mutation
found,O
,,O
4,O
mutations,B-DNA_Mutation
have,O
been,O
previously,O
described,O
(,B-DNA_Mutation
mutations,I-DNA_Mutation
in,O
codons,B-locus
935,I-locus
,,I-locus
1061,B-locus
,,I-locus
1309,B-locus
and,O
1554,B-locus
),I-locus
,,O
3,O
mutations,B-DNA_Mutation
in,O
the,O
APC,B-Gene_protein
gene,O
are,O
described,O
here,O
for,O
the,O
first,O
time,O
,,O
namely,O
the,O
mutations,B-DNA_Mutation
in,O
codons,B-locus
712,I-locus
,,I-locus
759,B-locus
and,O
767,B-locus
.,I-locus
 , 

,O
 , 
#25840688
Genetic,O
dissimilarity,O
between,O
primary,O
colorectal,O
carcinomas,O
and,O
their,O
lymph,O
node,O
metastases,O
:,O
ploidy,O
,,O
p53,B-Gene_protein
,,I-Gene_protein
bcl-2,B-Gene_protein
,,I-Gene_protein
and,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
expression,O
--,O
a,O
pilot,O
study,O
.,O
 , 


,O
The,O
current,O
paradigm,O
of,O
metastasis,O
proposes,O
that,O
rare,O
cells,O
within,O
primary,O
tumors,O
acquire,O
metastatic,O
capability,O
via,O
sequential,O
mutations,B-DNA_Mutation
,,I-DNA_Mutation
suggesting,O
that,O
metastases,O
are,O
genetically,O
dissimilar,O
from,O
their,O
primary,O
tumors,O
.,O
 , 
This,O
study,O
investigated,O
the,O
changes,O
in,O
the,O
level,O
of,O
expression,O
of,O
a,O
well,O
-,O
defined,O
panel,O
of,O
cell,O
proliferation,O
,,O
differentiation,O
,,O
and,O
apoptosis,O
markers,O
between,O
the,O
primary,O
colorectal,O
cancer,O
(,O
CRC,O
),O
and,O
the,O
corresponding,O
synchronous,O
lymph,O
node,O
(,O
LN,O
),O
metastasis,O
from,O
the,O
same,O
patients,O
.,O
 , 
DNA,O
flow,O
cytometry,O
and,O
immunostaining,O
of,O
p53,B-Gene_protein
,,I-Gene_protein
bcl-2,B-Gene_protein
,,I-Gene_protein
and,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
were,O
carried,O
out,O
on,O
36,O
cases,O
of,O
CRC,O
radical,O
resection,O
specimens,O
with,O
their,O
corresponding,O
LN,O
metastases,O
.,O
 , 
There,O
was,O
very,O
low,O
probability,O
that,O
the,O
histological,O
patterns,O
of,O
primary,O
tumors,O
and,O
LN,O
metastases,O
are,O
independent,O
(,O
p,O
 ,O
<,O
 ,O
0.001,O
),O
.,O
 , 
Metastatic,O
tumors,O
were,O
significantly,O
more,O
diffusely,O
positive,O
for,O
p53,B-Gene_protein
than,O
the,O
primary,O
tumors,O
(,O
p,O
 ,O
<,O
 ,O
0.001,O
),O
.,O
 , 
Conversely,O
,,O
primary,O
tumors,O
were,O
significantly,O
more,O
diffusely,O
positive,O
for,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
than,O
metastatic,O
tumors,O
(,O
p,O
 ,O
=,O
 ,O
0.011,O
),O
.,O
 , 
No,O
significant,O
difference,O
was,O
found,O
between,O
the,O
LNs,O
and,O
the,O
primary,O
tumors,O
in,O
bcl-2,B-Gene_protein
positivity,O
(,O
p,O
 ,O
=,O
 ,O
0.538,O
),O
and,O
DNA,O
aneuploidy,B-DNA_Mutation
(,O
p,O
 ,O
=,O
 ,O
0.35,O
),O
,,O
with,O
a,O
tendency,O
towards,O
negative,O
bcl-2,B-Gene_protein
and,O
less,O
aneuploidy,B-DNA_Mutation
in,O
LN,O
metastases,O
than,O
primary,O
tumors,O
.,O
 , 
In,O
conclusion,O
,,O
LN,O
metastatic,O
colorectal,O
carcinomas,O
have,O
a,O
tendency,O
of,O
being,O
less,O
differentiated,O
,,O
with,O
a,O
higher,O
incidence,O
of,O
diffuse,O
p53,B-Gene_protein
staining,O
,,O
lower,O
incidence,O
of,O
bcl-2,B-Gene_protein
staining,O
,,O
and,O
less,O
aneuploidy,B-DNA_Mutation
in,O
comparison,O
to,O
their,O
primary,O
counterparts,O
suggesting,O
a,O
more,O
aggressive,O
biological,O
behavior,O
,,O
which,O
could,O
indicate,O
the,O
necessity,O
for,O
more,O
aggressive,O
adjuvant,O
therapy,O
.,O

,O
 , 
#23797718
BRAFV600E,B-Protein_Mutation
immunohistochemistry,O
facilitates,O
universal,O
screening,O
of,O
colorectal,O
cancers,O
for,O
Lynch,O
syndrome,O
.,O
 , 


,B-Gene_protein
BRAFV600E,B-Protein_Mutation
mutation,B-Mutation
in,O
microsatellite,B-DNA_Mutation
-,I-DNA_Mutation
unstable,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
colorectal,O
carcinomas,O
(,O
CRCs,O
),O
virtually,O
excludes,O
Lynch,O
syndrome,O
(,O
LS,O
),O
.,O
 , 
In,O
microsatellite,O
-,O
stable,O
(,O
MSS,O
),O
CRCs,O
it,O
predicts,O
poor,O
prognosis,O
.,O
 , 
We,O
propose,O
a,O
universal,O
CRC,O
LS,O
screening,O
algorithm,O
using,O
concurrent,O
reflex,O
immunohistochemistry,O
(,O
IHC,O
),O
for,O
BRAFV600E,B-Gene_protein
and,O
mismatch,O
-,O
repair,O
(,O
MMR,O
),O
proteins,O
.,O
 , 
We,O
compared,O
BRAFV600E,B-Protein_Mutation
IHC,O
with,O
multiplex,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
and,O
matrix,O
-,O
assisted,O
laser,O
desorption,O
/,O
ionization,O
-,O
time,O
of,O
flight,O
mass,O
spectrometry,O
in,O
216,O
consecutive,O
CRCs,O
from,O
2011,O
.,O
 , 
Discordant,O
cases,O
were,O
resolved,O
with,O
real,O
-,O
time,O
PCR,O
.,O
 , 
BRAFV600E,B-Gene_protein
IHC,O
was,O
performed,O
on,O
51,O
CRCs,O
from,O
the,O
Australasian,O
Colorectal,O
Cancer,O
Family,O
Registry,O
(,O
ACCFR,O
),O
,,O
which,O
were,O
fully,O
characterized,O
for,O
BRAF,B-Gene_protein
mutation,B-Mutation
by,O
allele,O
-,O
specific,O
PCR,O
,,O
MMR,O
status,O
(,O
MMR,O
IHC,O
and,O
MSI,B-DNA_Mutation
),I-DNA_Mutation
,,O
MLH1,B-Gene_protein
promoter,B-locus
methylation,B-DNA_modification
,,I-DNA_modification
and,O
germline,O
MLH1,B-Gene_protein
mutation,B-DNA_Mutation
.,I-DNA_Mutation
 , 
We,O
then,O
assessed,O
MMR,O
and,O
BRAFV600E,B-Protein_Mutation
IHC,O
on,O
1403,O
consecutive,O
CRCs,O
.,O
 , 
By,O
matrix,O
-,O
assisted,O
laser,O
desorption,O
/,O
ionization,O
-,O
time,O
of,O
flight,O
mass,O
spectrometry,O
15,O
cases,O
did,O
not,O
yield,O
a,O
BRAF,B-Gene_protein
result,O
,,O
whereas,O
38/201,O
(,O
19,O
%,O
),O
were,O
positive,O
.,O
 , 
By,O
IHC,O
45/216,O
(,O
20,O
%,O
),O
were,O
positive,O
.,O
 , 
Of,O
the,O
7,O
discordant,O
cases,O
,,O
real,O
-,O
time,O
PCR,O
confirmed,O
the,O
IHC,O
result,O
in,O
6,O
.,O
 , 
In,O
the,O
51,O
CRCs,O
from,O
the,O
ACCFR,O
,,O
IHC,O
was,O
concordant,O
with,O
allele,O
-,O
specific,O
PCR,O
in,O
50,O
cases,O
.,O
 , 
BRAFV600E,B-Protein_Mutation
and,O
MSI,O
IHC,O
on,O
1403,O
CRCs,O
demonstrated,O
the,O
following,O
phenotypes,O
:,O
BRAF,B-Gene_protein
/,I-Gene_protein
MSS,O
(,O
1029,O
cases,O
,,O
73,O
%,O
),O
,,O
BRAF,B-Gene_protein
/,I-Gene_protein
MSS,O
(,O
98,O
,,O
7,O
%,O
),O
,,O
BRAF,B-Gene_protein
/,I-Gene_protein
MSI,I-DNA_Mutation
(,O
183,O
,,O
13,O
%,O
),O
,,O
and,O
BRAF,B-Gene_protein
/,I-Gene_protein
MSI,I-DNA_Mutation
(,O
93,O
,,O
7,O
%,O
),O
.,O
 , 
All,O
11/1403,O
cancers,O
associated,O
with,O
proven,O
LS,O
were,O
BRAF,B-Gene_protein
/,I-Gene_protein
MSI,I-DNA_Mutation
.,I-DNA_Mutation
 , 
We,O
conclude,O
that,O
BRAF,B-Gene_protein
IHC,O
is,O
highly,O
concordant,O
with,O
2,O
commonly,O
used,O
PCR,O
-,O
based,O
BRAFV600E,B-Protein_Mutation
assays,O
;,O
it,O
performed,O
well,O
in,O
identifying,O
MLH1,B-Gene_protein
mutation,B-Mutation
carriers,O
from,O
the,O
ACCFR,O
and,O
identified,O
all,O
cases,O
of,O
proven,O
LS,O
among,O
the,O
1403,O
CRCs,O
.,O
 , 
Reflex,O
BRAFV600E,B-Gene_protein
and,O
MMR,O
IHC,O
are,O
simple,O
cheap,O
tests,O
that,O
facilitate,O
universal,O
LS,O
screening,O
and,O
identify,O
the,O
poor,O
prognosis,O
of,O
the,O
BRAFV600E,B-Gene_protein
-,B-Mutation
mutant,I-Mutation
MSS,O
CRC,O
phenotype,O
.,O
 , 

,O
 , 
#10439970
Marfan,O
-,O
like,O
habitus,O
and,O
familial,O
adenomatous,O
polyposis,O
in,O
two,O
unrelated,O
males,O
:,O
a,O
significant,O
association,O
?,O
 , 


,O
Familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
can,O
be,O
considered,O
as,O
a,O
condition,O
of,O
the,O
whole,O
body,O
as,O
extracolonic,O
features,O
derived,O
from,O
all,O
the,O
three,O
embryonic,O
lineages,O
are,O
recorded,O
with,O
varying,O
frequency,O
in,O
addition,O
to,O
the,O
presence,O
of,O
multiple,O
adenomas,O
in,O
the,O
large,O
intestine,O
.,O
 , 
Here,O
,,O
we,O
describe,O
two,O
unrelated,O
cases,O
of,O
FAP,O
with,O
unusual,O
extracolonic,O
phenotypes,O
,,O
namely,O
several,O
abnormalities,O
of,O
mesodermal,O
origin,O
strongly,O
resembling,O
Marfan,O
syndrome,O
(,O
MFS,O
),O
or,O
a,O
Marfan,O
-,O
like,O
habitus,O
.,O
 , 
Conventional,O
cytogenetic,O
and,O
FISH,O
analysis,O
did,O
not,O
reveal,O
any,O
gross,O
chromosomal,O
rearrangement,B-DNA_Mutation
on,O
the,O
long,B-locus
arm,I-locus
of,I-locus
chromosome,I-locus
5,I-locus
where,O
the,O
APC,B-Gene_protein
and,O
FBN2,B-Gene_protein
genes,O
were,O
located,O
.,O
 , 
However,O
,,O
in,O
case,O
2,O
the,O
FAP,O
-,O
causing,O
mutation,B-DNA_Mutation
in,O
the,O
APC,B-Gene_protein
gene,O
was,O
found,O
in,O
the,O
donor,B-locus
splice,I-locus
site,I-locus
of,O
exon,B-locus
4,I-locus
and,O
was,O
shown,O
to,O
result,O
in,O
a,O
frameshift,O
and,O
a,O
premature,O
termination,O
codon,O
.,O
 , 
We,O
propose,O
that,O
such,O
connective,O
tissue,O
abnormalities,O
may,O
result,O
from,O
germline,O
APC,B-Gene_protein
mutations,B-DNA_Mutation
in,O
combination,O
with,O
specific,O
genetic,O
and/or,O
environmental,O
modifying,O
factors,O
.,O
 , 

,O
 , 
#11521793
Cancer,O
genetics,O
in,O
oncology,O
practice,O
.,O
 , 


,O
Cancer,O
is,O
a,O
genetic,O
disease,O
caused,O
by,O
the,O
progressive,O
accumulation,O
of,O
mutations,B-DNA_Mutation
in,O
critical,O
genes,O
that,O
control,O
cell,O
growth,O
and,O
differentiation,O
.,O
 , 
Completion,O
of,O
the,O
Human,O
Genome,O
Project,O
promises,O
to,O
revolutionize,O
the,O
practice,O
of,O
Medicine,O
,,O
especially,O
Oncology,O
care,O
.,O
 , 
The,O
tremendous,O
gains,O
in,O
the,O
knowledge,O
of,O
the,O
structure,O
and,O
function,O
of,O
human,O
genes,O
will,O
surely,O
impact,O
the,O
diagnosis,O
,,O
prognosis,O
and,O
treatment,O
of,O
cancer,O
.,O
 , 
Moreover,O
,,O
it,O
will,O
lead,O
to,O
more,O
effective,O
cancer,O
control,O
through,O
the,O
use,O
of,O
genetics,O
to,O
quantify,O
individual,O
cancer,O
risks,O
.,O
 , 
This,O
article,O
reviews,O
the,O
current,O
status,O
of,O
genetic,O
testing,O
and,O
counseling,O
for,O
cancer,O
risk,O
assessment,O
and,O
will,O
suggest,O
a,O
framework,O
for,O
integrating,O
such,O
counseling,O
into,O
oncology,O
practice,O
.,O
 , 

,O
 , 
#24568449
Associations,O
of,O
single,B-RNA_Mutation
nucleotide,I-RNA_Mutation
polymorphisms,I-RNA_Mutation
in,O
miR-146a,B-RNA
,,I-RNA
miR-196a,B-RNA
,,I-RNA
miR-149,B-RNA
and,O
miR-499,B-RNA
with,O
colorectal,O
cancer,O
susceptibility,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
MicroRNAs,O
(,O
miRNAs,O
),O
are,O
an,O
abundant,O
class,O
of,O
endogenous,O
small,O
non,O
-,O
coding,O
RNAs,O
of,O
20,O
-,O
25,O
nucleotides,O
in,O
length,O
that,O
function,O
as,O
negative,O
gene,O
regulators,O
.,O
 , 
MiRNAs,O
play,O
roles,O
in,O
most,O
biological,O
processes,O
,,O
as,O
well,O
as,O
diverse,O
human,O
diseases,O
including,O
cancer,O
.,O
 , 
Recently,O
,,O
many,O
studies,O
investigated,O
the,O
association,O
between,O
SNPs,B-RNA_Mutation
in,O
miR-146a,B-RNA
rs2910164,B-dbSNP
,,I-dbSNP
miR-196a2,B-RNA
rs11614913,B-dbSNP
,,I-dbSNP
miR-149,B-RNA
rs229283,B-dbSNP
,,I-dbSNP
miR-499,B-RNA
rs3746444,B-dbSNP
and,O
colorectal,O
cancer,O
(,O
CRC,O
),O
,,O
which,O
results,O
have,O
been,O
inconclusive,O
.,O
 , 


,O
#,O
#,O
METHODOLOGY,O
/,O
PRINCIPAL,O
FINDINGS,O

,O
PubMed,O
,,O
EMBASE,O
,,O
CNKI,O
databases,O
were,O
searched,O
with,O
the,O
last,O
search,O
updated,O
on,O
November,O
5,O
,,O
2013,O
.,O
 , 
For,O
miR-196a2,B-RNA
rs11614913,B-dbSNP
,,I-dbSNP
a,O
significantly,O
decreased,O
risk,O
of,O
CRC,O
development,O
was,O
observed,O
under,O
three,O
genetic,O
models,O
(,O
dominant,O
model,O
:,O
OR,O
=,O
0.848,O
,,O
95%CI,O
:,O
0.735,O
-,O
0.979,O
,,O
P,O
=,O
0.025,O
;,O
recessive,O
model,O
:,O
OR,O
=,O
0.838,O
,,O
95%CI,O
:,O
0.721,O
-,O
0.974,O
,,O
P,O
=,O
0.021,O
;,O
homozygous,O
model,O
:,O
OR,O
=,O
0.754,O
,,O
95%CI,O
:,O
0.627,O
-,O
0.907,O
,,O
 , 
P,O
=,O
0.003,O
),O
.,O
 , 
In,O
the,O
subgroup,O
analyses,O
,,O
miR-196a2*T,B-RNA
variant,B-RNA_Mutation
was,O
associated,O
with,O
a,O
significantly,O
decreased,O
susceptibility,O
of,O
CRC,O
(,O
allele,O
model,O
:,O
OR,O
=,O
0.839,O
,,O
95%CI,O
:,O
0.749,O
-,O
0.940,O
,,O
P,O
=,O
0.000,O
;,O
dominant,O
model,O
:,O
OR,O
=,O
0.770,O
,,O
95%CI,O
:,O
0.653,O
-,O
0.980,O
,,O
P,O
=,O
0.002,O
;,O
recessive,O
model,O
:,O
OR,O
=,O
0.802,O
,,O
95%CI,O
:,O
0.685,O
-,O
0.939,O
,,O
P,O
=,O
0.006,O
;,O
homozygous,O
model,O
:,O
 , 
OR,O
=,O
0.695,O
,,O
95%CI,O
:,O
0.570,O
-,O
0.847,O
,,O
P,O
=,O
0.000,O
),O
.,O
 , 
As,O
for,O
miR-149,B-RNA
rs2292832,B-dbSNP
,,I-dbSNP
the,O
two,O
genetic,O
models,O
(,O
recessive,O
model,O
:,O
OR,O
=,O
1.199,O
,,O
95,O
%,O
CI,O
1.028,O
-,O
1.398,O
,,O
P,O
=,O
0.021,O
;,O
heterozygous,O
model,O
:,O
OR,O
=,O
1.226,O
,,O
95,O
%,O
CI,O
1.039,O
-,O
1.447,O
,,O
P,O
=,O
0.013,O
),O
demonstrated,O
increased,O
susceptibility,O
to,O
CRC,O
.,O
 , 
On,O
subgroup,O
analysis,O
,,O
significantly,O
increased,O
susceptibility,O
of,O
CRC,O
was,O
found,O
in,O
the,O
genetic,O
models,O
(,O
recessive,O
model,O
:,O
OR,O
=,O
1.180,O
,,O
95,O
%,O
CI,O
1.008,O
-,O
1.382,O
,,O
P,O
=,O
0.040,O
;,O
heterozygous,O
model,O
:,O
 , 
OR,O
=,O
1.202,O
,,O
95,O
%,O
CI,O
1.013,O
-,O
1.425,O
,,O
P,O
=,O
0.013,O
),O
in,O
the,O
Asian,O
group,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
These,O
findings,O
supported,O
that,O
the,O
miR-196a2,B-RNA
rs11614913,B-dbSNP
and,O
miR-149,B-RNA
rs2292832,B-dbSNP
polymorphisms,B-RNA_Mutation
may,O
contribute,O
to,O
susceptibility,O
to,O
CRC,O
.,O
 , 

,O
 , 
#26446363
Co,O
-,O
occurrence,O
of,O
nonsense,B-DNA_Mutation
mutations,I-DNA_Mutation
in,O
MSH6,B-Gene_protein
and,O
MSH2,B-Gene_protein
in,O
Lynch,O
syndrome,O
families,O
evidencing,O
that,O
not,O
all,O
truncating,B-DNA_Mutation
mutations,I-DNA_Mutation
are,O
equal,O
.,O
 , 


,O
The,O
majority,O
of,O
pathogenic,O
mismatch,O
repair,O
(,O
MMR,O
),O
gene,O
mutations,B-DNA_Mutation
detected,O
in,O
Lynch,O
syndrome,O
patients,O
are,O
truncating,O
(,O
frameshift,O
or,O
nonsense,O
),O
.,O
 , 
However,O
,,O
the,O
classification,O
of,O
terminal,O
truncating,O
mutations,B-DNA_Mutation
is,O
sometimes,O
difficult,O
and,O
predictive,O
testing,O
based,O
on,O
non,B-DNA_Mutation
-,I-DNA_Mutation
deleterious,I-DNA_Mutation
variants,I-DNA_Mutation
can,O
have,O
very,O
serious,O
consequences,O
.,O
 , 
Here,O
,,O
we,O
report,O
eight,O
probands,O
that,O
have,O
two,O
germline,O
nonsense,B-DNA_Mutation
mutations,I-DNA_Mutation
,,I-DNA_Mutation
namely,O
MSH6,B-Gene_protein
c.1030C,B-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
,,I-DNA_Mutation
p.(Gln344Ter,B-Protein_Mutation
),I-Protein_Mutation
and,O
MSH2,B-Gene_protein
c.2785C,B-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
,,I-DNA_Mutation
p.(Arg929Ter,B-Protein_Mutation
),I-Protein_Mutation
,,I-Protein_Mutation
and,O
one,O
additional,O
patient,O
who,O
presented,O
only,O
the,O
MSH2,B-Gene_protein
mutation,B-Mutation
previously,O
reported,O
as,O
deleterious,O
.,O
 , 
The,O
novel,O
MSH6,B-Gene_protein
truncating,B-DNA_Mutation
mutation,I-DNA_Mutation
was,O
classified,O
as,O
deleterious,O
,,O
as,O
it,O
is,O
predicted,O
to,O
encode,O
a,O
protein,O
with,O
loss,B-Protein_Mutation
of,O
1017,O
amino,O
acid,O
residues,O
.,O
 , 
The,O
MSH2,B-Gene_protein
mutation,B-DNA_Mutation
,,I-DNA_Mutation
which,O
is,O
expected,O
to,O
encode,O
a,O
protein,O
lacking,B-Protein_Mutation
six,O
amino,O
acid,O
residues,O
,,O
was,O
considered,O
a,O
variant,B-Mutation
of,O
unknown,O
significance,O
.,O
 , 
Five,O
tumors,O
of,O
the,O
eight,O
double,O
-,B-Mutation
mutant,I-Mutation
individuals,O
had,O
normal,O
MSH2,B-Gene_protein
expression,O
,,O
whereas,O
MSH6,B-Gene_protein
immunoexpression,O
was,O
lost,O
in,O
all,O
evaluable,O
cases,O
.,O
 , 
None,O
of,O
the,O
variants,B-Mutation
were,O
detected,O
in,O
normal,O
controls,O
or,O
associated,O
with,O
other,O
MMR,O
germline,O
mutations,B-DNA_Mutation
in,O
our,O
series,O
.,O
 , 
This,O
study,O
emphasizes,O
that,O
not,O
all,O
truncating,B-DNA_Mutation
mutations,I-DNA_Mutation
are,O
equal,O
and,O
that,O
one,O
must,O
be,O
cautious,O
in,O
the,O
interpretation,O
of,O
the,O
presumed,O
deleterious,O
effect,O
of,O
terminal,O
frameshift,O
or,O
nonsense,B-DNA_Mutation
mutations,I-DNA_Mutation
.,I-DNA_Mutation
 , 

,O
 , 
#9691992
A,O
novel,O
missense,B-DNA_Mutation
mutation,I-DNA_Mutation
and,O
frameshift,B-DNA_Mutation
mutations,I-DNA_Mutation
in,O
the,O
type,B-Gene_protein
II,I-Gene_protein
receptor,I-Gene_protein
of,I-Gene_protein
transforming,I-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
gene,O
in,O
sporadic,O
colon,O
cancer,O
with,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 


,B-DNA_Mutation
Microsatellite,I-DNA_Mutation
instability,I-DNA_Mutation
of,O
DNA,O
samples,O
of,O
79,O
sporadic,O
colon,O
cancer,O
patients,O
were,O
analyzed,O
.,O
 , 
These,O
samples,O
were,O
also,O
screened,O
to,O
search,O
mutations,B-DNA_Mutation
in,O
the,O
repeat,O
sequences,O
in,O
the,O
gene,O
for,O
the,O
type,B-Gene_protein
II,I-Gene_protein
receptor,I-Gene_protein
of,I-Gene_protein
transforming,I-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
(,B-Gene_protein
TGF,I-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
),I-Gene_protein
using,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
,,O
electrophoresis,O
with,O
urea,O
gel,O
,,O
and,O
PCR,O
-,O
single,O
strand,O
conformation,O
polymorphism,O
(,O
PCR,O
-,O
SSCP,O
),O
method,O
.,O
 , 
The,O
incidence,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
,,I-DNA_Mutation
defined,O
as,O
severe,O
replication,O
error,O
phenotype,O
(,O
RER,O
),O
with,O
microsatellite,B-DNA_Mutation
alterations,I-DNA_Mutation
in,O
more,O
than,O
three,O
loci,O
,,O
was,O
6,O
%,O
.,O
 , 
Deletion,B-DNA_Mutation
and,O
insertion,B-DNA_Mutation
of,O
an,O
A,O
residue,O
in,O
the,O
(,B-locus
A)10,I-locus
region,I-locus
,,I-locus
which,O
cause,O
frameshift,B-DNA_Mutation
mutation,I-DNA_Mutation
,,I-DNA_Mutation
were,O
found,O
in,O
four,O
samples,O
and,O
their,O
incidence,O
in,O
the,O
samples,O
with,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
was,O
80,O
%,O
.,O
 , 
A,O
novel,O
nucleotide,B-DNA_Mutation
substitution,I-DNA_Mutation
of,I-DNA_Mutation
T,I-DNA_Mutation
for,I-DNA_Mutation
G,I-DNA_Mutation
at,O
1918,B-locus
,,I-locus
which,O
causes,O
missense,B-DNA_Mutation
mutation,I-DNA_Mutation
of,O
arginine,B-Protein_Mutation
to,I-Protein_Mutation
leucine,I-Protein_Mutation
at,O
codon,B-locus
528,I-locus
,,I-locus
was,O
found,O
in,O
a,O
sample,O
with,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 
The,O
mutation,B-DNA_Mutation
at,O
1918,B-locus
was,O
in,O
highly,O
conservative,O
amino,O
acid,O
residue,O
.,O

,O
 , 
#22376259
Linkage,O
disequilibrium,O
and,O
haplotype,O
analysis,O
of,O
COX-2,B-Gene_protein
and,O
risk,O
of,O
colorectal,O
adenoma,O
development,O
.,O
 , 


,B-DNA_Mutation
Single,I-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNPs,I-DNA_Mutation
),I-DNA_Mutation
in,O
the,O
promoter,B-locus
and,O
untranslated,B-locus
region,I-locus
of,O
cyclooxygenase,B-Gene_protein
(,B-Gene_protein
COX)-2,I-Gene_protein
,,O
an,O
inducible,O
enzyme,O
responsible,O
for,O
the,O
synthesis,O
of,O
prostaglandins,O
,,O
have,O
been,O
reported,O
to,O
modulate,O
the,O
risk,O
for,O
many,O
human,O
cancers,O
.,O
 , 
We,O
performed,O
comprehensive,O
linkage,O
disequilibrium,O
(,O
LD,O
),O
and,O
haplotype,O
analyses,O
of,O
13,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
of,O
the,O
COX-2,B-Gene_protein
gene,O
and,O
examined,O
its,O
susceptibility,O
to,O
adenoma,O
development,O
in,O
72,O
African,O
American,O
cases,O
and,O
142,O
controls,O
.,O
 , 
Results,O
revealed,O
significant,O
variation,O
in,O
LD,O
patterns,O
with,O
consequence,O
for,O
adenoma,O
development,O
.,O
 , 
Two,O
distinct,O
haplotype,B-locus
blocks,I-locus
were,O
identified,O
;,O
one,O
block,O
covered,O
the,O
coding,O
regions,B-locus
of,I-locus
exon,I-locus
1,I-locus
,,I-locus
introns,B-locus
and,O
a,O
section,O
of,O
the,O
3'-unstranslated,B-locus
region,I-locus
(,B-locus
3'-UTR,I-locus
),I-locus
,,O
whereas,O
the,O
second,O
block,O
resided,O
solely,O
in,O
the,O
3'-UTR,B-locus
region,O
.,O
 , 
A,O
haplotype,O
in,O
block,O
1,O
increased,O
the,O
risk,O
of,O
adenoma,O
development,O
by,O
threefold,O
(,O
odds,O
ratio,O
[,O
OR]=,O
2.9,O
,,O
confidence,O
interval,O
[,O
CI]=,O
1.8,O
-,O
3.7,O
,,O
P=,O
0.002,O
),O
.,O
 , 
Regression,O
analysis,O
showed,O
,,O
increase,O
in,O
copies,O
of,O
minor,O
alleles,O
of,O
6,064(T,B-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
),I-DNA_Mutation
polymorphism,B-DNA_Mutation
associated,O
with,O
increased,O
odds,O
of,O
adenoma,O
development,O
by,O
80,O
%,O
(,O
OR,O
=,O
1.80,O
,,O
CI,O
=,O
1.09,O
-,O
3.21,O
,,O
P=,O
0.034,O
),O
,,O
10,848(G,B-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
),I-DNA_Mutation
by,O
84,O
%,O
(,O
OR,O
=,O
1.84,O
,,O
CI,O
=,O
1.05,O
-,O
3.23,O
,,O
P=,O
0.034,O
),O
and,O
10,935(A,B-DNA_Mutation
>,I-DNA_Mutation
G,I-DNA_Mutation
),I-DNA_Mutation
by,O
32,O
%,O
(,O
OR,O
=,O
1.32,O
,,O
CI,O
=,O
1.12,O
-,O
3.69,O
,,O
P=,O
0.036,O
),O
.,O
 , 
These,O
results,O
support,O
the,O
hypothesis,O
that,O
COX-2,B-Gene_protein
gene,O
might,O
play,O
a,O
role,O
in,O
the,O
etiology,O
of,O
colon,O
cancer,O
and,O
warrant,O
further,O
investigation,O
in,O
other,O
cancers,O
.,O
 , 
Besides,O
,,O
these,O
variations,B-DNA_Mutation
should,O
be,O
taken,O
into,O
account,O
for,O
disease,O
-,O
based,O
association,O
studies,O
in,O
which,O
the,O
COX-2,B-Gene_protein
polymorphism,B-DNA_Mutation
is,O
considered,O
as,O
a,O
candidate,O
gene,O
.,O
 , 
Clin,O
Trans,O
Sci,O
2012,O
;,O
Volume,O
5,O
:,O
60,O
-,O
64,O
.,O
 , 

,O
 , 
#23012243
The,O
frequency,O
of,O
previously,O
undetectable,O
deletions,B-DNA_Mutation
involving,O
3,B-locus
',I-locus
Exons,I-locus
of,O
the,O
PMS2,B-Gene_protein
gene,O
.,O
 , 


,O
Lynch,O
syndrome,O
is,O
characterized,O
by,O
mutations,B-DNA_Mutation
in,O
one,O
of,O
four,O
mismatch,O
repair,O
genes,O
,,O
MLH1,B-Gene_protein
,,I-Gene_protein
MSH2,B-Gene_protein
,,I-Gene_protein
MSH6,B-Gene_protein
,,I-Gene_protein
or,O
PMS2,B-Gene_protein
.,I-Gene_protein
 , 
Clinical,O
mutation,B-DNA_Mutation
analysis,O
of,O
these,O
genes,O
includes,O
sequencing,O
of,O
exonic,O
regions,O
and,O
deletion,B-DNA_Mutation
/,B-DNA_Mutation
duplication,I-DNA_Mutation
analysis,O
.,O
 , 
However,O
,,O
detection,O
of,O
deletions,B-DNA_Mutation
and,O
duplications,B-DNA_Mutation
in,O
PMS2,B-Gene_protein
has,O
previously,O
been,O
confined,O
to,O
Exons,B-locus
1,I-locus
-,I-locus
11,I-locus
due,O
to,O
gene,O
conversion,O
between,O
PMS2,B-Gene_protein
and,O
the,O
pseudogene,O
PMS2CL,B-Gene_protein
in,O
the,O
remaining,O
3,B-locus
',I-locus
exons,I-locus
(,B-locus
Exons,I-locus
12,I-locus
-,I-locus
15,I-locus
),I-locus
.,O
 , 
We,O
have,O
recently,O
described,O
an,O
MLPA,O
-,O
based,O
method,O
that,O
permits,O
detection,O
of,O
deletions,B-DNA_Mutation
of,O
PMS2,B-Gene_protein
Exons,B-locus
12,I-locus
-,I-locus
15,I-locus
;,I-locus
however,O
,,O
the,O
frequency,O
of,O
such,O
deletions,B-DNA_Mutation
has,O
not,O
yet,O
been,O
determined,O
.,O
 , 
To,O
address,O
this,O
question,O
,,O
we,O
tested,O
for,O
3,B-locus
',I-locus
deletions,B-DNA_Mutation
in,O
58,O
samples,O
that,O
were,O
reported,O
to,O
be,O
negative,O
for,O
PMS2,B-Gene_protein
mutations,B-DNA_Mutation
using,O
previously,O
available,O
methods,O
.,O
 , 
All,O
samples,O
were,O
from,O
individuals,O
whose,O
tumors,O
exhibited,O
loss,O
of,O
PMS2,B-Gene_protein
immunohistochemical,O
staining,O
without,O
concomitant,O
loss,O
of,O
MLH1,B-Gene_protein
immunostaining,O
.,O
 , 
We,O
identified,O
seven,O
samples,O
in,O
this,O
cohort,O
with,O
deletions,B-DNA_Mutation
in,O
the,O
3,B-locus
',I-locus
region,I-locus
of,O
PMS2,B-Gene_protein
,,I-Gene_protein
including,O
three,O
previously,O
reported,O
samples,O
with,O
deletions,B-DNA_Mutation
of,O
Exons,B-locus
13,I-locus
-,I-locus
15,I-locus
(,O
two,O
samples,O
),O
and,O
Exons,B-locus
14,I-locus
-,I-locus
15,I-locus
.,I-locus
 , 
Also,O
detected,O
were,O
deletions,B-DNA_Mutation
of,O
Exons,B-locus
12,I-locus
-,I-locus
15,I-locus
,,I-locus
Exon,B-locus
13,I-locus
,,I-locus
and,O
Exon,B-locus
14,I-locus
(,O
two,O
samples,O
),O
.,O
 , 
Breakpoint,O
analysis,O
of,O
the,O
intragenic,O
deletions,B-DNA_Mutation
suggests,O
they,O
occurred,O
through,O
Alu,O
-,O
mediated,O
recombination,O
.,O
 , 
Our,O
results,O
indicate,O
that,O
∼12,O
%,O
of,O
samples,O
suspected,O
of,O
harboring,O
a,O
PMS2,B-Gene_protein
mutation,B-DNA_Mutation
based,O
on,O
immunohistochemical,O
staining,O
,,O
for,O
which,O
mutations,B-DNA_Mutation
have,O
not,O
yet,O
been,O
identified,O
,,O
would,O
benefit,O
from,O
testing,O
using,O
the,O
new,O
methodology,O
.,O
 , 

,O
 , 
#25029911
Egr-1,B-Gene_protein
regulates,O
the,O
transcription,O
of,O
NGX6,B-Gene_protein
gene,O
through,O
a,O
Sp1,B-Gene_protein
/,B-Gene_protein
Egr-1,I-Gene_protein
overlapping,O
site,O
in,O
the,O
promoter,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
 , 
As,O
a,O
novel,O
candidate,O
metastasis,O
suppressor,O
gene,O
,,O
Nasopharyngeal,B-Gene_protein
carcinoma,I-Gene_protein
-,I-Gene_protein
associated,I-Gene_protein
gene,I-Gene_protein
6,I-Gene_protein
(,B-Gene_protein
NGX6,I-Gene_protein
),I-Gene_protein
is,O
involved,O
in,O
cellular,O
growth,O
,,O
cell,O
cycle,O
progression,O
and,O
tumor,O
angiogenesis,O
.,O
 , 
Previous,O
studies,O
have,O
shown,O
that,O
NGX6,B-Gene_protein
gene,O
is,O
down,O
-,O
regulated,O
in,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
However,O
,,O
little,O
is,O
known,O
about,O
its,O
transcriptional,O
regulation,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
We,O
defined,O
the,O
minimal,O
promoter,O
of,O
NGX6,B-Gene_protein
gene,O
in,O
a,O
186,O
-,O
bp,O
region,O
(,O
from-86,B-locus
to,I-locus
+100,I-locus
),I-locus
through,O
mutation,B-DNA_Mutation
construct,O
methods,O
and,O
luciferase,O
assays,O
.,O
 , 
Results,O
from,O
Electrophoretic,O
mobility,O
shift,O
assays,O
(,O
EMSA,O
),O
and,O
Chromatin,O
immunoprecipitation,O
(,O
ChIP,O
),O
revealed,O
that,O
Early,B-Gene_protein
growth,I-Gene_protein
response,I-Gene_protein
gene,I-Gene_protein
1,I-Gene_protein
(,B-Gene_protein
Egr-1,I-Gene_protein
),I-Gene_protein
binds,O
to,O
the,O
Sp1,B-Gene_protein
/,I-Gene_protein
Egr-1,I-Gene_protein
overlapping,O
site,O
of,O
NGX6,B-Gene_protein
minimal,O
promoter,O
.,O
 , 
Overexpression,O
of,O
Egr-1,B-Gene_protein
increased,O
the,O
promoter,O
activity,O
and,O
mRNA,O
level,O
of,O
NGX6,B-Gene_protein
gene,O
;,O
while,O
knock,O
-,O
down,O
of,O
endogenous,O
Egr-1,B-Gene_protein
decreased,O
mRNA,O
expression,O
of,O
NGX6,B-Gene_protein
gene,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
These,O
results,O
demonstrate,O
that,O
Egr-1,B-Gene_protein
regulates,O
NGX6,B-Gene_protein
gene,O
transcription,O
through,O
an,O
overlapping,O
Sp1,B-Gene_protein
/,I-Gene_protein
Egr-1,I-Gene_protein
binding,O
site,O
as,O
a,O
positive,O
regulator,O
of,O
NGX6,B-Gene_protein
gene,O
.,O
 , 

,O
 , 
#15987719
Cells,O
with,O
pathogenic,O
biallelic,B-DNA_Mutation
mutations,I-DNA_Mutation
in,O
the,O
human,O
MUTYH,B-Gene_protein
gene,O
are,O
defective,O
in,O
DNA,O
damage,O
binding,O
and,O
repair,O
.,O
 , 


,O
Inherited,O
biallelic,B-DNA_Mutation
mutations,I-DNA_Mutation
in,O
the,O
human,O
MUTYH,B-Gene_protein
gene,O
are,O
responsible,O
for,O
the,O
recessive,O
syndrome,O
--,O
adenomatous,O
colorectal,O
polyposis,O
(,O
MUTYH,O
associated,O
polyposis,O
,,O
MAP)--which,O
significantly,O
increases,O
the,O
risk,O
of,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
Defective,O
MUTYH,B-Gene_protein
activity,O
causes,O
G,B-DNA_Mutation
:,I-DNA_Mutation
C,I-DNA_Mutation
to,I-DNA_Mutation
T,I-DNA_Mutation
:,I-DNA_Mutation
A,I-DNA_Mutation
transversions,B-DNA_Mutation
in,O
tumour,O
APC,B-Gene_protein
and,O
other,O
genes,O
thereby,O
altering,O
genomic,O
integrity,O
.,O
 , 
We,O
report,O
that,O
of,O
the,O
four,O
established,O
cell,O
lines,O
,,O
derived,O
from,O
patients,O
with,O
the,O
MAP,O
phenotype,O
and,O
containing,O
biallelic,O
MUTYH,B-Gene_protein
mutations,B-DNA_Mutation
,,I-DNA_Mutation
three,O
contain,O
altered,O
expressions,O
of,O
MUTYH,B-Gene_protein
protein,O
(,B-Gene_protein
MUTYH,I-Gene_protein
Y165C(-/-,B-Protein_Mutation
),I-Protein_Mutation
,,I-Protein_Mutation
MUTYH,B-Gene_protein
1103delC,B-Protein_Mutation
/,I-Protein_Mutation
G382D,I-Protein_Mutation
and,O
MUTYH,B-Gene_protein
 , 
Y165C,B-Protein_Mutation
/,B-Protein_Mutation
G382D,I-Protein_Mutation
but,O
not,O
MUTYH,B-Gene_protein
G382D(-/-,B-Protein_Mutation
),I-Protein_Mutation
),I-Protein_Mutation
,,O
but,O
that,O
all,O
four,O
cell,O
lines,O
have,O
wild,O
type,O
levels,O
of,O
MUTYH,B-Gene_protein
mRNA,O
.,O
 , 
Mutant,B-DNA_Mutation
MUTYH,B-Gene_protein
proteins,O
in,O
these,O
four,O
cell,O
lines,O
possess,O
significantly,O
lowered,O
binding,O
and,O
cleavage,O
activities,O
with,O
heteroduplex,O
oligonucleotides,O
containing,O
A.8,B-Protein_Mutation
-,I-Protein_Mutation
oxoG,I-Protein_Mutation
and,O
8,B-Protein_Mutation
-,I-Protein_Mutation
oxoA.G,I-Protein_Mutation
mispairs,O
.,O
 , 
Transfection,O
of,O
mitochondrial,O
or,O
nuclear,O
MUTYH,B-Gene_protein
cDNAs,O
partially,O
correct,O
altered,O
MUTYH,B-Gene_protein
expression,O
and,O
activity,O
in,O
these,O
defective,O
cell,O
lines,O
.,O
 , 
Finally,O
,,O
we,O
surprisingly,O
find,O
that,O
defective,O
MUTYH,B-Gene_protein
may,O
not,O
alter,O
cell,O
survival,O
after,O
hydrogen,O
peroxide,O
and,O
menadione,O
treatments,O
.,O
 , 
The,O
Y165C,B-Protein_Mutation
and,O
1103delC,B-Protein_Mutation
mutations,B-Protein_Mutation
significantly,O
reduce,O
MUTYH,B-Gene_protein
protein,O
stability,O
and,O
thus,O
repair,O
activity,O
,,O
whereas,O
the,O
G382D,B-Protein_Mutation
mutation,B-Protein_Mutation
produces,O
dysfunctional,O
protein,O
only,O
suggesting,O
different,O
functional,O
molecular,O
mechanisms,O
by,O
which,O
the,O
MAP,O
phenotype,O
may,O
contribute,O
to,O
the,O
development,O
of,O
CRC,O
.,O
 , 

,O
 , 
#24225759
Traditional,O
serrated,O
adenoma,O
of,O
the,O
colorectum,O
:,O
clinicopathologic,O
implications,O
and,O
endoscopic,O
findings,O
of,O
the,O
precursor,O
lesions,O
.,O
 , 



,O
#,O
#,O
OBJECTIVES,O

,O
To,O
investigate,O
the,O
clinicopathologic,O
and,O
endoscopic,O
features,O
of,O
precursor,O
lesions,O
associated,O
with,O
traditional,O
serrated,O
adenomas,O
(,O
TSAs,O
),O
.,O
 , 


,O
#,O
#,O
METHODS,O

,B-DNA_Mutation
Mutation,I-DNA_Mutation
studies,O
for,O
BRAF,B-Gene_protein
,,I-Gene_protein
KRAS,B-Gene_protein
,,I-Gene_protein
PIK3CA,B-Gene_protein
,,I-Gene_protein
and,O
EGFR,B-Gene_protein
and,O
immunohistochemical,O
staining,O
for,O
Ki-67,B-Gene_protein
were,O
performed,O
on,O
107,O
TSAs,O
from,O
104,O
patients,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Nondysplastic,O
hyperplastic,O
polyp,O
(,O
HP,O
),O
or,O
sessile,O
serrated,O
adenoma,O
/,O
polyp,O
(,O
SSA,O
/,O
P,O
),O
precursor,O
lesions,O
were,O
found,O
in,O
56,O
(,O
52.3,O
%,O
),O
TSAs,O
,,O
among,O
which,O
32,O
(,O
57.1,O
%,O
),O
cases,O
showed,O
a,O
flat,O
-,O
elevated,O
lesion,O
with,O
a,O
type,O
II,O
pit,O
pattern,O
during,O
endoscopy,O
.,O
 , 
TSAs,O
with,O
an,O
SSA,O
/,O
P,O
precursor,O
lesion,O
were,O
usually,O
found,O
in,O
the,O
proximal,O
colon,O
,,O
while,O
TSAs,O
with,O
an,O
HP,O
or,O
with,O
no,O
precursor,O
lesion,O
were,O
mainly,O
located,O
in,O
the,O
distal,O
colon,O
and,O
rectum,O
(,O
P,O
<,O
.001,O
),O
.,O
 , 
TSAs,O
with,O
a,O
precursor,O
lesion,O
showed,O
a,O
lower,O
frequency,O
of,O
conventional,O
epithelial,O
dysplasia,O
and,O
KRAS,B-Gene_protein
mutation,B-DNA_Mutation
as,O
well,O
as,O
a,O
higher,O
frequency,O
of,O
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
compared,O
with,O
those,O
with,O
no,O
precursor,O
lesion,O
(,O
P,O
=,O
.002,O
,,O
P,O
<,O
.001,O
,,O
and,O
P,O
<,O
.001,O
,,O
respectively,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
 , 
A,O
significant,O
proportion,O
of,O
HP,O
or,O
SSA,O
/,O
P,O
precursor,O
lesions,O
accompanied,O
by,O
TSAs,O
can,O
be,O
detected,O
by,O
endoscopy,O
based,O
on,O
both,O
their,O
flat,O
-,O
elevated,O
growth,O
and,O
type,O
II,O
pit,O
patterns,O
.,O
 , 
The,O
heterogeneity,O
of,O
TSAs,O
in,O
terms,O
of,O
clinicopathologic,O
and,O
molecular,O
features,O
correlated,O
with,O
the,O
status,O
or,O
type,O
of,O
precursor,O
lesions,O
.,O
 , 

,O
 , 
#8709782
Molecular,O
genetic,O
tests,O
as,O
a,O
guide,O
to,O
surgical,O
management,O
of,O
familial,O
adenomatous,O
polyposis,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
 , 
In,O
familial,O
adenomatous,O
polyposis,O
the,O
only,O
curative,O
treatment,O
is,O
colectomy,O
,,O
and,O
the,O
choice,O
of,O
operation,O
lies,O
between,O
restorative,O
proctocolectomy,O
(,O
RPC,O
),O
and,O
colectomy,O
with,O
ileorectal,O
anastomosis,O
(,O
IRA,O
),O
.,O
 , 
The,O
RPC,O
procedure,O
carries,O
a,O
higher,O
morbidity,O
but,O
,,O
unlike,O
IRA,O
,,O
removes,O
the,O
risk,O
of,O
subsequent,O
rectal,O
cancer,O
.,O
 , 
Since,O
the,O
course,O
of,O
familial,O
adenomatous,O
polyposis,O
is,O
influenced,O
by,O
the,O
site,O
of,O
mutation,B-DNA_Mutation
in,O
the,O
polyposis,B-Gene_protein
gene,O
,,O
DNA,O
analysis,O
might,O
be,O
helpful,O
in,O
treatment,O
decisions,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
We,O
evaluated,O
the,O
incidence,O
of,O
rectal,O
cancer,O
in,O
polyposis,O
patients,O
who,O
had,O
undergone,O
IRA,O
,,O
and,O
examined,O
whether,O
the,O
requirement,O
for,O
subsequent,O
rectal,O
excision,O
because,O
of,O
cancer,O
or,O
uncontrollable,O
polyps,O
was,O
related,O
to,O
the,O
site,O
of,O
mutation,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
#,O
#,O
FINDINGS,O

,O
Between,O
1956,O
and,O
mid-1995,O
,,O
225,O
patients,O
registered,O
at,O
the,O
Netherlands,O
Polyposis,O
Registry,O
had,O
undergone,O
IRA,O
.,O
 , 
In,O
87,O
of,O
them,O
,,O
a,O
pathogenetic,O
mutation,B-DNA_Mutation
was,O
detected,O
.,O
 , 
72,O
patients,O
had,O
a,O
mutation,B-DNA_Mutation
located,O
before,O
codon,B-locus
1250,I-locus
and,O
15,O
patients,O
after,O
this,O
codon,O
.,O
 , 
The,O
cumulative,O
risk,O
of,O
rectal,O
cancer,O
20,O
years,O
after,O
surgery,O
was,O
12,O
%,O
,,O
and,O
at,O
that,O
time,O
42,O
%,O
had,O
undergone,O
rectal,O
excision,O
.,O
 , 
The,O
risk,O
of,O
secondary,O
surgery,O
was,O
higher,O
in,O
patients,O
with,O
mutations,B-DNA_Mutation
in,O
the,O
region,O
after,O
codon,B-locus
1250,I-locus
than,O
in,O
patients,O
with,O
mutations,O
before,O
this,O
codon,O
(,O
relative,O
risk,O
2.7,O
,,O
p,O
<,O
0.05,O
),O
.,O
 , 


,O
#,O
#,O
INTERPRETATION,O

,O
 , 
On,O
this,O
evidence,O
,,O
IRA,O
should,O
be,O
the,O
primary,O
treatment,O
for,O
polyposis,O
in,O
patients,O
with,O
mutations,B-DNA_Mutation
before,O
codon,B-locus
1250,I-locus
,,I-locus
and,O
RPC,O
in,O
those,O
with,O
mutations,B-DNA_Mutation
after,O
this,O
codon,O
.,O
 , 

,O
 , 
#1347643
Progression,O
of,O
colorectal,O
cancer,O
is,O
associated,O
with,O
multiple,O
tumor,B-Gene_protein
suppressor,I-Gene_protein
gene,O
defects,B-DNA_Mutation
but,O
inhibition,O
of,O
tumorigenicity,O
is,O
accomplished,O
by,O
correction,O
of,O
any,O
single,O
defect,O
via,O
chromosome,B-locus
transfer,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
Carcinogenesis,O
is,O
a,O
multistage,O
process,O
that,O
has,O
been,O
characterized,O
both,O
by,O
the,O
activation,O
of,O
cellular,O
oncogenes,O
and,O
by,O
the,O
loss,B-Mutation
of,I-Mutation
function,I-Mutation
of,O
tumor,O
suppressor,O
genes,O
.,O
 , 
Colorectal,O
cancer,O
has,O
been,O
associated,O
with,O
the,O
activation,O
of,O
ras,B-Gene_protein
oncogenes,O
and,O
with,O
the,O
deletion,B-DNA_Mutation
of,O
multiple,O
chromosomal,O
regions,O
including,O
chromosomes,B-locus
5q,I-locus
,,I-locus
17p,I-locus
,,I-locus
and,I-locus
18q,I-locus
.,I-locus
 , 
Such,O
chromosome,B-DNA_Mutation
loss,I-DNA_Mutation
is,O
often,O
suggestive,O
of,O
the,O
deletion,B-DNA_Mutation
or,O
loss,B-Mutation
of,I-Mutation
function,I-Mutation
of,O
tumor,O
suppressor,O
genes,O
.,O
 , 
The,O
candidate,O
tumor,O
suppressor,O
genes,O
from,O
these,O
regions,O
are,O
,,O
respectively,O
,,O
MCC,B-Gene_protein
and/or,O
APC,B-Gene_protein
,,I-Gene_protein
p53,B-Gene_protein
,,I-Gene_protein
and,O
DCC,B-Gene_protein
.,I-Gene_protein
 , 
In,O
order,O
to,O
further,O
our,O
understanding,O
of,O
the,O
molecular,O
and,O
genetic,O
mechanisms,O
involved,O
in,O
tumor,O
progression,O
and,O
,,O
thereby,O
,,O
of,O
normal,O
cell,O
growth,O
,,O
it,O
is,O
important,O
to,O
determine,O
whether,O
defects,O
in,O
one,O
or,O
more,O
of,O
these,O
loci,O
contribute,O
functionally,O
in,O
the,O
progression,O
to,O
malignancy,O
in,O
colorectal,O
cancer,O
and,O
whether,O
correction,O
of,O
any,O
of,O
these,O
defects,O
restores,O
normal,O
growth,O
control,O
in,O
vitro,O
and,O
in,O
vivo,O
.,O
 , 
To,O
address,O
this,O
question,O
,,O
we,O
have,O
utilized,O
the,O
technique,O
of,O
microcell,O
-,O
mediated,O
chromosome,O
transfer,O
to,O
introduce,O
normal,O
human,O
chromosomes,B-locus
5,I-locus
,,I-locus
17,I-locus
,,I-locus
and,I-locus
18,I-locus
individually,O
into,O
recipient,O
colorectal,O
cancer,O
cells,O
.,O
 , 
Additionally,O
,,O
chromosome,B-locus
15,I-locus
was,O
introduced,O
into,O
SW480,O
cells,O
as,O
an,O
irrelevant,O
control,O
chromosome,O
.,O
 , 
While,O
the,O
introduction,O
of,O
chromosome,B-locus
17,I-locus
into,O
the,O
tumorigenic,O
colorectal,O
cell,O
line,O
SW480,O
yielded,O
no,O
viable,O
clones,O
,,O
cell,O
lines,O
were,O
established,O
after,O
the,O
introduction,O
of,O
chromosomes,B-locus
15,I-locus
,,I-locus
5,I-locus
,,I-locus
and,I-locus
18,I-locus
.,I-locus
 , 
Hybrids,O
containing,O
chromosome,B-locus
18,I-locus
are,O
morphologically,O
similar,O
to,O
the,O
parental,O
line,O
,,O
whereas,O
those,O
containing,O
chromosome,B-locus
5,I-locus
are,O
morphologically,O
distinct,O
from,O
the,O
parental,O
cell,O
line,O
,,O
being,O
small,O
,,O
polygonal,O
,,O
and,O
tightly,O
packed,O
.,O
 , 
SW480,O
-,O
chromosome,O
5,O
hybrids,O
are,O
strongly,O
suppressed,O
for,O
tumorigenicity,O
,,O
while,O
SW480,O
-,O
chromosome,O
18,O
hybrids,O
produce,O
slowly,O
growing,O
tumors,O
in,O
some,O
of,O
the,O
animals,O
injected,O
.,O
 , 
Hybrids,O
containing,O
the,O
introduced,O
chromosome,B-locus
18,I-locus
but,O
was,O
significantly,O
reduced,O
in,O
several,O
of,O
the,O
tumor,O
reconstitute,O
cell,O
lines,O
.,O
 , 
Introduction,O
of,O
chromosome,B-locus
5,I-locus
had,O
little,O
to,O
no,O
effect,O
on,O
responsiveness,O
,,O
whereas,O
transfer,O
ot,O
chromosome,B-locus
18,I-locus
restored,O
responsiveness,O
to,O
some,O
degree,O
.,O
 , 
Our,O
findings,O
indicate,O
that,O
while,O
multiple,O
defects,B-Mutation
in,O
tumor,O
suppressor,O
genes,O
seem,O
to,O
be,O
required,O
for,O
progression,O
to,O
the,O
malignant,O
state,O
in,O
colorectal,O
cancer,O
,,O
correction,O
of,O
only,O
a,O
single,O
defect,B-Mutation
can,O
have,O
significant,O
effects,O
in,O
vivo,O
and/or,O
in,O
vitro,O
.,O

,O
 , 
#17186357
The,O
T393C,B-Mutation
polymorphism,O
in,O
the,O
gene,O
GNAS1,B-Gene_protein
of,O
G,B-Gene_protein
protein,I-Gene_protein
is,O
associated,O
with,O
survival,O
of,O
patients,O
with,O
invasive,O
breast,O
carcinoma,O
.,O
 , 


,O
The,O
GNAS1,B-Gene_protein
locus,O
encodes,O
the,O
G(alpha)s,B-Gene_protein
protein,I-Gene_protein
which,O
stimulates,O
the,O
formation,O
of,O
cyclic,O
AMP,O
(,O
cAMP,O
),O
.,O
 , 
Subsequently,O
the,O
cAMP,O
pathway,O
mediates,O
various,O
pleiotropic,O
effects,O
including,O
regulation,O
of,O
apoptosis,O
and,O
proliferation,O
.,O
 , 
We,O
have,O
recently,O
shown,O
that,O
genotypes,O
of,O
the,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphism,I-DNA_Mutation
(,B-DNA_Mutation
SNP,I-DNA_Mutation
),I-DNA_Mutation
T393C,B-DNA_Mutation
in,O
the,O
gene,O
GNAS1,B-Gene_protein
are,O
associated,O
with,O
survival,O
of,O
patients,O
suffering,O
from,O
bladder,O
,,O
renal,O
cell,O
and,O
colorectal,O
carcinoma,O
.,O
 , 
In,O
the,O
present,O
study,O
,,O
the,O
genotypes,O
of,O
the,O
T393C,B-DNA_Mutation
SNP,B-DNA_Mutation
were,O
determined,O
in,O
279,O
patients,O
with,O
invasive,O
breast,O
carcinoma,O
.,O
 , 
Comparing,O
the,O
genotypes,O
with,O
the,O
overall,O
survival,O
as,O
well,O
as,O
important,O
clinico,O
-,O
pathological,O
parameters,O
showed,O
that,O
carriers,O
of,O
the,O
T,O
allele,O
had,O
a,O
significantly,O
less,O
favourable,O
course,O
of,O
the,O
disease,O
when,O
compared,O
to,O
carriers,O
of,O
the,O
homozygous,O
CC,O
genotype,O
.,O
 , 
In,O
multivariate,O
analysis,O
the,O
homozygous,O
TT,O
genotype,O
was,O
independently,O
associated,O
with,O
a,O
decreased,O
overall,O
survival,O
.,O
 , 
Our,O
results,O
suggest,O
that,O
the,O
GNAS1,B-Gene_protein
T393C,B-DNA_Mutation
SNP,B-DNA_Mutation
is,O
a,O
novel,O
genetic,O
host,O
factor,O
for,O
disease,O
progression,O
in,O
patients,O
with,O
invasive,O
breast,O
carcinoma,O
.,O
 , 

,O
 , 
#1325867
Direct,O
chromosome,O
analysis,O
of,O
seven,O
primary,O
colorectal,O
carcinomas,O
.,O
 , 


,O
Chromosome,O
studies,O
were,O
performed,O
on,O
direct,O
preparations,O
of,O
seven,O
cases,O
of,O
primary,O
colorectal,O
carcinomas,O
.,O
 , 
Two,O
cases,O
had,O
relatively,O
simple,O
chromosome,B-DNA_Mutation
changes,I-DNA_Mutation
:,I-DNA_Mutation
48,XY,+8,+21/51,B-DNA_Mutation
,,I-DNA_Mutation
XY,+8,+9,+10,+i(17q),+21,B-DNA_Mutation
,,I-DNA_Mutation
and,O
47,der(X)t(X;14)(q11;q11)-Y,B-DNA_Mutation
,,I-DNA_Mutation
t(6;18)(p22;q24)+7,+8,der(19)t,I-DNA_Mutation
(,I-DNA_Mutation
19;?)(q13,I-DNA_Mutation
;,I-DNA_Mutation
?,I-DNA_Mutation
),I-DNA_Mutation
.,I-DNA_Mutation
 , 
The,O
five,O
others,O
had,O
complicated,O
deletions,B-DNA_Mutation
and,O
translocations,B-DNA_Mutation
;,I-DNA_Mutation
1p-,B-DNA_Mutation
was,O
noted,O
in,O
five,O
cases,O
,,O
and,O
i(17q,B-locus
),I-locus
was,O
noted,O
in,O
three,O
cases,O
.,O

,O
 , 
#22396040
Meta,O
-,O
analyses,O
of,O
the,O
associations,O
between,O
four,O
common,O
TGF,B-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
genetic,O
polymorphisms,B-DNA_Mutation
and,O
risk,O
of,O
colorectal,O
tumor,O
.,O
 , 


,O
The,O
associations,O
between,O
four,O
common,O
genetic,O
polymorphisms,B-DNA_Mutation
of,O
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
(,B-Gene_protein
TGF,I-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
-509,B-DNA_Mutation
C,I-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
,,I-DNA_Mutation
+869,B-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
+915,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
and,O
-800,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
),I-DNA_Mutation
and,O
risk,O
of,O
colorectal,O
tumor,O
(,O
including,O
adenoma,O
and,O
cancer,O
),O
have,O
been,O
widely,O
studied,O
.,O
 , 
To,O
date,O
,,O
no,O
conclusions,O
could,O
be,O
available,O
because,O
of,O
controversial,O
results,O
reported,O
.,O
 , 
Thus,O
,,O
we,O
conducted,O
a,O
meta,O
-,O
analysis,O
to,O
further,O
assess,O
the,O
associations,O
.,O
 , 
We,O
searched,O
the,O
databases,O
of,O
Medline,O
,,O
Embase,O
,,O
and,O
Wangfang,O
to,O
identify,O
eligible,O
studies,O
,,O
and,O
latest,O
update,O
was,O
on,O
January,O
1,O
,,O
2012,O
.,O
 , 
Odds,O
ratio,O
(,O
OR,O
),O
and,O
95,O
%,O
confidence,O
interval,O
(,O
95%CI,O
),O
were,O
calculated,O
to,O
present,O
the,O
associations,O
.,O
 , 
Our,O
meta,O
-,O
analysis,O
indicated,O
that,O
TGF,B-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
-509,B-DNA_Mutation
C,I-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
,,I-DNA_Mutation
+869,B-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
+915,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
and,O
-800,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
were,O
not,O
associated,O
with,O
risk,O
of,O
colorectal,O
adenoma,O
(,O
OR,O
=,O
0.89,O
for,O
C,O
carriers,O
vs.,O
TT,O
for,O
-509,B-DNA_Mutation
C,I-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
,,I-DNA_Mutation
1.03,O
for,O
C,O
carriers,O
vs.,O
TT,O
for,O
+869,B-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
1.09,O
for,O
C,O
carriers,O
vs.,O
GG,O
for,O
+915,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
and,O
1.19,O
for,O
A,O
carriers,O
vs.,O
GG,O
for,O
800,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
),I-DNA_Mutation
.,O
 , 
However,O
,,O
C,O
allele,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
-509,B-DNA_Mutation
C,I-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
and,O
A,O
allele,O
of,O
-800,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
were,O
associated,O
with,O
increased,O
risk,O
of,O
colorectal,O
cancer,O
(,O
CRC,O
),O
,,O
and,O
OR,O
(,O
95%CI,O
),O
was,O
1.23,O
(,O
0.99,O
-,O
1.52,O
),O
for,O
CC,O
vs.,O
TT,O
for,O
-509,B-DNA_Mutation
C,I-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
and,O
6.64,O
(,O
3.46,O
-,O
12.72,O
),O
for,O
A,O
carriers,O
vs.,O
GG,O
.,O
 , 
The,O
positive,O
association,O
between,O
-509,O
C,O
allele,O
and,O
risk,O
of,O
CRC,O
was,O
more,O
obvious,O
when,O
subgroup,O
analyses,O
were,O
conducted,O
for,O
population,O
-,O
based,O
and,O
large,O
sample,O
-,O
sized,O
studies,O
as,O
well,O
as,O
Caucasians,O
.,O
 , 
In,O
contrast,O
,,O
we,O
did,O
not,O
observed,O
any,O
associations,O
between,O
TGF,B-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
 ,B-DNA_Mutation
+869,I-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
+915,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
C,I-DNA_Mutation
,,I-DNA_Mutation
and,O
risk,O
of,O
CRC,O
.,O
 , 
This,O
study,O
indicated,O
that,O
C,O
allele,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
β1,I-Gene_protein
-,I-Gene_protein
509,I-DNA_Mutation
C,I-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
and,O
A,O
allele,O
of,O
-800,B-DNA_Mutation
G,I-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
might,O
contribute,O
to,O
the,O
increased,O
risk,O
of,O
CRC,O
,,O
and,O
could,O
be,O
used,O
as,O
two,O
of,O
genetic,O
marks,O
for,O
screening,O
individuals,O
at,O
high,O
risk,O
of,O
CRC,O
.,O
 , 
Because,O
of,O
modest,O
limitation,O
,,O
large,O
sample,O
-,O
sized,O
studies,O
were,O
required,O
to,O
confirm,O
the,O
findings,O
.,O
 , 

,O
 , 
#22575968
Assessing,O
disease,O
risk,O
in,O
genome,O
-,O
wide,O
association,O
studies,O
using,O
family,O
history,O
.,O
 , 


,O
We,O
show,O
how,O
to,O
use,O
reports,O
of,O
cancer,O
in,O
family,O
members,O
to,O
discover,O
additional,O
genetic,O
associations,O
or,O
confirm,O
previous,O
findings,O
in,O
genome,O
-,O
wide,O
association,O
(,O
GWA,O
),O
studies,O
conducted,O
in,O
case,O
-,O
control,O
,,O
cohort,O
,,O
or,O
cross,O
-,O
sectional,O
studies,O
.,O
 , 
Our,O
novel,O
family,O
history,O
-,O
based,O
approach,O
allows,O
economical,O
association,O
studies,O
for,O
multiple,O
cancers,O
,,O
without,O
genotyping,O
of,O
relatives,O
(,O
as,O
required,O
in,O
family,O
studies,O
),O
,,O
follow,O
-,O
up,O
of,O
participants,O
(,O
as,O
required,O
in,O
cohort,O
studies,O
),O
,,O
or,O
oversampling,O
of,O
specific,O
cancer,O
cases,O
(,O
as,O
required,O
in,O
case,O
-,O
control,O
studies,O
),O
.,O
 , 
We,O
empirically,O
evaluate,O
the,O
performance,O
of,O
the,O
proposed,O
family,O
history,O
-,O
based,O
approach,O
in,O
studying,O
associations,O
with,O
prostate,O
and,O
ovarian,O
cancers,O
,,O
using,O
data,O
from,O
GWA,O
studies,O
previously,O
conducted,O
within,O
the,O
Prostate,O
,,O
Lung,O
,,O
Colorectal,O
,,O
and,O
Ovarian,O
Cancer,O
Screening,O
Trial,O
.,O
 , 
The,O
family,O
history,O
-,O
based,O
method,O
may,O
be,O
particularly,O
useful,O
for,O
investigating,O
genetic,O
susceptibility,O
to,O
rare,O
diseases,O
for,O
which,O
accruing,O
cases,O
may,O
be,O
very,O
difficult,O
,,O
by,O
using,O
disease,O
information,O
from,O
nongenotyped,O
relatives,O
of,O
participants,O
in,O
multiple,O
case,O
-,O
control,O
and,O
cohort,O
studies,O
designed,O
primarily,O
for,O
other,O
purposes,O
.,O
 , 

,O
 , 
#12702972
Coprocytobiology,O
:,O
on,O
the,O
nature,O
of,O
cellular,O
elements,O
from,O
stools,O
in,O
the,O
pathophysiology,O
of,O
colonic,O
disease,O
.,O
 , 


,O
The,O
gastrointestinal,O
epithelium,O
is,O
known,O
to,O
undergo,O
constant,O
and,O
rapid,O
renewal,O
resulting,O
in,O
millions,O
of,O
cells,O
being,O
shed,O
into,O
the,O
fecal,O
stream,O
every,O
day,O
.,O
 , 
The,O
conventional,O
wisdom,O
was,O
that,O
these,O
cells,O
disintegrate,O
upon,O
exfoliation,O
and,O
will,O
not,O
survive,O
the,O
transit,O
through,O
the,O
intestinal,O
tract,O
.,O
 , 
In,O
1990,O
,,O
we,O
(,O
P.N.,O
),O
made,O
the,O
discovery,O
that,O
a,O
significant,O
number,O
of,O
these,O
cells,O
remain,O
intact,O
and,O
viable,O
and,O
that,O
they,O
can,O
be,O
isolated,O
.,O
 , 
The,O
implications,O
of,O
this,O
important,O
discovery,O
became,O
apparent,O
when,O
we,O
demonstrated,O
that,O
these,O
cells,O
are,O
exclusively,O
of,O
colonic,O
origin,O
,,O
are,O
anatomically,O
representative,O
of,O
the,O
entire,O
colon,O
,,O
and,O
can,O
be,O
used,O
for,O
clinical,O
investigations,O
of,O
disease,O
processes,O
.,O
 , 
The,O
term,O
coprocytobiology,O
(,O
CCB,O
),O
was,O
coined,O
to,O
encompass,O
the,O
broad,O
range,O
of,O
applications,O
of,O
this,O
new,O
technology,O
.,O
 , 
The,O
somatic,O
cell,O
sampling,O
and,O
recovery,O
(,O
SCSR,O
),O
process,O
involves,O
the,O
isolation,O
of,O
exfoliated,O
colonocytes,O
from,O
a,O
small,O
sample,O
of,O
stool,O
(,O
approximately,O
1,O
g,O
),O
collected,O
and,O
transported,O
in,O
a,O
unique,O
medium,O
at,O
ambient,O
temperature,O
,,O
providing,O
cells,O
for,O
the,O
detection,O
of,O
a,O
number,O
of,O
biomarkers,O
of,O
disease,O
propensity,O
.,O
 , 
These,O
exfoliated,O
colonocytes,O
express,O
cytokeratins,O
indicating,O
epithelial,O
lineage,O
as,O
well,O
as,O
colon,O
-,O
specific,O
antigen,O
.,O
 , 
Over,O
the,O
years,O
,,O
the,O
study,O
of,O
exfoliated,O
colonocytes,O
has,O
provided,O
striking,O
new,O
insights,O
into,O
the,O
biology,O
of,O
colon,O
cancer,O
and,O
inflammatory,O
bowel,O
disease,O
,,O
including,O
detection,O
of,O
p53,B-Gene_protein
gene,O
mutations,B-DNA_Mutation
,,I-DNA_Mutation
reverse,O
transcriptase,O
polymerase,O
chain,O
reaction,O
amplification,O
,,O
and,O
identification,O
of,O
CD44,B-Gene_protein
splice,B-DNA_Mutation
variants,I-DNA_Mutation
,,I-DNA_Mutation
neoplasia,O
-,O
associated,O
specific,O
binding,O
of,O
plant,O
lectins,B-Gene_protein
,,I-Gene_protein
and,O
expression,O
of,O
COX-2,B-Gene_protein
,,I-Gene_protein
the,O
inducible,O
form,O
of,O
cyclooxygenase,B-Gene_protein
.,I-Gene_protein
 , 
The,O
functional,O
diversity,O
of,O
cells,O
isolated,O
by,O
SCSR,O
is,O
revealed,O
by,O
the,O
demonstration,O
of,O
cell,O
surface,O
markers,O
such,O
as,O
secretory,O
component,O
,,O
IgA,B-Gene_protein
,,I-Gene_protein
and,O
IgG,B-Gene_protein
on,O
the,O
one,O
hand,O
and,O
the,O
amplification,O
and,O
cloning,O
of,O
the,O
human,B-Gene_protein
insulin,I-Gene_protein
receptor,I-Gene_protein
and,O
the,O
expression,O
of,O
the,O
multidrug,O
resistance,O
gene,O
mdr-1,B-Gene_protein
on,O
the,O
other,O
hand,O
.,O
 , 
This,O
review,O
portrays,O
the,O
immense,O
potential,O
of,O
CCB,O
as,O
a,O
powerful,O
tool,O
for,O
investigating,O
the,O
pathophysiology,O
of,O
disease,O
,,O
identifying,O
genetic,O
variants,B-DNA_Mutation
in,O
pharmacogenetics,O
,,O
assessment,O
of,O
mucosal,O
immunity,O
,,O
and,O
several,O
other,O
applications,O
that,O
use,O
somatic,O
cells,O
.,O
 , 

,O
 , 
#24435063
Interest,O
and,O
informational,O
preferences,O
regarding,O
genomic,O
testing,O
for,O
modest,O
increases,O
in,O
colorectal,O
cancer,O
risk,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O
/,O
AIMS,O

,O
 , 
This,O
study,O
explored,O
the,O
interest,O
in,O
genomic,O
testing,O
for,O
modest,O
changes,O
in,O
colorectal,O
cancer,O
risk,O
and,O
preferences,O
for,O
receiving,O
genomic,O
risk,O
communications,O
among,O
individuals,O
with,O
intermediate,O
disease,O
risk,O
due,O
to,O
a,O
family,O
history,O
of,O
colorectal,O
cancer,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
Surveys,O
were,O
conducted,O
on,O
272,O
men,O
and,O
women,O
at,O
intermediate,O
risk,O
for,O
colorectal,O
cancer,O
enrolled,O
in,O
a,O
randomized,O
trial,O
comparing,O
a,O
remote,O
personalized,O
risk,O
communication,O
intervention,O
(,O
TeleCARE,O
),O
aimed,O
at,O
promoting,O
colonoscopy,O
to,O
a,O
generic,O
print,O
control,O
condition,O
.,O
 , 
Guided,O
by,O
Leventhal,O
's,O
Common,O
Sense,O
Model,O
of,O
Self,O
-,O
Regulation,O
,,O
we,O
examined,O
demographic,O
and,O
psychosocial,O
factors,O
possibly,O
associated,O
with,O
interest,O
in,O
SNP,B-DNA_Mutation
testing,O
.,O
 , 
Descriptive,O
statistics,O
and,O
logistic,O
regression,O
models,O
were,O
used,O
to,O
identify,O
factors,O
associated,O
with,O
interest,O
in,O
SNP,O
testing,O
and,O
preferences,O
for,O
receiving,O
genomic,O
risk,O
communications,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Three,O
-,O
fourths,O
of,O
participants,O
expressed,O
interest,O
in,O
SNP,B-DNA_Mutation
testing,O
for,O
colorectal,O
cancer,O
risk,O
.,O
 , 
Testing,O
interest,O
did,O
not,O
markedly,O
change,O
across,O
behavior,O
modifier,O
scenarios,O
.,O
 , 
Participants,O
preferred,O
to,O
receive,O
genomic,O
risk,O
communications,O
from,O
a,O
variety,O
of,O
sources,O
:,O
printed,O
materials,O
(,O
69.5,O
%,O
),O
,,O
oncologists,O
(,O
54.8,O
%,O
),O
,,O
primary,O
-,O
care,O
physicians,O
(,O
58.4,O
%,O
),O
,,O
and,O
the,O
web,O
(,O
58.1,O
%,O
),O
.,O
 , 
Overall,O
,,O
persons,O
who,O
were,O
unmarried,O
(,O
p,O
=,O
0.029,O
),O
,,O
younger,O
(,O
p,O
=,O
0.003,O
),O
and,O
with,O
greater,O
cancer,O
-,O
related,O
fear,O
(,O
p,O
=,O
0.019,O
),O
were,O
more,O
likely,O
to,O
express,O
interest,O
in,O
predictive,O
genomic,O
testing,O
for,O
colorectal,O
cancer,O
risk,O
.,O
 , 
In,O
a,O
stratified,O
analysis,O
,,O
cancer,O
-,O
related,O
fear,O
was,O
associated,O
with,O
the,O
interest,O
in,O
predictive,O
genomic,O
testing,O
in,O
the,O
intervention,O
group,O
(,O
p,O
=,O
0.017,O
),O
,,O
but,O
not,O
the,O
control,O
group,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Individuals,O
with,O
intermediate,O
familial,O
risk,O
for,O
colorectal,O
cancer,O
are,O
highly,O
interested,O
in,O
genomic,O
testing,O
for,O
modest,O
increases,O
in,O
disease,O
risk,O
,,O
specifically,O
unmarried,O
persons,O
,,O
younger,O
age,O
groups,O
and,O
those,O
with,O
greater,O
cancer,O
fear,O
.,O
 , 

,O
 , 
#25374237
Association,O
between,O
survivin,B-Gene_protein
gene,O
polymorphisms,B-DNA_Mutation
and,O
the,O
susceptibility,O
to,O
colon,O
cancer,O
development,O
in,O
the,O
Turkish,O
population,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Colon,O
cancer,O
is,O
one,O
of,O
the,O
most,O
common,O
cancers,O
worldwide,O
.,O
 , 
Apoptosis,O
is,O
a,O
necessary,O
physiological,O
process,O
for,O
cell,O
elimination,O
which,O
is,O
very,O
important,O
both,O
cellular,O
homeostasis,O
and,O
cell,O
proliferation,O
and,O
differantiation,O
.,O
 , 
Dysregulation,O
can,O
lead,O
to,O
uncontrolled,O
cell,O
growth,O
and,O
tumor,O
development,O
.,O
 , 
Survivin,B-Gene_protein
,,I-Gene_protein
a,O
member,O
of,O
the,O
IAP,O
family,O
,,O
plays,O
a,O
key,O
role,O
in,O
promotion,O
of,O
cell,O
proliferation,O
as,O
well,O
as,O
inhibition,O
of,O
apoptosis,O
in,O
cancer,O
cells,O
.,O
 , 
The,O
aim,O
of,O
this,O
study,O
was,O
to,O
investigate,O
whether,O
specific,O
genetic,O
polymorphisms,B-DNA_Mutation
of,O
survivin,B-Gene_protein
could,O
be,O
associated,O
with,O
colon,O
cancer,O
development,O
and,O
progression,O
in,O
a,O
Turkish,O
population,O
.,O
 , 
Our,O
study,O
is,O
the,O
first,O
to,O
our,O
knowledge,O
to,O
investigate,O
the,O
relationship,O
between,O
colon,O
cancer,O
risk,O
and,O
survivin,B-Gene_protein
gene,O
polymorphisms,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
#,O
#,O
MATERIALS,O
AND,O
METHODS,O

,O
 , 
The,O
relation,O
between,O
colon,O
cancer,O
and,O
survivin,B-Gene_protein
-31,B-DNA_Mutation
G,I-DNA_Mutation
/,I-DNA_Mutation
C,I-DNA_Mutation
(,B-dbSNP
rs9904341,I-dbSNP
),I-dbSNP
,,O
-241,B-DNA_Mutation
C,I-DNA_Mutation
/,I-DNA_Mutation
T,I-DNA_Mutation
(,B-dbSNP
rs17878467,I-dbSNP
),I-dbSNP
and,O
-625,B-DNA_Mutation
C,I-DNA_Mutation
/,I-DNA_Mutation
G,I-DNA_Mutation
(,B-dbSNP
rs8073069,I-dbSNP
),I-dbSNP
polymorphism,B-DNA_Mutation
in,O
promotor,B-locus
site,I-locus
of,O
survivin,B-Gene_protein
gene,O
associated,O
with,O
apoptosis,O
was,O
investigated,O
using,O
the,O
polymerase,O
chain,O
reaction,O
-,O
restriction,O
fragment,O
length,O
polymorphism,O
(,O
PCR,O
-,O
RFLP,O
),O
method,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Individuals,O
with,O
-31C,O
allele,O
and,O
CC,O
genotype,O
were,O
found,O
to,O
have,O
a,O
higher,O
risk,O
of,O
developing,O
colon,O
cancer,O
(,O
OR=13.4,O
,,O
p=0.01,O
),O
.,O
 , 
The,O
-241,O
CT,O
genotype,O
considerably,O
increased,O
the,O
risk,O
of,O
colon,O
cancer,O
(,O
OR=12.0,O
,,O
p=0.0001,O
),O
.,O
 , 
However,O
,,O
there,O
was,O
no,O
significant,O
varaition,O
of,O
the,O
survivin,B-Gene_protein
-625,B-DNA_Mutation
C,I-DNA_Mutation
/,I-DNA_Mutation
G,I-DNA_Mutation
polymorphism,B-DNA_Mutation
among,O
colon,O
cancer,O
patients,O
and,O
controls,O
in,O
our,O
study,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
 , 
This,O
study,O
provides,O
the,O
first,O
evidence,O
that,O
survivin,B-Gene_protein
-31,B-DNA_Mutation
G,I-DNA_Mutation
/,I-DNA_Mutation
C,I-DNA_Mutation
and,O
-241,B-DNA_Mutation
C,I-DNA_Mutation
/,I-DNA_Mutation
T,I-DNA_Mutation
SNP,B-DNA_Mutation
significantly,O
contribute,O
to,O
the,O
risk,O
of,O
colon,O
cancer,O
in,O
the,O
Turkish,O
population,O
.,O
 , 

,O
 , 
#24196785
Amplification,B-DNA_Mutation
of,O
PVT-1,B-Gene_protein
is,O
involved,O
in,O
poor,O
prognosis,O
via,O
apoptosis,O
inhibition,O
in,O
colorectal,O
cancers,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
 , 
We,O
previously,O
conducted,O
gene,O
expression,O
microarray,O
analyses,O
to,O
identify,O
novel,O
indicators,O
for,O
colorectal,O
cancer,O
(,O
CRC,O
),O
metastasis,O
and,O
prognosis,O
from,O
which,O
we,O
identified,O
PVT-1,B-Gene_protein
as,O
a,O
candidate,O
gene,O
.,O
 , 
PVT-1,B-Gene_protein
,,I-Gene_protein
which,O
encodes,O
a,O
long,O
noncoding,O
RNA,O
,,O
mapped,O
to,O
chromosome,B-locus
8q24,I-locus
whose,O
copy,B-DNA_Mutation
-,I-DNA_Mutation
number,I-DNA_Mutation
amplification,I-DNA_Mutation
is,O
one,O
of,O
the,O
most,O
frequent,O
events,O
in,O
a,O
wide,O
variety,O
of,O
malignant,O
diseases,O
.,O
 , 
However,O
,,O
PVT-1,B-Gene_protein
molecular,O
mechanism,O
of,O
action,O
remains,O
unclear,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
We,O
conducted,O
cell,O
proliferation,O
and,O
invasion,O
assays,O
using,O
colorectal,O
cancer,O
cell,O
lines,O
transfected,O
with,O
PVT-1siRNA,B-Gene_protein
or,O
negative,O
control,O
siRNA,O
.,O
 , 
Gene,O
expression,O
microarray,O
analyses,O
on,O
these,O
cell,O
lines,O
were,O
also,O
carried,O
out,O
to,O
investigate,O
the,O
molecular,O
function,O
of,O
PVT-1,B-Gene_protein
.,I-Gene_protein
 , 
Further,O
,,O
we,O
investigated,O
the,O
impact,O
of,O
PVT-1,B-Gene_protein
expression,O
on,O
the,O
prognosis,O
of,O
164,O
colorectal,O
cancer,O
patients,O
by,O
qRT,O
-,O
PCR,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
CRC,O
cells,O
transfected,O
with,O
PVT-1,B-Gene_protein
siRNA,O
exhibited,O
significant,O
loss,O
of,O
their,O
proliferation,O
and,O
invasion,O
capabilities,O
.,O
 , 
In,O
these,O
cells,O
,,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
signalling,O
pathway,O
and,O
apoptotic,O
signals,O
were,O
significantly,O
activated,O
.,O
 , 
In,O
addition,O
,,O
univariate,O
and,O
multivariate,O
analysis,O
revealed,O
that,O
PVT-1,B-Gene_protein
expression,O
level,O
was,O
an,O
independent,O
risk,O
factor,O
for,O
overall,O
survival,O
of,O
colorectal,O
cancer,O
patients,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,B-Gene_protein
PVT-1,I-Gene_protein
,,I-Gene_protein
which,O
maps,O
to,O
8q24,B-locus
,,I-locus
generates,O
antiapoptotic,O
activity,O
in,O
CRC,O
,,O
and,O
abnormal,O
expression,O
of,O
PVT-1,B-Gene_protein
was,O
a,O
prognostic,O
indicator,O
for,O
CRC,O
patients,O
.,O
 , 

,O
 , 
#1299227
Colorectal,O
carcinoma,O
.,O
 , 
DNA,B-DNA_Mutation
ploidy,I-DNA_Mutation
pattern,I-DNA_Mutation
and,O
prognosis,O
with,O
reference,O
to,O
tumor,O
DNA,B-DNA_Mutation
heterogeneity,I-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
Nuclear,O
DNA,O
content,O
was,O
measured,O
in,O
72,O
colorectal,O
carcinomas,O
using,O
single,O
-,O
cell,O
microspectrophotometry,O
on,O
Feulgen,O
-,O
stained,O
smears,O
.,O
 , 
Four,O
samples,O
were,O
analyzed,O
from,O
each,O
tumor,O
.,O
 , 
Patients,O
were,O
followed,O
for,O
41,O
-,O
65,O
months,O
(,O
average,O
,,O
53,O
),O
.,O
 , 
DNA,B-DNA_Mutation
heterogeneity,I-DNA_Mutation
(,O
both,O
aneuploid,B-DNA_Mutation
and,O
nonaneuploid,B-DNA_Mutation
patterns,O
),O
was,O
present,O
in,O
44,O
%,O
of,O
the,O
cases,O
.,O
 , 
Sixty,O
-,O
eight,O
percent,O
of,O
the,O
tumors,O
showed,O
an,O
aneuploid,B-DNA_Mutation
DNA,O
pattern,O
in,O
at,O
least,O
one,O
of,O
the,O
samples,O
.,O
 , 
Patients,O
with,O
nonaneuploid,B-DNA_Mutation
tumors,O
tended,O
to,O
have,O
a,O
survival,O
advantage,O
over,O
patients,O
with,O
homogeneously,O
aneuploid,B-DNA_Mutation
tumors,O
and,O
demonstrated,O
a,O
significantly,O
longer,O
disease,O
-,O
free,O
survival,O
.,O
 , 
The,O
DNA,B-DNA_Mutation
ploidy,I-DNA_Mutation
pattern,O
is,O
of,O
potential,O
value,O
in,O
conjunction,O
with,O
histopathologic,O
prognostic,O
parameters,O
in,O
colorectal,O
carcinoma,O
.,O
 , 
Since,O
colorectal,O
tumors,O
exhibit,O
pronounced,O
DNA,B-DNA_Mutation
heterogeneity,I-DNA_Mutation
,,I-DNA_Mutation
multiple,O
samples,O
are,O
required,O
from,O
each,O
tumor,O
to,O
permit,O
a,O
proper,O
evaluation,O
of,O
its,O
DNA,O
pattern,O
.,O
 , 
The,O
DNA,B-DNA_Mutation
heterogeneity,I-DNA_Mutation
may,O
represent,O
tumor,O
progression,O
and,O
can,O
partly,O
explain,O
the,O
conflicting,O
results,O
reported,O
concerning,O
DNA,O
pattern,O
and,O
prognosis,O
in,O
colorectal,O
carcinoma,O
.,O
 , 

,O
 , 
#26302849
Polymorphisms,B-DNA_Mutation
of,O
PRLHR,B-Gene_protein
and,O
HSPA12A,B-Gene_protein
and,O
risk,O
of,O
gastric,O
and,O
colorectal,O
cancer,O
in,O
the,O
Chinese,O
Han,O
population,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Gastric,O
and,O
colorectal,O
cancers,O
have,O
a,O
major,O
impact,O
on,O
public,O
health,O
,,O
and,O
are,O
the,O
most,O
common,O
malignant,O
tumors,O
in,O
China,O
.,O
 , 
The,O
aim,O
of,O
this,O
research,O
was,O
to,O
study,O
whether,O
polymorphisms,B-DNA_Mutation
of,O
CHCHD3P1,B-Gene_protein
-,I-Gene_protein
HSP90AB7P,I-Gene_protein
,,I-Gene_protein
GRID1,B-Gene_protein
,,I-Gene_protein
HSPA12A,B-Gene_protein
,,I-Gene_protein
PRLHR,B-Gene_protein
,,I-Gene_protein
SBF2,B-Gene_protein
,,I-Gene_protein
POLD3,B-Gene_protein
and,O
C11orf93,B-Gene_protein
-,I-Gene_protein
C11orf92,I-Gene_protein
genes,O
are,O
associated,O
with,O
the,O
risk,O
of,O
gastric,O
and,O
colorectal,O
cancers,O
in,O
the,O
Chinese,O
Han,O
population,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
We,O
genotyped,O
seven,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNPs,I-DNA_Mutation
),I-DNA_Mutation
from,O
seven,O
genes,O
.,O
 , 
We,O
selected,O
588,O
patients,O
with,O
gastric,O
cancer,O
and,O
449,O
with,O
colorectal,O
cancer,O
,,O
along,O
with,O
703,O
healthy,O
controls,O
.,O
 , 
All,O
these,O
SNPs,B-DNA_Mutation
were,O
evaluated,O
using,O
the,O
χ²,O
test,O
and,O
genetic,O
model,O
analysis,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
The,O
genotype,O
",O
A,O
/,O
T,O
",O
of,O
rs12413624,B-dbSNP
in,O
PRLHR,B-Gene_protein
gene,O
was,O
associated,O
with,O
a,O
decreased,O
risk,O
of,O
colorectal,O
cancer,O
in,O
allele,O
model,O
analysis,O
 , 
[,O
odds,O
ratio,O
(,O
OR,O
),O
 ,O
=,O
 ,O
0.81,O
;,O
95,O
%,O
confidence,O
interval,O
(,O
CI,O
),O
 ,O
=,O
 ,O
0.68,O
-,O
0.97,O
;,O
p,O
 ,O
=,O
 ,O
0.018,O
],O
and,O
log,O
-,O
additive,O
model,O
analysis,O
(,O
OR,O
 ,O
=,O
 ,O
0.81,O
;,O
95,O
%,O
CI,O
 ,O
=,O
 ,O
0.66,O
-,O
0.98,O
;,O
p,O
 ,O
=,O
 ,O
0.032,O
),O
.,O
 , 
The,O
genotype,O
",O
A,O
/,O
G,O
",O
of,O
rs1665650,B-dbSNP
in,O
HSPA12A,B-Gene_protein
gene,O
was,O
associated,O
with,O
a,O
decreased,O
risk,O
of,O
gastric,O
cancer,O
in,O
overdominant,O
model,O
analysis,O
(,O
OR,O
 ,O
=,O
 ,O
0.77,O
;,O
95,O
%,O
CI,O
 ,O
=,O
 ,O
0.60,O
-,O
0.99,O
;,O
p,O
 ,O
=,O
 ,O
0.038,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Our,O
results,O
provide,O
evidence,O
that,O
variants,B-DNA_Mutation
of,O
PRLHR,B-Gene_protein
gene,O
are,O
a,O
protective,O
factor,O
in,O
colorectal,O
cancer,O
and,O
variants,B-DNA_Mutation
of,O
HSPA12A,B-Gene_protein
gene,O
are,O
a,O
protective,O
factor,O
in,O
gastric,O
cancer,O
in,O
the,O
Chinese,O
Han,O
population,O
.,O
 , 

,O
 , 
#26710976
Mismatch,O
repair,O
defects,O
and,O
Lynch,O
syndrome,O
:,O
The,O
role,O
of,O
the,O
basic,O
scientist,O
in,O
the,O
battle,O
against,O
cancer,O
.,O
 , 


,O
We,O
have,O
currently,O
entered,O
a,O
genomic,O
era,O
of,O
cancer,O
research,O
which,O
may,O
soon,O
lead,O
to,O
a,O
genomic,O
era,O
of,O
cancer,O
treatment,O
.,O
 , 
Patient,O
DNA,O
sequencing,O
information,O
may,O
lead,O
to,O
a,O
personalized,O
approach,O
to,O
managing,O
an,O
individual,O
's,O
cancer,O
as,O
well,O
as,O
future,O
cancer,O
risk,O
.,O
 , 
The,O
success,O
of,O
this,O
approach,O
,,O
however,O
,,O
begins,O
not,O
necessarily,O
in,O
the,O
clinician,O
's,O
office,O
,,O
but,O
rather,O
at,O
the,O
laboratory,O
bench,O
of,O
the,O
basic,O
scientist,O
.,O
 , 
The,O
basic,O
scientist,O
plays,O
a,O
critical,O
role,O
since,O
the,O
DNA,O
sequencing,O
information,O
is,O
of,O
limited,O
use,O
unless,O
one,O
knows,O
the,O
function,O
of,O
the,O
gene,O
that,O
is,O
altered,O
and,O
the,O
manner,O
by,O
which,O
a,O
sequence,O
alteration,O
affects,O
that,O
function,O
.,O
 , 
The,O
role,O
of,O
basic,O
science,O
research,O
in,O
aiding,O
the,O
clinical,O
management,O
of,O
a,O
disease,O
is,O
perhaps,O
best,O
exemplified,O
by,O
considering,O
the,O
case,O
of,O
Lynch,O
syndrome,O
,,O
a,O
hereditary,O
disease,O
that,O
predisposes,O
patients,O
to,O
colorectal,O
and,O
other,O
cancers,O
.,O
 , 
This,O
review,O
will,O
examine,O
how,O
the,O
diagnosis,O
,,O
treatment,O
and,O
even,O
prevention,O
of,O
Lynch,O
syndrome,O
-,O
associated,O
cancers,O
has,O
benefitted,O
from,O
extensive,O
basic,O
science,O
research,O
on,O
the,O
DNA,O
mismatch,O
repair,O
genes,O
whose,O
alteration,O
underlies,O
this,O
condition,O
.,O
 , 

,O
 , 
#18097606
Transcriptional,O
regulation,O
of,O
the,O
COX-2,B-Gene_protein
expression,O
by,O
nitric,O
oxide,O
in,O
colon,O
cancer,O
cell,O
lines,O
.,O
 , 


,O
To,O
determine,O
the,O
effect,O
of,O
nitric,O
oxide,O
(,O
NO,O
),O
on,O
the,O
cyclooxygenase-2,B-Gene_protein
(,B-Gene_protein
COX-2,I-Gene_protein
),I-Gene_protein
regulation,O
in,O
colon,O
cancer,O
cell,O
lines,O
we,O
used,O
the,O
physiological,O
NO,O
donor,O
GSNO,O
.,O
 , 
The,O
proximal,B-locus
6.6,I-locus
kb,I-locus
of,O
the,O
COX-2,B-Gene_protein
promoter,B-locus
was,O
cloned,O
into,O
the,O
pGL3,O
basic,O
vector,O
and,O
the,O
sequential,O
deletion,B-DNA_Mutation
of,O
the,O
6.6,B-locus
kb,I-locus
COX-2,B-Gene_protein
promoter,B-locus
generated,O
promoter,O
constructs,O
of,O
4,O
,,O
2.6,O
,,O
1.9,O
and,O
0.9,O
kb,O
.,O
 , 
These,O
constructs,O
clearly,O
show,O
that,O
the,O
main,O
regulatory,O
region,O
lies,O
within,O
0.9,O
kb,O
of,O
the,O
transcription,O
start,O
site,O
.,O
 , 
Therefore,O
,,O
constructs,O
of,O
the,O
main,O
transcription,O
binding,O
sites,O
within,O
this,O
region,O
namely,O
CRE,B-locus
,,I-locus
NF,B-locus
-,I-locus
IL6,I-locus
and,O
NF,B-locus
-,I-locus
kappaB,I-locus
and,O
mutations,B-DNA_Mutation
of,O
these,O
sites,O
were,O
used,O
to,O
monitor,O
the,O
transcriptional,O
activation,O
of,O
COX-2,B-Gene_protein
.,I-Gene_protein
 , 
This,O
study,O
was,O
performed,O
on,O
the,O
colon,O
cancer,O
cell,O
lines,O
HCA7,O
and,O
HCT116,O
which,O
have,O
a,O
differential,O
expression,O
of,O
COX-2,B-Gene_protein
.,I-Gene_protein
 , 
There,O
was,O
no,O
evidence,O
that,O
the,O
luciferase,B-Gene_protein
activity,O
is,O
negatively,O
affected,O
by,O
NO,O
as,O
was,O
previously,O
reported,O
.,O
 , 
The,O
CRE,B-locus
and,O
NF,B-locus
-,I-locus
IL6,I-locus
binding,O
sites,O
within,O
this,O
region,O
were,O
responsible,O
for,O
the,O
constitutive,O
and,O
physiological,O
NO,O
-,O
induced,O
COX-2,B-Gene_protein
transcriptional,O
activity,O
in,O
the,O
HCA7,O
and,O
HCT116,O
cells,O
.,O
 , 
While,O
NF,B-Gene_protein
-,I-Gene_protein
kappaB,I-Gene_protein
involvement,O
was,O
only,O
observed,O
in,O
the,O
HCT116,O
cells,O
,,O
the,O
cell,O
lines,O
displayed,O
increased,O
NF,B-Gene_protein
-,I-Gene_protein
kappaB,I-Gene_protein
transcriptional,O
activity,O
after,O
exposure,O
to,O
NO,O
.,O

,O
 , 
#17007003
Collision,O
tumor,O
of,O
the,O
rectum,O
:,O
a,O
case,O
report,O
of,O
metastatic,O
gastric,O
adenocarcinoma,O
plus,O
primary,O
rectal,O
adenocarcinoma,O
.,O
 , 


,O
Collision,O
tumors,O
are,O
thought,O
to,O
arise,O
from,O
the,O
accidental,O
meeting,O
and,O
interpenetration,O
of,O
two,O
independent,O
tumors,O
.,O
 , 
We,O
report,O
here,O
a,O
highly,O
unusual,O
case,O
of,O
a,O
61,O
-,O
year,O
old,O
man,O
who,O
had,O
a,O
unique,O
tumor,O
that,O
was,O
composed,O
of,O
a,O
metastatic,O
adenocarcinoma,O
from,O
the,O
stomach,O
to,O
the,O
rectum,O
,,O
which,O
harbored,O
a,O
collision,O
tumor,O
of,O
primary,O
rectal,O
adenocarcinoma,O
.,O
 , 
The,O
clonalities,O
of,O
the,O
two,O
histologically,O
distinct,O
lesions,O
of,O
the,O
rectal,O
mass,O
were,O
confirmed,O
by,O
immunohistochemical,O
and,O
molecular,O
analysis,O
.,O
 , 
Although,O
histologic,O
examination,O
is,O
the,O
cornerstone,O
in,O
pathology,O
,,O
immunohistochemical,O
and,O
molecular,O
analysis,O
can,O
provide,O
evidence,O
regarding,O
whether,O
tumors,O
originate,O
from,O
the,O
same,O
clone,O
or,O
different,O
clones,O
.,O
 , 
To,O
the,O
best,O
of,O
our,O
knowledge,O
,,O
this,O
is,O
the,O
first,O
reported,O
case,O
of,O
such,O
an,O
occurrence,O
.,O
 , 

,O
 , 
#12000733
CpG,B-locus
island,I-locus
methylation,B-DNA_modification
in,O
aberrant,O
crypt,O
foci,O
of,O
the,O
colorectum,O
.,O
 , 


,O
Aberrant,O
crypt,O
foci,O
(,O
ACF,O
),O
are,O
postulated,O
to,O
be,O
the,O
earliest,O
precursor,O
lesion,O
in,O
colorectal,O
carcinogenesis,O
,,O
and,O
CpG,B-locus
island,I-locus
methylation,B-DNA_modification
has,O
been,O
described,O
as,O
an,O
important,O
molecular,O
pathway,O
.,O
 , 
We,O
therefore,O
studied,O
methylation,B-DNA_modification
in,O
ACF,O
from,O
patients,O
with,O
familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
or,O
sporadic,O
colorectal,O
cancer,O
.,O
 , 
We,O
assessed,O
methylation,B-DNA_modification
status,O
of,O
the,O
p16,B-Gene_protein
tumor,O
suppressor,O
gene,O
,,O
MINT1,B-Gene_protein
(,B-Gene_protein
methylated,I-Gene_protein
in,I-Gene_protein
tumor,I-Gene_protein
1,I-Gene_protein
),I-Gene_protein
,,O
MINT2,B-Gene_protein
,,I-Gene_protein
MINT31,B-Gene_protein
,,I-Gene_protein
O(6)-methylguanine,B-Gene_protein
-,I-Gene_protein
DNA,I-Gene_protein
methyltransferase,I-Gene_protein
gene,O
,,O
and,O
hMLH1,B-Gene_protein
mismatch,O
repair,O
gene,O
.,O
 , 
We,O
compared,O
methylation,B-DNA_modification
to,O
ACF,O
histopathology,O
,,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
proto,O
-,O
oncogene,O
mutation,B-DNA_Mutation
,,I-DNA_Mutation
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
at,O
chromosome,B-locus
1p,I-locus
,,I-locus
and,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 
Methylation,B-DNA_modification
was,O
present,O
in,O
34,O
%,O
(,O
21,O
of,O
61,O
),O
of,O
ACF,O
,,O
including,O
both,O
FAP,O
and,O
sporadic,O
types,O
,,O
but,O
was,O
more,O
frequent,O
in,O
sporadic,O
ACF,O
 , 
[,O
53,O
%,O
(,O
18,O
of,O
34,O
),O
versus,O
11,O
%,O
(,O
3,O
of,O
27,O
),O
,,O
P,O
=,O
0.002,O
],O
,,O
especially,O
dysplastic,O
sporadic,O
ACF,O
[,O
75,O
%,O
(,O
3,O
of,O
4,O
),O
versus,O
8,O
%,O
(,O
2,O
of,O
24,O
),O
,,O
P,O
=,O
0.004,O
],O
.,O
 , 
MINT31,B-Gene_protein
was,O
more,O
frequently,O
methylated,B-DNA_modification
in,O
heteroplastic,O
ACF,O
than,O
dysplastic,O
ACF,O
 , 
[,O
35,O
%,O
(,O
11,O
of,O
31,O
),O
versus,O
7,O
%,O
(,O
2,O
of,O
30,O
),O
,,O
P,O
=,O
0.01,O
],O
.,O
 , 
Strong,O
associations,O
of,O
ACF,O
methylation,B-DNA_modification
with,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutation,B-DNA_Mutation
(,O
P,O
=,O
0.007,O
),O
and,O
with,O
loss,B-DNA_Mutation
of,O
chromosome,B-locus
1p,I-locus
(,O
P,O
=,O
0.04,O
),O
were,O
observed,O
,,O
but,O
methylation,B-DNA_modification
was,O
the,O
only,O
molecular,O
abnormality,O
identified,O
in,O
16,O
%,O
(,O
10,O
of,O
61,O
),O
of,O
ACF,O
.,O
 , 
Our,O
findings,O
suggest,O
that,O
methylation,B-DNA_modification
in,O
ACF,O
is,O
an,O
early,O
event,O
in,O
the,O
pathogenesis,O
of,O
a,O
subset,O
of,O
colorectal,O
carcinomas,O
,,O
and,O
that,O
ACF,O
from,O
FAP,O
patients,O
and,O
patients,O
with,O
sporadic,O
colorectal,O
cancer,O
have,O
distinct,O
epigenetic,B-DNA_Mutation
changes,I-DNA_Mutation
that,O
reflect,O
differences,O
in,O
molecular,O
pathogenesis,O
.,O
 , 

,O
 , 
#9609758
Expression,O
of,O
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
beta,I-Gene_protein
receptors,I-Gene_protein
in,O
normal,O
human,O
colon,O
and,O
sporadic,O
adenocarcinomas,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O
&,O
AIMS,O

,O
 , 
An,O
absence,O
or,O
a,O
presence,O
of,O
mutated,B-DNA_Mutation
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
(,I-Gene_protein
TGF)-beta,I-Gene_protein
receptors,I-Gene_protein
is,O
a,O
possible,O
hypothesis,O
explaining,O
the,O
resistance,O
of,O
cancer,O
cells,O
to,O
the,O
growth,O
-,O
inhibitory,O
effect,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
.,I-Gene_protein
 , 
Mutations,B-DNA_Mutation
involving,O
microsatellite,O
-,O
like,O
regions,O
of,O
the,O
type,B-Gene_protein
II,I-Gene_protein
TGF,I-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
receptor,I-Gene_protein
have,O
been,O
described,O
in,O
subgroups,O
of,O
colorectal,O
cancers,O
.,O
 , 
The,O
aim,O
of,O
this,O
study,O
was,O
to,O
investigate,O
the,O
expression,O
and,O
distribution,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
receptors,I-Gene_protein
in,O
sporadic,O
colorectal,O
cancers,O
and,O
normal,O
tissues,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
Thirty,O
-,O
three,O
sporadic,O
colorectal,O
cancers,O
and,O
20,O
normal,O
colonic,O
tissues,O
were,O
explored,O
by,O
immunohistochemistry,O
for,O
the,O
expression,O
of,O
type,B-Gene_protein
I,I-Gene_protein
and,I-Gene_protein
type,I-Gene_protein
II,I-Gene_protein
TGF,I-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
receptors,I-Gene_protein
.,I-Gene_protein
 , 
Eighteen,O
tumor,O
and,O
20,O
normal,O
samples,O
were,O
used,O
for,O
radioactive,O
thermocycling,O
and,O
sequencing,O
of,O
the,O
two,O
microsatellite,O
-,O
like,O
regions,O
of,O
the,O
type,B-Gene_protein
II,I-Gene_protein
receptor,I-Gene_protein
.,I-Gene_protein
 , 


,O
#,O
#,O
RESULTS,O

,O
Both,O
receptors,O
were,O
overexpressed,O
in,O
tumors,O
compared,O
with,O
normal,O
samples,O
.,O
 , 
There,O
was,O
a,O
relationship,O
between,O
the,O
abundance,O
of,O
type,B-Gene_protein
II,I-Gene_protein
receptor,I-Gene_protein
expression,O
and,O
the,O
degree,O
of,O
differentiation,O
of,O
the,O
tumors,O
but,O
not,O
the,O
Dukes,O
',O
staging,O
or,O
the,O
localization,O
of,O
the,O
neoplasias,O
.,O
 , 
No,O
mutation,B-DNA_Mutation
was,O
observed,O
in,O
the,O
microsatellite,O
-,O
like,O
regions,O
of,O
receptor,B-Gene_protein
II,I-Gene_protein
in,O
any,O
of,O
the,O
samples,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Sporadic,O
colorectal,O
cancers,O
do,O
not,O
show,O
an,O
absence,O
or,O
a,O
presence,O
of,O
mutated,B-DNA_Mutation
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
receptors,I-Gene_protein
that,O
could,O
explain,O
a,O
resistance,O
to,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
-,I-Gene_protein
mediated,O
growth,O
inhibition,O
.,O
 , 
The,O
pathways,O
to,O
tumorigenesis,O
of,O
sporadic,O
colorectal,O
cancers,O
may,O
be,O
different,O
from,O
those,O
of,O
some,O
hereditary,O
ones,O
.,O
 , 

,O
 , 
#7557155
DNA,O
mismatch,O
repair,O
and,O
cancer,O
.,O
 , 


,O
The,O
genetic,O
basis,O
of,O
cancer,O
involves,O
certain,O
classes,O
of,O
genes,O
,,O
particularly,O
oncogenes,O
,,O
tumor,O
-,O
suppressor,O
genes,O
,,O
and,O
DNA,O
mismatch,O
repair,O
genes,O
.,O
 , 
Originally,O
identified,O
in,O
bacteria,O
and,O
yeast,O
,,O
the,O
human,O
homologues,O
of,O
DNA,O
mismatch,O
repair,O
genes,O
have,O
been,O
implicated,O
in,O
the,O
pathogenesis,O
of,O
the,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
syndromes,O
,,O
as,O
well,O
as,O
a,O
variety,O
of,O
different,O
sporadic,O
cancers,O
.,O
 , 
An,O
appreciation,O
of,O
their,O
role,O
in,O
cancer,O
is,O
predicated,O
on,O
an,O
understanding,O
of,O
their,O
function,O
in,O
the,O
processes,O
of,O
DNA,O
repair,O
.,O
 , 
This,O
article,O
reviews,O
the,O
recent,O
developments,O
and,O
advances,O
in,O
the,O
biology,O
of,O
the,O
human,O
DNA,O
mismatch,O
repair,O
genes,O
and,O
their,O
involvement,O
in,O
the,O
pathogenesis,O
of,O
cancer,O
.,O
 , 

,O
 , 
#18184403
Expression,O
of,O
beclin-1,B-Gene_protein
,,I-Gene_protein
an,O
autophagy,O
-,O
related,O
protein,O
,,O
in,O
gastric,O
and,O
colorectal,O
cancers,O
.,O
 , 


,O
Autophagy,O
plays,O
important,O
roles,O
in,O
both,O
cell,O
death,O
and,O
cell,O
survival,O
.,O
 , 
Beclin-1,B-Gene_protein
,,I-Gene_protein
a,O
key,O
regulator,O
of,O
autophagy,O
formation,O
,,O
has,O
been,O
considered,O
as,O
a,O
haploinsufficient,B-DNA_Mutation
tumor,O
suppressor,O
.,O
 , 
Loss,O
of,O
expression,O
or,O
point,O
mutation,B-DNA_Mutation
could,O
serve,O
as,O
a,O
mechanism,O
of,O
loss,O
of,O
beclin-1,B-Gene_protein
tumor,O
suppressor,O
function,O
in,O
cancers,O
.,O
 , 
However,O
,,O
our,O
recent,O
study,O
revealed,O
that,O
point,O
mutation,B-DNA_Mutation
of,O
the,O
beclin-1,B-Gene_protein
gene,O
is,O
a,O
rare,O
event,O
in,O
common,O
human,O
cancers,O
.,O
 , 
In,O
this,O
study,O
we,O
investigated,O
beclin-1,B-Gene_protein
protein,O
expression,O
in,O
103,O
colorectal,O
and,O
60,O
gastric,O
carcinoma,O
tissues,O
by,O
immunohistochemistry,O
using,O
a,O
tissue,O
microarray,O
approach,O
.,O
 , 
In,O
the,O
cancers,O
,,O
expression,O
of,O
beclin-1,B-Gene_protein
was,O
detected,O
in,O
95,O
%,O
of,O
the,O
colorectal,O
carcinomas,O
and,O
83,O
%,O
of,O
the,O
gastric,O
carcinomas,O
.,O
 , 
In,O
contrast,O
,,O
normal,O
mucosal,O
cells,O
of,O
both,O
stomach,O
and,O
colon,O
showed,O
no,O
or,O
very,O
weak,O
expression,O
of,O
beclin-1,B-Gene_protein
.,I-Gene_protein
 , 
There,O
was,O
no,O
significant,O
association,O
of,O
beclin-1,B-Gene_protein
expression,O
with,O
clinocopathologic,O
characteristics,O
,,O
including,O
invasion,O
,,O
metastasis,O
and,O
stage,O
.,O
 , 
The,O
beclin-1,B-Gene_protein
expression,O
of,O
colorectal,O
and,O
gastric,O
cancers,O
in,O
the,O
present,O
study,O
is,O
quite,O
in,O
contrast,O
to,O
that,O
of,O
the,O
breast,O
cancers,O
in,O
the,O
previous,O
study,O
,,O
which,O
showed,O
a,O
decreased,O
beclin-1,B-Gene_protein
expression,O
in,O
breast,O
cancer,O
cells,O
compared,O
to,O
normal,O
breast,O
cells,O
.,O
 , 
Our,O
data,O
indicate,O
that,O
beclin-1,B-Gene_protein
inactivation,O
by,O
loss,O
of,O
expression,O
may,O
not,O
occur,O
in,O
colorectal,O
and,O
gastric,O
cancers,O
.,O
 , 
Rather,O
,,O
increased,O
expression,O
of,O
beclin-1,B-Gene_protein
in,O
the,O
malignant,O
colorectal,O
and,O
gastric,O
epithelial,O
cells,O
compared,O
to,O
their,O
normal,O
mucosal,O
epithelial,O
cells,O
suggests,O
that,O
neo,O
-,O
expression,O
of,O
beclin-1,B-Gene_protein
may,O
play,O
a,O
role,O
in,O
both,O
colorectal,O
and,O
gastric,O
tumorigenesis,O
.,O
 , 

,O
 , 
#22810479
Is,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutation,B-DNA_Mutation
a,O
prognostic,O
factor,O
for,O
colorectal,O
cancer,O
:,O
a,O
systematic,O
review,O
and,O
meta,O
-,O
analysis,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
:,O
 , 
The,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
is,O
one,O
of,O
the,O
commonly,O
mutated,B-DNA_Mutation
oncogenes,O
associated,O
with,O
colorectal,O
cancer,O
.,O
 , 
However,O
,,O
its,O
prognostic,O
significance,O
for,O
patients,O
with,O
colorectal,O
cancer,O
remains,O
inconclusive,O
.,O
 , 


,O
#,O
#,O
OBJECTIVE,O

,O
:,O
To,O
derive,O
a,O
more,O
precise,O
estimation,O
of,O
the,O
prognostic,O
significance,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutations,B-DNA_Mutation
,,I-DNA_Mutation
a,O
systematic,O
review,O
and,O
meta,O
-,O
analysis,O
were,O
performed,O
.,O
 , 


,O
#,O
#,O
DATA,O
SOURCES,O

,O
:,O
 , 
We,O
searched,O
PubMed,O
,,O
Embase,O
,,O
and,O
the,O
Cochrane,O
databases,O
from,O
January,O
1992,O
to,O
November,O
2011,O
.,O
 , 


,O
#,O
#,O
STUDY,O
SELECTION,O

,O
:,O
 , 
The,O
prognostic,O
value,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutations,B-DNA_Mutation
was,O
examined,O
in,O
patients,O
with,O
colorectal,O
cancer,O
who,O
did,O
not,O
receive,O
preoperative,O
chemotherapy,O
or,O
radiation,O
.,O
 , 


,O
#,O
#,O
MAIN,O
OUTCOME,O
MEASURES,O

,O
:,O
 , 
The,O
effect,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutations,B-DNA_Mutation
on,O
the,O
overall,O
survival,O
was,O
measured,O
by,O
the,O
HR,O
and,O
95,O
%,O
CIs,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
:,O
 , 
The,O
pooled,O
HR,O
for,O
the,O
association,O
between,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutations,B-DNA_Mutation
and,O
overall,O
survival,O
in,O
patients,O
with,O
colorectal,O
cancer,O
was,O
1.04,O
(,O
95,O
%,O
CI,O
:,O
0.99,O
-,O
1.10,O
,,O
p,O
=,O
0.11,O
),O
.,O
 , 
Subgroup,O
analysis,O
showed,O
significant,O
reductions,O
in,O
the,O
overall,O
survival,O
associated,O
with,O
mutations,O
at,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
codon,B-locus
12,I-locus
,,I-locus
the,O
articles,O
that,O
reported,O
HR,O
directly,O
,,O
and,O
the,O
studies,O
published,O
before,O
and,O
after,O
2005,O
,,O
although,O
publication,O
bias,O
was,O
present,O
.,O
 , 
All,O
the,O
associations,O
disappeared,O
after,O
adjustment,O
with,O
the,O
trim,O
-,O
and,O
-,O
fill,O
method,O
.,O
 , 
The,O
pooled,O
HR,O
of,O
3,O
studies,O
examining,O
mutations,O
at,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
codon,B-locus
13,I-locus
was,O
1.47,O
(,O
95,O
%,O
CI,O
:,O
1.09,O
-,O
1.97,O
,,O
p,O
=,O
0.02,O
),O
,,O
and,O
no,O
publication,O
bias,O
was,O
observed,O
.,O
 , 
No,O
significant,O
association,O
was,O
observed,O
in,O
different,O
study,O
regions,O
.,O
 , 


,O
#,O
#,O
LIMITATIONS,O

,O
:,O
 , 
The,O
heterogeneity,O
in,O
the,O
study,O
populations,O
is,O
a,O
potential,O
problem,O
,,O
the,O
use,O
of,O
different,O
staging,O
systems,O
or,O
small,O
groups,O
of,O
different,O
stages,O
may,O
contribute,O
to,O
heterogeneity,O
,,O
and,O
residual,O
confounding,O
may,O
have,O
influenced,O
the,O
results,O
in,O
those,O
studies,O
that,O
did,O
not,O
completely,O
adjust,O
for,O
other,O
factors,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
:,O
 , 
Overall,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutations,B-DNA_Mutation
seem,O
not,O
to,O
correlate,O
with,O
the,O
prognosis,O
of,O
patients,O
with,O
colorectal,O
cancer,O
.,O
 , 
The,O
association,O
remains,O
to,O
be,O
confirmed,O
with,O
a,O
more,O
precise,O
analysis,O
of,O
a,O
large,O
sample,O
.,O
 , 

,O
 , 
#10962562
BRCA1,B-Gene_protein
activation,O
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
.,I-locus
 , 


,O
Breast,O
cancer,O
susceptibility,O
gene,O
BRCA1,B-Gene_protein
has,O
been,O
implicated,O
in,O
the,O
control,O
of,O
gene,O
regulation,O
and,O
such,O
regulated,O
genes,O
are,O
thought,O
to,O
mediate,O
the,O
biological,O
role,O
of,O
BRCA1,B-Gene_protein
.,I-Gene_protein
 , 
Overexpression,O
of,O
BRCA1,B-Gene_protein
induces,O
GADD45,B-Gene_protein
,,I-Gene_protein
a,O
p53,B-Gene_protein
-,I-Gene_protein
regulated,O
and,O
stress,O
-,O
inducible,O
gene,O
.,O
 , 
However,O
,,O
the,O
molecular,O
mechanism,O
by,O
which,O
BRCA1,B-Gene_protein
induces,O
the,O
expression,O
GADD45,B-Gene_protein
remains,O
unclear,O
.,O
 , 
In,O
this,O
report,O
,,O
we,O
have,O
shown,O
that,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
is,O
strongly,O
activated,O
following,O
expression,O
of,O
wild,O
-,O
type,O
BRCA1,B-Gene_protein
.,I-Gene_protein
 , 
In,O
contrast,O
,,O
both,O
the,O
tumor,O
-,O
derived,O
BRCA1,B-Gene_protein
mutants,B-DNA_Mutation
(,B-Protein_Mutation
p1749R,I-Protein_Mutation
and,O
Y1853insA,B-Protein_Mutation
),I-Protein_Mutation
and,O
truncated,O
BRCA1,B-Gene_protein
mutant,B-Protein_Mutation
protein,O
(,B-Protein_Mutation
Delta500,I-Protein_Mutation
-,I-Protein_Mutation
1863,I-Protein_Mutation
BRCA1,B-Gene_protein
),I-Gene_protein
,,O
which,O
lack,O
transactivation,O
activity,O
,,O
were,O
unable,O
to,O
activate,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
,,I-locus
indicating,O
that,O
the,O
BRCA1,B-Gene_protein
-,I-Gene_protein
mediated,O
activation,O
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
requires,O
normal,O
transcriptional,O
properties,O
of,O
BRCA1,B-Gene_protein
.,I-Gene_protein
 , 
BRCA1,B-Gene_protein
did,O
not,O
induce,O
the,O
c,B-Gene_protein
-,I-Gene_protein
Jun,I-Gene_protein
and,O
c,B-Gene_protein
-,I-Gene_protein
fos,I-Gene_protein
promoters,B-locus
,,I-locus
which,O
rules,O
out,O
a,O
general,O
effect,O
of,O
BRCA1,B-Gene_protein
on,O
other,O
immediate,O
-,O
responsive,O
genes,O
.,O
 , 
Expression,O
of,O
the,O
human,O
papillomavirus,O
E6,O
and,O
the,O
dominant,O
-,O
negative,O
mutant,B-DNA_Mutation
p53,B-Gene_protein
proteins,O
had,O
no,O
effect,O
on,O
the,O
induction,O
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
by,O
BRCA1,B-Gene_protein
,,I-Gene_protein
suggesting,O
that,O
activation,O
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
by,O
BRCA1,B-Gene_protein
is,O
independent,O
of,O
cellular,O
p53,B-Gene_protein
function,O
.,O
 , 
With,O
the,O
5'-deletion,O
analysis,O
,,O
the,O
BRCA1,B-locus
-,I-locus
responsive,I-locus
element,I-locus
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
was,O
mapped,O
at,O
the,O
region,O
from,O
-121,B-locus
to,I-locus
-75,I-locus
.,I-locus
 , 
Disruption,O
of,O
this,O
region,O
resulted,O
in,O
the,O
abrogation,O
of,O
BRCA1,B-Gene_protein
activation,O
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
.,I-locus
 , 
Taken,O
together,O
,,O
these,O
results,O
demonstrate,O
that,O
the,O
mechanism,O
by,O
which,O
BRCA1,B-Gene_protein
induces,O
GADD45,B-Gene_protein
is,O
mainly,O
through,O
the,O
transactivation,O
of,O
the,O
GADD45,B-Gene_protein
promoter,B-locus
,,I-locus
further,O
demonstrating,O
the,O
evidence,O
that,O
GADD45,B-Gene_protein
acts,O
as,O
one,O
of,O
the,O
BRCA1,B-Gene_protein
-,I-Gene_protein
regulated,O
genes,O
.,O
 , 
Oncogene,O
(,O
2000,O
),O
19,O
,,O
4050,O
-,O
4057,O
.,O
 , 

,O
 , 
#22388025
Editorial,O
:,O
sessile,O
serrated,O
adenomas,O
and,O
their,O
pit,O
patterns,O
:,O
we,O
must,O
first,O
see,O
the,O
forest,O
through,O
the,O
trees,O
.,O
 , 


,O
Serrated,O
lesions,O
of,O
the,O
colorectum,O
include,O
hyperplastic,O
polyps,O
,,O
which,O
are,O
non,O
-,O
neoplastic,O
,,O
and,O
sessile,O
serrated,O
adenomas,O
(,O
SSAs,O
,,O
also,O
known,O
as,O
sessile,O
serrated,O
polyps,O
),O
and,O
traditional,O
serrated,O
adenomas,O
,,O
which,O
are,O
premalignant,O
.,O
 , 
It,O
is,O
believed,O
that,O
up,O
to,O
30,O
%,O
of,O
colon,O
cancers,O
and,O
many,O
post,O
-,O
colonoscopy,O
cancers,O
arise,O
from,O
serrated,O
neoplasms,O
.,O
 , 
Post,O
-,O
colonoscopy,O
cancers,O
have,O
been,O
found,O
to,O
have,O
a,O
molecular,O
signature,O
similar,O
to,O
SSAs,O
,,O
including,O
CpG,B-locus
island,I-locus
methylation,B-DNA_modification
,,I-DNA_modification
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
,,I-DNA_Mutation
and,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 
A,O
novel,O
pit,O
pattern,O
,,O
Type,O
II,O
-,O
O,O
,,O
has,O
been,O
demonstrated,O
to,O
have,O
a,O
high,O
specificity,O
for,O
SSAs,O
.,O
 , 
Unfortunately,O
,,O
the,O
sensitivity,O
is,O
too,O
low,O
to,O
utilize,O
a,O
Type,O
II,O
-,O
O,O
pit,O
pattern,O
to,O
determine,O
which,O
serrated,O
lesion,O
is,O
neoplastic,O
and,O
needs,O
resection,O
.,O
 , 
Moreover,O
,,O
there,O
is,O
significant,O
endoscopist,O
-,O
related,O
variability,O
in,O
the,O
detection,O
of,O
serrated,O
lesions,O
of,O
the,O
colon,O
.,O
 , 
Efforts,O
to,O
improve,O
the,O
detection,O
of,O
serrated,O
neoplasms,O
are,O
warranted,O
.,O
 , 

,O
 , 
#14645426
Toward,O
new,O
strategies,O
to,O
select,O
young,O
endometrial,O
cancer,O
patients,O
for,O
mismatch,O
repair,O
gene,O
mutation,B-DNA_Mutation
analysis,O
.,O
 , 



,O
#,O
#,O
PURPOSE,O

,O
To,O
determine,O
the,O
frequency,O
of,O
mismatch,O
repair,O
(,O
MMR,O
),O
gene,O
germline,O
mutations,B-DNA_Mutation
in,O
endometrial,O
cancer,O
patients,O
who,O
were,O
diagnosed,O
at,O
less,O
than,O
50,O
years,O
of,O
age,O
;,O
to,O
relate,O
the,O
presence,O
of,O
mutations,O
to,O
family,O
history,O
,,O
histopathologic,O
data,O
,,O
presence,O
of,O
tumor,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
,,O
and,O
immunostaining,O
;,O
and,O
to,O
formulate,O
criteria,O
for,O
genetic,O
testing,O
in,O
these,O
patients,O
.,O
 , 


,O
#,O
#,O
PATIENTS,O
AND,O
METHODS,O

,O
Endometrial,O
cancer,O
patients,O
(,O
N,O
=,O
58,O
),O
,,O
who,O
were,O
diagnosed,O
at,O
less,O
than,O
50,O
years,O
of,O
age,O
,,O
were,O
included,O
and,O
questioned,O
about,O
their,O
family,O
history,O
.,O
 , 
Mutation,O
analysis,O
of,O
the,O
MLH1,B-Gene_protein
,,I-Gene_protein
MSH2,B-Gene_protein
,,I-Gene_protein
and,O
MSH6,B-Gene_protein
genes,O
was,O
performed,O
(,O
denaturing,O
gradient,O
gel,O
electrophoresis,O
and,O
sequence,O
analysis,O
to,O
detect,O
small,O
mutations,O
and,O
multiplex,O
ligation,O
-,O
dependent,O
probe,O
amplification,O
to,O
detect,O
large,O
deletions,O
or,O
duplications,O
),O
.,O
 , 
For,O
MSI,B-DNA_Mutation
analysis,O
,,O
five,O
consensus,O
markers,O
were,O
used,O
,,O
and,O
immunostaining,O
of,O
the,O
three,O
MMR,O
proteins,O
was,O
performed,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
In,O
five,O
of,O
22,O
patients,O
with,O
a,O
positive,O
first,O
-,O
degree,O
family,O
history,O
for,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
(,O
HNPCC)-related,O
cancers,O
,,O
pathogenic,O
germline,O
mutations,B-DNA_Mutation
were,O
found,O
(,O
one,O
MLH1,B-Gene_protein
,,I-Gene_protein
three,O
MSH2,B-Gene_protein
,,I-Gene_protein
and,O
one,O
MSH6,B-Gene_protein
),I-Gene_protein
.,O
 , 
Four,O
mutation,O
carriers,O
belonged,O
to,O
families,O
fulfilling,O
the,O
revised,O
Amsterdam,O
criteria,O
.,O
 , 
No,O
mutations,O
were,O
found,O
in,O
the,O
35,O
patients,O
without,O
such,O
family,O
history,O
(,O
P,O
=,O
.006,O
),O
.,O
 , 
MSI,B-DNA_Mutation
was,O
detected,O
in,O
20,O
of,O
57,O
cancers,O
,,O
among,O
which,O
four,O
were,O
from,O
mutation,B-DNA_Mutation
carriers,O
.,O
 , 
In,O
23,O
of,O
51,O
cancers,O
,,O
one,O
or,O
more,O
MMR,O
protein,O
was,O
absent,O
;,O
in,O
all,O
five,O
mutation,B-DNA_Mutation
carriers,O
,,O
immunostaining,O
indicated,O
the,O
involved,O
MMR,O
gene,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
In,O
23,O
%,O
of,O
the,O
young,O
endometrial,O
cancer,O
patients,O
with,O
at,O
least,O
one,O
first,O
-,O
degree,O
relative,O
with,O
an,O
HNPCC,O
-,O
related,O
cancer,O
,,O
an,O
MMR,O
gene,O
mutation,B-DNA_Mutation
was,O
detected,O
.,O
 , 
Therefore,O
,,O
presence,O
of,O
an,O
HNPCC,O
-,O
related,O
cancer,O
in,O
a,O
first,O
-,O
degree,O
relative,O
seems,O
to,O
be,O
an,O
important,O
selection,O
criterion,O
for,O
mutation,B-DNA_Mutation
analysis,O
.,O
 , 
Subsequent,O
immunostaining,O
of,O
MMR,O
proteins,O
will,O
point,O
to,O
the,O
gene(s,O
),O
that,O
should,O
be,O
analyzed,O
.,O
 , 

,O
 , 
#8261516
Hypermutability,B-DNA_Mutation
and,O
mismatch,O
repair,O
deficiency,O
in,O
RER+,O
tumor,O
cells,O
.,O
 , 


,O
A,O
subset,O
of,O
sporadic,O
colorectal,O
tumors,O
and,O
most,O
tumors,O
developing,O
in,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
patients,O
display,O
frequent,O
alterations,B-DNA_Mutation
in,O
microsatellite,B-locus
sequences,I-locus
.,I-locus
 , 
Such,O
tumors,O
have,O
been,O
thought,O
to,O
manifest,O
replication,O
errors,O
(,O
RER+,O
),O
,,O
but,O
the,O
basis,O
for,O
the,O
alterations,O
has,O
remained,O
conjectural,O
.,O
 , 
We,O
demonstrate,O
that,O
the,O
mutation,B-DNA_Mutation
rate,O
of,O
(,O
CA)n,O
repeats,O
in,O
RER+,O
tumor,O
cells,O
is,O
at,O
least,O
100,O
-,O
fold,O
that,O
in,O
RER-,O
tumor,O
cells,O
and,O
show,O
by,O
in,O
vitro,O
assay,O
that,O
increased,O
mutability,O
of,O
RER+,O
cells,O
is,O
associated,O
with,O
a,O
profound,O
defect,O
in,O
strand,O
-,O
specific,O
mismatch,O
repair,O
.,O
 , 
This,O
deficiency,O
was,O
observed,O
with,O
microsatellite,B-DNA_Mutation
heteroduplexes,I-DNA_Mutation
as,O
well,O
as,O
with,O
heteroduplexes,B-DNA_Mutation
containing,O
single,B-DNA_Mutation
base,I-DNA_Mutation
-,I-DNA_Mutation
base,I-DNA_Mutation
mismatches,I-DNA_Mutation
and,O
affected,O
an,O
early,O
step,O
in,O
the,O
repair,O
pathway,O
.,O
 , 
Thus,O
,,O
a,O
true,O
mutator,O
phenotype,O
exists,O
in,O
a,O
subset,O
of,O
tumor,O
cells,O
,,O
the,O
responsible,O
defect,O
is,O
likely,O
to,O
cause,O
transitions,B-DNA_Mutation
and,O
transversions,B-DNA_Mutation
in,O
addition,O
to,O
microsatellite,B-locus
alterations,B-DNA_Mutation
,,I-DNA_Mutation
and,O
a,O
biochemical,O
basis,O
for,O
this,O
phenotype,O
has,O
been,O
identified,O
.,O
 , 

,O
 , 
#16426918
Mismatch,O
repair,O
genes,O
in,O
renal,O
cortical,O
neoplasms,O
.,O
 , 


,B-DNA_Mutation
Mutation,I-DNA_Mutation
of,O
human,O
mutL,B-Gene_protein
homolog,I-Gene_protein
1,I-Gene_protein
(,B-Gene_protein
MLH-1,I-Gene_protein
),I-Gene_protein
and,O
human,O
mutS,B-Gene_protein
homolog,I-Gene_protein
2,I-Gene_protein
(,B-Gene_protein
MSH-2,I-Gene_protein
),I-Gene_protein
has,O
been,O
linked,O
with,O
the,O
pathogenesis,O
of,O
colorectal,O
carcinoma,O
in,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
syndrome,O
and,O
other,O
carcinomas,O
.,O
 , 
Mutations,B-DNA_Mutation
of,O
these,O
genes,O
in,O
renal,O
cell,O
carcinomas,O
were,O
recently,O
described,O
.,O
 , 
The,O
aim,O
of,O
this,O
study,O
was,O
to,O
examine,O
the,O
expression,O
of,O
MLH-1,B-Gene_protein
and,O
MSH-2,B-Gene_protein
in,O
renal,O
cortical,O
neoplasms,O
of,O
various,O
histological,O
types,O
by,O
immunohistochemistry,O
.,O
 , 
Thirty,O
-,O
eight,O
(,O
n,O
=,O
38,O
),O
resected,O
renal,O
tumors,O
were,O
obtained,O
from,O
the,O
surgical,O
pathology,O
files,O
of,O
the,O
UMass,O
Memorial,O
Healthcare,O
,,O
including,O
clear,O
cell,O
carcinomas,O
(,O
CLEARs,O
,,O
n,O
=,O
20,O
),O
,,O
papillary,O
carcinomas,O
(,O
PAPs,O
,,O
n,O
=,O
8),O
,,O
chromophobe,O
carcinomas,O
(,O
CHRs,O
,,O
n,O
=,O
4,O
),O
,,O
and,O
oncocytomas,O
(,O
ONCs,O
,,O
n,O
=,O
6,O
),O
.,O
 , 
Positive,O
immunostaining,O
for,O
MLH-1,B-Gene_protein
and,O
MSH-2,B-Gene_protein
was,O
graded,O
by,O
the,O
number,O
of,O
positive,O
tumor,O
cell,O
nuclei,O
,,O
as,O
follows,O
:,O
0,O
,,O
negative,O
;,O
1,O
,,O
up,O
to,O
one,O
third,O
of,O
positive,O
nuclei,O
;,O
2,O
,,O
one,O
to,O
two,O
thirds,O
positive,O
;,O
and,O
3,O
,,O
greater,O
than,O
two,O
thirds,O
positive,O
.,O
 , 
Loss,B-DNA_Mutation
of,O
MLH-1,B-Gene_protein
or,O
MSH-2,B-Gene_protein
was,O
defined,O
as,O
a,O
tumor,O
with,O
grade,O
0,O
or,O
1,O
,,O
compared,O
with,O
the,O
normal,O
tubules,O
.,O
 , 
Normal,O
tubules,O
and,O
intercalated,O
ducts,O
contained,O
cells,O
positive,O
for,O
MLH-1,B-Gene_protein
and,O
MSH-2,B-Gene_protein
in,O
all,O
cases,O
.,O
 , 
For,O
both,O
antibodies,O
,,O
positive,O
staining,O
in,O
tumors,O
ranged,O
from,O
grade,O
1,O
to,O
3,O
in,O
the,O
CLEAR,O
and,O
PAP,O
but,O
was,O
only,O
grade,O
2,O
to,O
3,O
in,O
the,O
CHR,O
and,O
ONC,O
.,O
 , 
Loss,B-DNA_Mutation
of,O
MLH-1,B-Gene_protein
and/or,O
MSH-2,B-Gene_protein
occurred,O
in,O
malignant,O
tumors,O
but,O
not,O
in,O
ONC,O
.,O
 , 
Loss,B-DNA_Mutation
of,O
MLH-1,B-Gene_protein
was,O
present,O
in,O
8,O
(,O
40,O
%,O
),O
of,O
20,O
CLEARs,O
and,O
4,O
(,O
50,O
%,O
),O
of,O
8,O
PAPs,O
,,O
compared,O
with,O
loss,B-DNA_Mutation
of,O
MSH-2,B-Gene_protein
in,O
4,O
(,O
20,O
%,O
),O
of,O
20,O
CLEARs,O
and,O
1,O
(,O
25,O
%,O
),O
of,O
4,O
CHRs,O
.,O
 , 
Our,O
results,O
suggest,O
that,O
loss,O
of,O
mismatch,O
repair,O
genes,O
is,O
involved,O
in,O
the,O
malignant,O
transformation,O
in,O
some,O
renal,O
carcinomas,O
,,O
particularly,O
those,O
derived,O
from,O
the,O
proximal,O
tubules,O
.,O
 , 

,O
 , 
#23512527
Psychosocial,O
consequences,O
of,O
predictive,O
genetic,O
testing,O
for,O
Lynch,O
syndrome,O
and,O
associations,O
to,O
surveillance,O
behaviour,O
in,O
a,O
7,O
-,O
year,O
follow,O
-,O
up,O
study,O
.,O
 , 


,O
We,O
evaluated,O
long,O
-,O
term,O
psychosocial,O
consequences,O
of,O
predictive,O
genetic,O
testing,O
,,O
and,O
surveillance,O
behaviour,O
in,O
Lynch,O
syndrome,O
(,O
LS,O
),O
.,O
 , 
We,O
conducted,O
a,O
longitudinal,O
study,O
of,O
208,O
participants,O
(,O
62,O
LS,O
mutation,B-DNA_Mutation
carriers,O
and,O
146,O
non,O
-,O
carriers,O
),O
who,O
provided,O
information,O
on,O
general,O
anxiety,O
(,O
State,O
-,O
Trait,O
Anxiety,O
Inventory,O
),O
,,O
fear,O
of,O
cancer,O
and,O
dying,O
,,O
satisfaction,O
with,O
life,O
,,O
risk,O
and,O
test,O
perceptions,O
,,O
and,O
surveillance,O
behaviour,O
in,O
the,O
baseline,O
questionnaire,O
before,O
testing,O
,,O
and,O
1,O
month,O
,,O
1,O
year,O
and,O
7,O
years,O
post,O
-,O
test,O
.,O
 , 
At,O
7,O
years,O
,,O
most,O
of,O
the,O
psychosocial,O
variables,O
remained,O
unchanged,O
,,O
regardless,O
of,O
mutation,B-DNA_Mutation
status,O
.,O
 , 
Carriers,O
tended,O
to,O
underestimate,O
their,O
colorectal,O
cancer,O
risk,O
but,O
were,O
more,O
worried,O
about,O
their,O
cancer,O
risk,O
than,O
their,O
counterparts,O
.,O
 , 
Non,O
-,O
carriers,O
reported,O
a,O
higher,O
degree,O
of,O
satisfaction,O
with,O
their,O
testing,O
decisions,O
(,O
P,O
<,O
0.05,O
),O
,,O
but,O
had,O
more,O
doubts,O
concerning,O
test,O
result,O
validity,O
than,O
carriers,O
(,O
P,O
<,O
0.05,O
),O
.,O
 , 
All,O
carriers,O
attended,O
a,O
post,O
-,O
test,O
colonoscopy,O
surveillance,O
,,O
while,O
16,O
%,O
of,O
non,O
-,O
carriers,O
reported,O
colonoscopy,O
examinations,O
.,O
 , 
Those,O
non,O
-,O
carriers,O
with,O
doubts,O
about,O
test,O
validity,O
were,O
more,O
likely,O
(,O
P,O
=,O
0.019,O
),O
to,O
report,O
post,O
-,O
test,O
colonoscopy,O
.,O
 , 
Of,O
the,O
carriers,O
,,O
17,O
%,O
had,O
an,O
interval,O
longer,O
than,O
3,O
years,O
between,O
their,O
colonoscopies,O
.,O
 , 
Fear,O
of,O
dying,O
soon,O
,,O
measured,O
at,O
1,O
-,O
month,O
post,O
-,O
test,O
follow,O
-,O
up,O
was,O
the,O
only,O
psychosocial,O
variable,O
predicting,O
non,O
-,O
compliance,O
in,O
recommended,O
surveillance,O
.,O
 , 
No,O
adverse,O
psychosocial,O
consequences,O
were,O
detected,O
,,O
and,O
respondents,O
were,O
satisfied,O
with,O
their,O
decision,O
to,O
testing,O
7,O
years,O
post,O
-,O
test,O
.,O
 , 
Among,O
the,O
carriers,O
,,O
solely,O
fear,O
of,O
dying,O
soon,O
predicted,O
non,O
-,O
compliance,O
in,O
recommended,O
surveillance,O
.,O
 , 
Some,O
non,O
-,O
carriers,O
were,O
still,O
worried,O
about,O
their,O
risk,O
and,O
had,O
doubts,O
about,O
the,O
validity,O
of,O
their,O
genetic,O
testing,O
results,O
predicting,O
post,O
-,O
test,O
colonoscopy,O
.,O
 , 

,O
 , 
#20725929
Leiden,O
Open,O
Variation,O
Database,O
of,O
the,O
MUTYH,B-Gene_protein
gene,O
.,O
 , 


,O
The,O
MUTYH,B-Gene_protein
gene,O
encodes,O
a,O
DNA,B-Gene_protein
glycosylase,I-Gene_protein
involved,O
in,O
base,O
excision,O
repair,O
(,O
BER,O
),O
.,O
 , 
Biallelic,O
pathogenic,O
MUTYH,B-Gene_protein
variants,B-DNA_Mutation
have,O
been,O
associated,O
with,O
colorectal,O
polyposis,O
and,O
cancer,O
.,O
 , 
The,O
pathogenicity,O
of,O
a,O
few,O
variants,B-DNA_Mutation
is,O
beyond,O
doubt,O
,,O
including,O
c.536A4G,B-DNA_Mutation
/,B-Protein_Mutation
p.,I-Protein_Mutation
Tyr179Cys,I-Protein_Mutation
and,O
c.1187G4A,B-DNA_Mutation
/,B-Protein_Mutation
p.,I-Protein_Mutation
Gly396Asp,I-Protein_Mutation
 , 
(,O
previously,O
c.494A4G,B-DNA_Mutation
/,B-Protein_Mutation
p.,I-Protein_Mutation
Tyr165Cys,I-Protein_Mutation
and,O
c.1145G4A,B-DNA_Mutation
/,I-DNA_Mutation
p.,I-Protein_Mutation
Gly382Asp).However,I-Protein_Mutation
,,O
for,O
a,O
substantial,O
fraction,O
of,O
the,O
detected,O
variants,B-DNA_Mutation
,,I-DNA_Mutation
the,O
clinical,O
significance,O
remains,O
uncertain,O
,,O
compromising,O
molecular,O
diagnostics,O
and,O
thereby,O
genetic,O
counseling,O
.,O
 , 
We,O
have,O
established,O
an,O
interactive,O
MUTYH,B-Gene_protein
gene,O
sequence,O
variant,O
database,O
(,O
www.lovd.nl/MUTYH,O
),O
with,O
the,O
aim,O
of,O
collecting,O
and,O
sharing,O
MUTYH,B-Gene_protein
genotype,O
and,O
phenotype,O
data,O
worldwide,O
.,O
 , 
To,O
support,O
standard,O
variant,B-DNA_Mutation
description,O
,,O
we,O
chose,O
NM_001128425.1,B-Gene_protein
as,O
the,O
reference,O
sequence,O
.,O
 , 
The,O
database,O
includes,O
records,O
with,O
variants,O
per,O
individual,O
,,O
linked,O
to,O
available,O
phenotype,O
and,O
geographic,O
origin,O
data,O
as,O
well,O
as,O
records,O
with,O
in,O
vitro,O
functional,O
and,O
in,O
silico,O
test,O
data,O
.,O
 , 
As,O
of,O
April,O
2010,O
,,O
the,O
database,O
contains,O
1968,O
published,O
and,O
423,O
unpublished,O
submitted,O
entries,O
,,O
and,O
230,O
and,O
61,O
unique,O
variants,B-DNA_Mutation
,,I-DNA_Mutation
respectively,O
.,O
 , 
This,O
open,O
-,O
access,O
repository,O
allows,O
all,O
involved,O
to,O
quickly,O
share,O
all,O
variants,B-DNA_Mutation
encountered,O
and,O
communicate,O
potential,O
consequences,O
,,O
which,O
will,O
be,O
especially,O
useful,O
to,O
classify,O
variants,B-DNA_Mutation
of,O
uncertain,O
significance,O
.,O
 , 

,O
 , 
#16885347
MLH3,B-Gene_protein
mutation,B-DNA_Mutation
in,O
endometrial,O
cancer,O
.,O
 , 


,B-Gene_protein
MLH3,I-Gene_protein
is,O
a,O
recently,O
described,O
member,O
of,O
the,O
DNA,O
mismatch,O
repair,O
gene,O
family,O
.,O
 , 
Based,O
on,O
its,O
interaction,O
with,O
the,O
MutL,B-Gene_protein
homologue,I-Gene_protein
MLH1,B-Gene_protein
,,I-Gene_protein
it,O
was,O
postulated,O
that,O
MLH3,B-Gene_protein
might,O
play,O
a,O
role,O
in,O
tumorigenesis,O
.,O
 , 
Germ,O
line,O
and,O
somatic,O
mutations,B-DNA_Mutation
in,O
MLH3,B-Gene_protein
have,O
been,O
identified,O
in,O
a,O
small,O
fraction,O
of,O
colorectal,O
cancers,O
,,O
but,O
the,O
role,O
of,O
MLH3,B-Gene_protein
in,O
colorectal,O
cancer,O
tumorigenesis,O
remains,O
controversial,O
.,O
 , 
We,O
investigated,O
MLH3,B-Gene_protein
's,I-Gene_protein
role,O
in,O
endometrial,O
tumorigenesis,O
through,O
analysis,O
of,O
tumor,O
and,O
germ,O
line,O
DNA,O
from,O
57,O
endometrial,O
cancer,O
patients,O
who,O
were,O
at,O
increased,O
risk,O
for,O
having,O
inherited,O
cancer,O
susceptibility,O
.,O
 , 
Patients,O
with,O
known,O
MSH2,B-Gene_protein
or,O
MSH6,B-Gene_protein
mutations,B-DNA_Mutation
were,O
excluded,O
as,O
well,O
as,O
those,O
who,O
had,O
MLH1,B-Gene_protein
-,B-DNA_modification
methylated,I-DNA_modification
tumors,O
.,O
 , 
Sixteen,O
different,O
variants,B-DNA_Mutation
were,O
identified,O
by,O
single,O
-,O
strand,O
conformational,O
variant,O
analysis,O
.,O
 , 
Of,O
the,O
12,O
missense,B-Mutation
changes,I-Mutation
identified,O
,,O
three,O
were,O
somatic,O
mutations,B-Mutation
.,I-Mutation
 , 
One,O
patient,O
had,O
a,O
germ,O
line,O
missense,B-Mutation
variant,I-Mutation
and,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
(,B-DNA_Mutation
LOH,I-DNA_Mutation
),I-DNA_Mutation
in,O
her,O
tumor,O
specimen,O
.,O
 , 
There,O
was,O
no,O
evidence,O
of,O
MLH3,B-Gene_protein
promoter,B-locus
methylation,B-DNA_modification
based,O
on,O
combined,O
bisulfite,O
restriction,O
analysis,O
.,O
 , 
The,O
identification,O
of,O
inherited,O
missense,B-Mutation
variants,I-Mutation
,,I-Mutation
somatic,O
missense,B-Mutation
mutations,I-Mutation
(,O
present,O
in,O
3,O
of,O
57,O
tumors,O
),O
,,O
and,O
LOH,B-DNA_Mutation
in,O
the,O
tumor,O
from,O
a,O
patient,O
with,O
a,O
germ,O
line,O
missense,B-Mutation
change,I-Mutation
suggest,O
a,O
role,O
for,O
MLH3,B-Gene_protein
in,O
endometrial,O
tumorigenesis,O
.,O
 , 

,O
 , 
#17938238
The,O
genetics,O
of,O
hereditary,O
colon,O
cancer,O
.,O
 , 


,O
The,O
genetic,O
basis,O
of,O
sporadic,O
colorectal,O
cancer,O
has,O
illuminated,O
our,O
knowledge,O
of,O
human,O
cancer,O
genetics,O
.,O
 , 
This,O
has,O
been,O
facilitated,O
and,O
catalyzed,O
by,O
an,O
appreciation,O
and,O
deep,O
understanding,O
of,O
the,O
forms,O
of,O
colorectal,O
cancer,O
that,O
harbor,O
an,O
inherited,O
predisposition,O
,,O
including,O
familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
,,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
or,O
Lynch,O
syndrome,O
,,O
the,O
hamartomatous,O
polyposis,O
syndromes,O
,,O
and,O
certain,O
other,O
rare,O
syndromes,O
.,O
 , 
Identification,O
of,O
germline,O
mutations,B-DNA_Mutation
in,O
pivotal,O
genes,O
underlying,O
the,O
inherited,O
forms,O
of,O
colorectal,O
cancer,O
has,O
yielded,O
many,O
dividends,O
,,O
including,O
functional,O
dissection,O
of,O
critical,O
molecular,O
pathways,O
that,O
have,O
been,O
revealed,O
to,O
be,O
important,O
in,O
development,O
,,O
cellular,O
homeostasis,O
,,O
and,O
cancer,O
;,O
new,O
approaches,O
in,O
chemoprevention,O
,,O
molecular,O
diagnostics,O
and,O
genetic,O
testing,O
,,O
and,O
therapy,O
;,O
and,O
underscoring,O
genotypic,O
-,O
phenotypic,O
relationships,O
.,O
 , 

,O
 , 
#23259783
Clinical,O
impact,O
of,O
PAI,B-Gene_protein
1,I-Gene_protein
4G/5,O
G,O
gene,O
polymorphism,B-DNA_Mutation
in,O
colorectal,O
carcinoma,O
patients,O
.,O
 , 


,B-Gene_protein
Plasminogen,I-Gene_protein
activator,I-Gene_protein
ihnibitor,I-Gene_protein
(,B-Gene_protein
PAI,I-Gene_protein
1,I-Gene_protein
),I-Gene_protein
belongs,O
to,O
the,O
plasminogen,O
activator,O
system,O
,,O
which,O
is,O
part,O
of,O
the,O
metastatic,O
cascade,O
and,O
significantly,O
contributes,O
to,O
invasive,O
growth,O
and,O
angiogenesis,O
of,O
malignant,O
tumors,O
.,O
 , 
Its,O
plasma,O
level,O
is,O
normally,O
low,O
but,O
4G/4,O
G,O
homozygotes,O
have,O
higher,O
concentrations,O
of,O
PAI,B-Gene_protein
1,I-Gene_protein
.,I-Gene_protein
 , 
This,O
genotype,O
may,O
be,O
associated,O
with,O
worse,O
prognosis,O
and,O
proximal,O
location,O
of,O
colorectal,O
cancer,O
than,O
5G/5,O
G,O
homozygotes,O
.,O
 , 
In,O
our,O
prospective,O
evaluation,O
we,O
examined,O
plasma,O
level,O
PAI,B-Gene_protein
1,I-Gene_protein
(,O
using,O
photometric,O
microplate,O
method,O
ELISA,O
),O
pre,O
-,O
surgery,O
and,O
,,O
subsequently,O
,,O
6,O
-,O
8,O
weeks,O
later,O
,,O
from,O
80,O
patients,O
.,O
 , 
For,O
the,O
PAI,B-Gene_protein
1,I-Gene_protein
rs1799889,B-dbSNP
-675,B-locus
 , 
4G/5,B-DNA_Mutation
G,I-DNA_Mutation
polymorphism,I-DNA_Mutation
test,O
the,O
PCR,O
amplification,O
was,O
used,O
.,O
 , 
Analysis,O
of,O
collected,O
data,O
was,O
confirmed,O
that,O
significantly,O
higher,O
plasma,O
levels,O
of,O
PAI,B-Gene_protein
1,I-Gene_protein
were,O
found,O
in,O
patients,O
before,O
starting,O
therapy,O
,,O
which,O
decreased,O
(,O
p=0.004,O
),O
after,O
initiation,O
of,O
treatment,O
.,O
 , 
Patients,O
with,O
higher,O
plasma,O
level,O
PAI,B-Gene_protein
1,I-Gene_protein
before,O
(,O
p=0.013,O
),O
and,O
after,O
therapy,O
(,O
p=0.004,O
),O
had,O
significantly,O
shorter,O
survival,O
.,O
 , 
We,O
found,O
no,O
relationship,O
between,O
polymorphisms,B-DNA_Mutation
of,O
PAI,B-Gene_protein
1,I-Gene_protein
(,B-locus
-675,I-locus
4G/5,B-DNA_Mutation
G,I-DNA_Mutation
),I-DNA_Mutation
in,O
relation,O
to,O
stage,O
,,O
survival,O
or,O
tumor,O
location,O
.,O
 , 
PAI,B-Gene_protein
1,I-Gene_protein
is,O
useful,O
as,O
a,O
negative,O
marker,O
of,O
prognosis,O
and,O
could,O
be,O
advantageous,O
when,O
planning,O
adjuvant,O
treatment,O
of,O
patients,O
with,O
colorectal,O
carcinoma,O
.,O
 , 
Although,O
opinions,O
on,O
the,O
importance,O
of,O
polymorphisms,B-DNA_Mutation
of,O
PAI,B-Gene_protein
1,I-Gene_protein
in,O
relation,O
to,O
the,O
prognosis,O
are,O
not,O
uniform,O
,,O
it,O
does,O
seem,O
that,O
their,O
role,O
in,O
the,O
prognosis,O
of,O
patients,O
with,O
colorectal,O
cancer,O
is,O
not,O
essential,O
.,O
 , 

,O
 , 
#23096495
Protein,O
tyrosine,O
phosphatase,O
receptor,O
-,O
like,O
genes,O
are,O
frequently,O
hypermethylated,B-DNA_modification
in,O
sporadic,O
colorectal,O
cancer,O
.,O
 , 


,O
The,O
activity,O
of,O
phosphatases,O
could,O
be,O
influenced,O
by,O
genetic,O
,,O
as,O
well,O
as,O
epigenetic,B-DNA_modification
alterations,O
.,O
 , 
In,O
our,O
study,O
,,O
we,O
have,O
investigated,O
the,O
methylation,B-DNA_modification
status,O
of,O
four,O
PTPRs,O
:,O
PTPRM,B-Gene_protein
,,I-Gene_protein
PTPRT,B-Gene_protein
,,I-Gene_protein
PTPRR,B-Gene_protein
and,O
PTPRZ1,B-Gene_protein
,,I-Gene_protein
which,O
were,O
pre,O
-,O
selected,O
using,O
microarray,O
techniques,O
as,O
being,O
alternatively,O
methylated,B-DNA_modification
in,O
sporadic,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
The,O
analyses,O
were,O
carried,O
out,O
on,O
131,O
surgical,O
specimens,O
obtained,O
from,O
sporadic,O
CRC,O
patients,O
.,O
 , 
The,O
methylation,B-DNA_modification
status,O
of,O
the,O
four,O
genes,O
was,O
examined,O
using,O
methyl,O
specific,O
PCR,O
(,O
MSP,O
),O
.,O
 , 
The,O
analysis,O
of,O
promoter,B-locus
methylation,B-DNA_modification
using,O
an,O
Illumina,O
27,O
K,O
microarray,O
revealed,O
four,O
protein,O
tyrosine,O
phosphatases,O
PTPRM,B-Gene_protein
,,I-Gene_protein
PTPRT,B-Gene_protein
,,I-Gene_protein
PTPRR,B-Gene_protein
and,O
PTPRZ1,B-Gene_protein
as,O
being,O
hypermethylated,B-DNA_modification
with,O
β,O
-,O
value,O
≥0.2,O
and,O
P≤0.05,O
.,O
 , 
Subsequent,O
analysis,O
using,O
MSP,O
confirmed,O
these,O
observations,O
-,O
the,O
frequency,O
of,O
promoter,B-locus
methylation,B-DNA_modification
was,O
significantly,O
higher,O
in,O
tumor,O
cells,O
compared,O
with,O
matched,O
normal,O
tissue,O
for,O
each,O
of,O
the,O
analyzed,O
genes,O
.,O
 , 
There,O
was,O
no,O
association,O
observed,O
between,O
the,O
methylation,B-DNA_modification
status,O
of,O
PTPRs,O
and,O
either,O
CIMP,O
,,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
(,B-locus
codon,I-locus
12,I-locus
),I-locus
and,O
BRAF,B-Gene_protein
(,B-locus
exon,I-locus
15,I-locus
,,I-locus
V600E,B-Protein_Mutation
),I-Protein_Mutation
mutations,B-Mutation
or,O
tumor,O
localization,O
(,O
proximal,O
/,O
distal,O
),O
.,O
 , 
The,O
results,O
of,O
our,O
study,O
show,O
a,O
statistically,O
significant,O
difference,O
between,O
promoter,O
methylation,O
in,O
cancerous,O
and,O
healthy,O
tissue,O
.,O
 , 
This,O
result,O
supports,O
the,O
hypothesis,O
that,O
the,O
PTPR,O
family,O
has,O
an,O
important,O
role,O
in,O
the,O
etiology,O
of,O
CRC,O
.,O
 , 

,O
 , 
#22899730
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
status,O
and,O
survival,O
after,O
colorectal,O
cancer,O
diagnosis,O
according,O
to,O
patient,O
and,O
tumor,O
characteristics,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,B-Gene_protein
BRAF,I-Gene_protein
mutations,B-DNA_Mutation
in,O
colorectal,O
cancer,O
(,O
CRC,O
),O
are,O
disproportionately,O
observed,O
in,O
tumors,O
exhibiting,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
and,O
are,O
associated,O
with,O
other,O
prognostic,O
factors,O
.,O
 , 
The,O
independent,O
association,O
between,O
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
status,O
and,O
CRC,O
survival,O
,,O
however,O
,,O
remains,O
unclear,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
We,O
evaluated,O
the,O
association,O
between,O
the,O
BRAF,B-Gene_protein
c.1799T,B-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
(,B-Protein_Mutation
p.,I-Protein_Mutation
V600E,I-Protein_Mutation
),I-Protein_Mutation
mutation,B-Mutation
and,O
survival,O
in,O
individuals,O
with,O
incident,O
invasive,O
CRC,O
diagnosed,O
between,O
1997,O
and,O
2007,O
in,O
Western,O
Washington,O
State,O
.,O
 , 
Tumor,O
specimens,O
were,O
tested,O
for,O
this,O
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
and,O
MSI,B-DNA_Mutation
status,O
.,O
 , 
We,O
used,O
Cox,O
regression,O
to,O
estimate,O
HRs,O
and,O
95,O
%,O
confidence,O
intervals,O
(,O
CI,O
),O
for,O
the,O
association,O
between,O
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
status,O
and,O
disease,O
-,O
specific,O
and,O
overall,O
survival,O
.,O
 , 
Stratified,O
analyses,O
were,O
conducted,O
by,O
age,O
,,O
sex,O
,,O
tumor,O
site,O
,,O
stage,O
,,O
and,O
MSI,B-DNA_Mutation
status,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
Among,O
1,980,O
cases,O
tested,O
,,O
12,O
%,O
were,O
BRAF,B-Gene_protein
c.1799T,B-DNA_Mutation
>,I-DNA_Mutation
 , 
A,B-DNA_Mutation
(,B-Protein_Mutation
p.,I-Protein_Mutation
V600E,I-Protein_Mutation
),I-Protein_Mutation
mutation,B-Mutation
-,I-Mutation
positive,O
(,O
n,O
=,O
247,O
),O
.,O
 , 
BRAF,B-Gene_protein
-,B-DNA_Mutation
mutated,I-DNA_Mutation
CRC,O
was,O
associated,O
with,O
poorer,O
disease,O
-,O
specific,O
survival,O
adjusting,O
for,O
age,O
,,O
sex,O
,,O
time,O
from,O
diagnosis,O
to,O
enrollment,O
,,O
stage,O
,,O
and,O
MSI,B-DNA_Mutation
status,O
(,O
HR,O
,,O
1.43,O
;,O
95,O
%,O
CI,O
,,O
1.05,O
-,O
1.95,O
),O
.,O
 , 
This,O
association,O
was,O
limited,O
to,O
cases,O
diagnosed,O
at,O
ages,O
<,O
50,O
(,O
HR,O
,,O
3.06,O
;,O
95,O
%,O
CI,O
,,O
1.70,O
-,O
5.52,O
),O
and,O
was,O
not,O
evident,O
in,O
cases,O
with,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
high,O
tumors,O
(,O
HR,O
,,O
0.94,O
;,O
95,O
%,O
CI,O
,,O
0.44,O
-,O
2.03,O
),O
.,O
 , 
Associations,O
with,O
overall,O
survival,O
were,O
similar,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Our,O
results,O
show,O
that,O
the,O
prevalence,O
of,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
in,O
CRC,O
differs,O
by,O
patient,O
and,O
tumor,O
characteristics,O
and,O
suggest,O
that,O
the,O
association,O
between,O
BRAF,B-Gene_protein
status,O
and,O
CRC,O
survival,O
may,O
differ,O
by,O
some,O
of,O
these,O
factors,O
.,O
 , 


,O
#,O
#,O
IMPACT,O

,O
The,O
presence,O
of,O
a,O
BRAF,B-Gene_protein
c.1799T,B-DNA_Mutation
>,I-DNA_Mutation
A,I-DNA_Mutation
(,B-Protein_Mutation
p.,I-Protein_Mutation
V600E,I-Protein_Mutation
),I-Protein_Mutation
mutation,B-Mutation
is,O
associated,O
with,O
significantly,O
poorer,O
prognosis,O
after,O
CRC,O
diagnosis,O
among,O
subgroups,O
of,O
patients,O
.,O
 , 

,O
 , 
#21479914
Variation,B-DNA_Mutation
in,O
the,O
CYP19A1,B-Gene_protein
gene,O
and,O
risk,O
of,O
colon,O
and,O
rectal,O
cancer,O
.,O
 , 


,B-Gene_protein
CYP19A1,I-Gene_protein
,,I-Gene_protein
or,O
aromatase,B-Gene_protein
,,I-Gene_protein
influences,O
estrogen,O
-,O
metabolizing,O
enzymes,O
and,O
may,O
influence,O
cancer,O
risk,O
.,O
 , 
We,O
examine,O
variation,B-DNA_Mutation
in,O
the,O
CYP19A1,B-Gene_protein
gene,O
and,O
risk,O
of,O
colorectal,O
cancer,O
using,O
data,O
from,O
population,O
-,O
based,O
case,O
-,O
control,O
studies,O
(,O
colon,O
n,O
=,O
1,574,O
cases,O
,,O
1,970,O
controls,O
;,O
rectal,O
n,O
=,O
791,O
cases,O
,,O
999,O
controls,O
),O
.,O
 , 
Four,O
SNPs,B-DNA_Mutation
were,O
statistically,O
significantly,O
associated,O
with,O
colon,O
cancer,O
and,O
four,O
were,O
associated,O
with,O
rectal,O
cancer,O
.,O
 , 
After,O
adjustment,O
for,O
multiple,O
comparisons,O
,,O
the,O
AA,O
genotype,O
of,O
rs12591359,B-dbSNP
was,O
associated,O
with,O
an,O
increased,O
risk,O
of,O
colon,O
cancer,O
(,O
OR,O
1.44,O
95,O
%,O
CI,O
1.16,O
-,O
1.80,O
),O
and,O
the,O
AA,O
genotype,O
of,O
rs2470144,B-dbSNP
was,O
associated,O
with,O
a,O
reduced,O
risk,O
of,O
rectal,O
cancer,O
(,O
OR,O
0.65,O
95,O
%,O
CI,O
0.50,O
-,O
0.84,O
),O
.,O
 , 
Variants,B-DNA_Mutation
of,O
CYP19A1,B-Gene_protein
were,O
associated,O
with,O
CIMP+,O
and,O
CIMP+/KRAS2,B-Gene_protein
-,B-Mutation
mutated,I-Mutation
tumors,O
.,O
 , 
CT,O
/,O
TT,O
genotypes,O
of,O
rs1961177,B-dbSNP
were,O
significantly,O
associated,O
with,O
an,O
increased,O
likelihood,O
of,O
a,O
MSI+,O
colon,O
tumor,O
(,O
OR,O
1.77,O
95,O
%,O
CI,O
1.26,O
-,O
2.37,O
),O
.,O
 , 
We,O
observed,O
statistically,O
significant,O
interactions,O
between,O
genetic,O
variation,B-DNA_Mutation
in,O
NFκB1,B-Gene_protein
and,O
CYP19A1,B-Gene_protein
for,O
both,O
colon,O
and,O
rectal,O
cancer,O
.,O
 , 
Our,O
data,O
suggest,O
the,O
importance,O
of,O
CYP19A1,B-Gene_protein
in,O
the,O
development,O
of,O
colon,O
and,O
rectal,O
cancer,O
and,O
that,O
estrogen,O
may,O
influence,O
risk,O
through,O
an,O
inflammation,O
-,O
related,O
mechanism,O
.,O
 , 

,O
 , 
#27070770
[,O
Rare,O
hereditary,O
syndromes,O
associated,O
with,O
polyposis,O
and,O
the,O
development,O
of,O
malignant,O
tumors,O
],O
.,O



,O
#,O
#,O
UNLABELLED,O

,O
Familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
and,O
Peutz,O
-,O
Jeghers,O
syndrome,O
are,O
genetic,O
diseases,O
characterized,O
by,O
gastrointestinal,O
polyps,O
,,O
extraintestinal,O
manifestations,O
,,O
and,O
autosomal,O
dominant,O
inheritance,O
.,O
 , 
The,O
carriers,O
of,O
these,O
diseases,O
from,O
early,O
childhood,O
are,O
at,O
risk,O
for,O
neoplasias,O
at,O
different,O
sites,O
,,O
which,O
are,O
symptomatic,O
at,O
various,O
ages,O
.,O
 , 


,O
#,O
#,O
AIM,O

,O
to,O
study,O
the,O
clinical,O
organ,O
-,O
specific,O
manifestations,O
in,O
patients,O
with,O
FAP,O
and,O
Peutz,O
-,O
Jeghers,O
,,O
genetics,O
update,O
and,O
possibilities,O
of,O
diagnosis,O
,,O
monitoring,O
,,O
and,O
treatment,O
of,O
these,O
diseases,O
.,O
 , 


,O
#,O
#,O
MATERIAL,O
AND,O
METHODS,O

,O
 , 
The,O
authors,O
give,O
the,O
results,O
of,O
their,O
examination,O
and,O
follow,O
-,O
up,O
of,O
children,O
with,O
FAP,O
and,O
Peutz,O
-,O
Jeghers,O
hamartoma,O
-,O
polypous,O
syndrome,O
.,O
 , 
In,O
addition,O
,,O
current,O
data,O
from,O
PubMed,O
,,O
Medline,O
(,O
including,O
reviews,O
,,O
original,O
articles,O
and,O
case,O
reports,O
),O
were,O
used,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
main,O
clinical,O
organ,O
-,O
specific,O
signs,O
of,O
multiple,O
tumors,O
in,O
FAP,O
and,O
Peutz,O
-,O
Jeghers,O
syndrome,O
are,O
shown,O
.,O
 , 
Data,O
on,O
the,O
assessment,O
of,O
a,O
risk,O
for,O
malignant,O
tumors,O
at,O
various,O
sites,O
in,O
the,O
affected,O
patients,O
and,O
their,O
family,O
members,O
at,O
different,O
ages,O
are,O
provided,O
.,O
 , 
Each,O
of,O
these,O
syndromes,O
has,O
a,O
dissimilar,O
genetic,O
foundation,O
.,O
 , 
FAP,O
is,O
caused,O
by,O
the,O
germline,O
mutations,B-DNA_Mutation
in,O
the,O
APC,B-Gene_protein
gene,O
,,O
Peutz,O
-,O
Jeghers,O
syndrome,O
is,O
by,O
the,O
STK11,B-Gene_protein
gene,O
,,O
which,O
predispose,O
individuals,O
to,O
specifically,O
associated,O
neoplasias,O
and,O
require,O
different,O
follow,O
-,O
up,O
strategies,O
.,O
 , 
Information,O
on,O
a,O
phenotype,O
-,O
genotype,O
correlation,O
may,O
serve,O
as,O
a,O
reference,O
point,O
for,O
the,O
possible,O
severity,O
and,O
various,O
manifestations,O
of,O
a,O
disease,O
.,O
 , 
An,O
update,O
on,O
the,O
molecular,O
pathogenesis,O
of,O
these,O
diseases,O
is,O
considered,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
Molecular,O
genetic,O
testing,O
of,O
the,O
genes,O
associated,O
with,O
FAP,O
and,O
Peutz,O
-,O
Jeghers,O
syndromes,O
makes,O
it,O
possible,O
to,O
timely,O
recognize,O
family,O
members,O
at,O
high,O
risk,O
,,O
to,O
plan,O
therapeutic,O
strategy,O
and,O
to,O
affect,O
the,O
course,O
of,O
a,O
disease,O
.,O
 , 
The,O
joint,O
participation,O
of,O
pediatricians,O
,,O
proctologists,O
,,O
oncologists,O
,,O
morphologists,O
,,O
geneticists,O
,,O
and,O
molecular,O
biologists,O
is,O
essential,O
to,O
timely,O
recognize,O
the,O
carriers,O
of,O
the,O
syndromes,O
and,O
a,O
better,O
prognosis,O
in,O
these,O
patients,O
.,O
 , 

,O
 , 
#23603433
Instability,O
at,O
the,O
FRA8I,B-locus
common,O
fragile,O
site,O
disrupts,O
the,O
genomic,O
integrity,O
of,O
the,O
KIAA0146,B-Gene_protein
,,I-Gene_protein
CEBPD,B-Gene_protein
and,O
PRKDC,B-Gene_protein
genes,O
in,O
colorectal,O
cancer,O
.,O
 , 


,O
Specific,O
patterns,O
of,O
genomic,B-DNA_Mutation
aberrations,I-DNA_Mutation
have,O
been,O
associated,O
with,O
different,O
types,O
of,O
malignancies,O
.,O
 , 
In,O
colorectal,O
cancer,O
,,O
losses,B-DNA_Mutation
of,O
chromosome,B-locus
arm,I-locus
8p,I-locus
and,O
gains,B-DNA_Mutation
of,O
chromosome,B-locus
arm,I-locus
8q,I-locus
are,O
among,O
the,O
most,O
common,O
chromosomal,O
rearrangements,O
,,O
suggesting,O
that,O
the,O
centromeric,B-locus
portion,O
of,O
chromosome,B-locus
8,I-locus
is,O
particularly,O
sensitive,O
to,O
breakage,O
.,O
 , 
Genomic,B-DNA_Mutation
alterations,I-DNA_Mutation
frequently,O
occur,O
in,O
the,O
early,O
stages,O
of,O
tumorigenesis,O
at,O
specific,O
genomic,O
regions,O
known,O
as,O
common,B-locus
fragile,I-locus
sites,I-locus
(,B-locus
cFSs,I-locus
),I-locus
.,O
 , 
CFSs,B-locus
represent,O
parts,O
of,O
the,O
normal,O
chromosome,O
structure,O
that,O
are,O
prone,O
to,O
breakage,O
under,O
replication,O
stress,O
.,O
 , 
In,O
this,O
study,O
,,O
we,O
identified,O
the,O
genomic,O
location,O
of,O
FRA8I,B-locus
,,I-locus
spanning,O
530,O
kb,O
at,O
8q11.21,B-locus
and,O
assessed,O
the,O
composition,O
of,O
the,O
fragile,O
DNA,O
sequence,O
.,O
 , 
FRA8I,B-locus
encompasses,O
KIAA0146,B-Gene_protein
,,I-Gene_protein
a,O
large,O
protein,O
-,O
coding,O
gene,O
with,O
yet,O
unknown,O
function,O
,,O
as,O
well,O
as,O
CEBPD,B-Gene_protein
and,O
part,O
of,O
PRKDC,B-Gene_protein
,,I-Gene_protein
two,O
genes,O
encoding,O
proteins,O
involved,O
in,O
tumorigenesis,O
in,O
a,O
variety,O
of,O
cancers,O
.,O
 , 
We,O
show,O
that,O
FRA8I,B-locus
is,O
unstable,O
in,O
lymphocytes,O
and,O
epithelial,O
cells,O
,,O
displaying,O
similar,O
expression,O
rates,O
.,O
 , 
We,O
examined,O
copy,B-DNA_Mutation
number,I-DNA_Mutation
alteration,I-DNA_Mutation
patterns,O
within,O
FRA8I,B-locus
in,O
a,O
panel,O
of,O
25,O
colorectal,O
cancer,O
cell,O
lines,O
and,O
surveyed,O
publically,O
available,O
profiles,O
of,O
56,O
additional,O
colorectal,O
cancer,O
cell,O
lines,O
.,O
 , 
Combining,O
these,O
data,O
shows,O
that,O
focal,O
recombination,O
events,O
disrupt,O
the,O
genomic,O
integrity,O
of,O
KIAA0146,B-Gene_protein
and,O
neighboring,O
cFS,B-locus
genes,O
in,O
12.3,O
%,O
of,O
colorectal,O
cancer,O
cell,O
lines,O
.,O
 , 
Moreover,O
,,O
data,O
analysis,O
revealed,O
evidence,O
that,O
KIAA0146,B-Gene_protein
is,O
a,O
translocation,O
partner,O
of,O
the,O
immunoglobulin,B-Gene_protein
heavy,I-Gene_protein
chain,I-Gene_protein
gene,O
in,O
recurrent,O
t(8;14)(q11;q32,B-locus
),I-locus
translocations,B-DNA_Mutation
in,O
a,O
subset,O
of,O
patients,O
with,O
B,O
-,O
cell,O
precursor,O
acute,O
lymphoblastic,O
leukemia,O
.,O
 , 
Our,O
data,O
molecularly,O
describe,O
a,O
region,O
of,O
enhanced,O
chromosomal,B-DNA_Mutation
instability,I-DNA_Mutation
in,O
the,O
human,O
genome,O
and,O
point,O
to,O
a,O
role,O
of,O
the,O
KIAA0146,B-Gene_protein
gene,O
in,O
tumorigenesis,O
.,O
 , 

,O
 , 
#26925673
Impact,O
of,O
Cellular,O
Genetic,O
Make,O
-,O
up,O
on,O
Colorectal,O
Cancer,O
Cell,O
Lines,O
Response,O
to,O
Ellagic,O
Acid,O
:,O
Implications,O
of,O
Small,O
Interfering,O
RNA,O
.,O



,O
#,O
#,O
BACKGROUND,O

,B-Gene_protein
K,I-Gene_protein
-,I-Gene_protein
Ras,I-Gene_protein
activation,O
is,O
an,O
early,O
event,O
in,O
colorectal,O
carcinogenesis,O
and,O
associated,O
mutations,B-DNA_Mutation
have,O
been,O
reported,O
in,O
about,O
40,O
%,O
of,O
colorectal,O
cancer,O
patients,O
.,O
 , 
These,O
mutations,B-DNA_Mutation
have,O
always,O
been,O
responsible,O
for,O
enhancing,O
malignancy,O
and,O
silencing,O
them,O
is,O
associated,O
with,O
attenuation,O
of,O
tumorigenicity,O
.,O
 , 
Among,O
downstream,O
effectors,O
are,O
the,O
RAF,B-Gene_protein
/,B-Gene_protein
MEK,I-Gene_protein
/,B-Gene_protein
ERK,I-Gene_protein
and,O
the,O
PI3K,B-Gene_protein
/,B-Gene_protein
Akt,I-Gene_protein
signaling,O
pathways,O
.,O
 , 
PI3K,B-Gene_protein
/,B-Gene_protein
Akt,I-Gene_protein
signaling,O
leads,O
to,O
reduction,O
of,O
apoptosis,O
,,O
stimulated,O
cell,O
growth,O
and,O
enhanced,O
proliferation,O
.,O
 , 
Ellagic,O
acid,O
(,O
EA,O
),O
,,O
a,O
naturally,O
occurring,O
antioxidant,O
,,O
has,O
recently,O
emerged,O
as,O
a,O
promising,O
anti,O
-,O
cancer,O
agent,O
.,O
 , 


,O
#,O
#,O
PURPOSE,O

,O
 , 
To,O
evaluate,O
the,O
impact,O
of,O
cellular,O
genetic,O
make-,O
up,O
of,O
two,O
colon,O
cancer,O
cell,O
lines,O
with,O
different,O
genetic,O
backgrounds,O
,,O
HCT-116,O
(,B-Gene_protein
K,I-Gene_protein
-,I-Gene_protein
Ras-/p53,B-Gene_protein
+,I-Gene_protein
),O
and,O
Caco-2,O
(,B-Gene_protein
K,I-Gene_protein
-,I-Gene_protein
Ras+/,I-Gene_protein
p53-,B-Gene_protein
),O
,,O
on,O
response,O
to,O
potential,O
anti,O
-,O
tumour,O
effects,O
of,O
EA,O
.,O
 , 
In,O
addition,O
,,O
the,O
influence,O
of,O
K,B-Gene_protein
-,I-Gene_protein
Ras,I-Gene_protein
silencing,O
in,O
HCT-,O
116,O
cells,O
was,O
investigated,O
.,O
 , 


,O
#,O
#,O
MATERIALS,O
AND,O
METHODS,O

,O
Cellular,O
proliferation,O
,,O
morphology,O
and,O
cell,O
cycle,O
analysis,O
were,O
carried,O
out,O
in,O
addition,O
to,O
Western,O
blotting,O
for,O
detecting,O
total,O
Akt,B-Gene_protein
and,O
p,O
-,B-Gene_protein
Akt,I-Gene_protein
(,O
at,O
Thr308,B-locus
and,O
Ser473,B-locus
),I-locus
in,O
the,O
presence,O
and,O
absence,O
of,O
different,O
concentrations,O
of,O
EA,O
.,O
 , 
Cell,O
proliferation,O
was,O
also,O
assessed,O
in,O
cells,O
transfected,O
with,O
different,O
concentrations,O
of,O
K,B-Gene_protein
-,I-Gene_protein
Ras,I-Gene_protein
siRNA,O
or,O
incubated,O
with,O
ellagic,O
acid,O
following,O
transfection,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
results,O
of,O
the,O
present,O
study,O
revealed,O
that,O
EA,O
exerts,O
anti,O
-,O
proliferative,O
and,O
dose,O
-,O
dependent,O
pro,O
-,O
apoptotic,O
effects,O
.,O
 , 
Cytostatic,O
and,O
cytotoxic,O
effects,O
were,O
also,O
observed,O
.,O
 , 
p,O
-,B-Gene_protein
Akt,I-Gene_protein
(,O
at,O
Thr308,B-locus
and,O
Ser473,B-locus
),I-locus
was,O
downregulated,O
.,O
 , 
Moreover,O
,,O
EA,O
treatment,O
was,O
found,O
to,O
(,O
i,O
),O
reduce,O
K,B-Gene_protein
-,I-Gene_protein
Ras,I-Gene_protein
protein,O
expression,O
;,O
(,O
ii,O
),O
in,O
cells,O
transfected,O
with,O
siRNA,O
and,O
co,O
-,O
treated,O
with,O
EA,O
,,O
pronounced,O
anti,O
-,O
proliferative,O
effects,O
as,O
well,O
as,O
depletion,O
of,O
p,O
-,B-Gene_protein
Akt,I-Gene_protein
(,O
at,O
Thr308,B-locus
),I-locus
were,O
detected,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Cellular,O
genetic,O
makeup,O
(,B-Gene_protein
K,I-Gene_protein
-,I-Gene_protein
Ras-/p53-,B-Gene_protein
),O
was,O
not,O
likely,O
to,O
impose,O
limitations,O
on,O
targeting,O
EA,O
in,O
treatment,O
of,O
colon,O
cancer,O
.,O
 , 
EA,O
had,O
a,O
multi,O
-,O
disciplinary,O
pro,O
-,O
apoptotic,O
anti,O
-,O
proliferative,O
approach,O
,,O
having,O
inhibited,O
Akt,B-Gene_protein
phosphorylation,O
,,O
induced,O
cell,O
cycle,O
arrest,O
and,O
showed,O
an,O
anti,O
-,O
proliferative,O
potential,O
in,O
HCT-116,O
cells,O
(,O
expressing,O
mutant,B-DNA_Mutation
K,B-Gene_protein
-,I-Gene_protein
Ras,I-Gene_protein
),I-Gene_protein
.,O
 , 

,O
 , 
#9731891
Microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
and,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
in,O
sporadic,O
right,O
and,O
left,O
colon,O
carcinoma,O
:,O
different,O
clinical,O
and,O
molecular,O
implications,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Left,O
and,O
right,O
colon,O
carcinomas,O
can,O
display,O
different,O
clinical,O
,,O
pathologic,O
,,O
and,O
genetic,O
characteristics,O
.,O
 , 
The,O
purpose,O
of,O
this,O
study,O
was,O
to,O
characterize,O
multiple,O
molecular,O
genetic,B-DNA_Mutation
alterations,I-DNA_Mutation
in,O
sporadic,O
colon,O
carcinoma,O
and,O
to,O
correlate,O
them,O
with,O
the,O
location,O
of,O
the,O
tumors,O
and,O
with,O
lymph,O
node,O
metastasis,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
One,O
hundred,O
and,O
twenty,O
-,O
five,O
cases,O
of,O
sporadic,O
colon,O
carcinoma,O
(,O
50,O
in,O
the,O
right,O
colon,O
and,O
75,O
in,O
the,O
left,O
colon,O
in,O
patients,O
with,O
no,O
family,O
history,O
of,O
colon,O
carcinoma,O
),O
were,O
studied,O
.,O
 , 
Status,O
of,O
the,O
p53,B-Gene_protein
gene,O
was,O
assessed,O
by,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
,,O
single,O
strand,O
conformation,O
polymorphism,O
,,O
and,O
sequencing,O
at,O
exons,B-locus
5,I-locus
-,I-locus
8,I-locus
.,I-locus
 , 
Microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
was,O
analyzed,O
with,O
five,O
microsatellite,O
markers,O
at,O
chromosome,B-locus
18,I-locus
.,I-locus
 , 
The,O
mismatch,O
repair,O
genes,O
hMLH1,B-Gene_protein
and,O
hMSH2,B-Gene_protein
were,O
studied,O
in,O
tumors,O
found,O
to,O
have,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
by,O
PCR,O
and,O
sequencing,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
In,O
the,O
125,O
cases,O
studied,O
,,O
there,O
were,O
53,O
tumors,O
with,O
mutations,B-DNA_Mutation
of,O
the,O
p53,B-Gene_protein
gene,O
.,O
 , 
p53,B-Gene_protein
mutations,B-DNA_Mutation
correlated,O
with,O
lymph,O
node,O
metastases,O
from,O
right,O
colon,O
carcinoma,O
cases,O
(,O
61,O
%,O
),O
,,O
and,O
all,O
cases,O
with,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
and,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
were,O
AJCC,O
/,O
 , 
UICC,O
Stage,O
III,O
 , 
(,O
Dukes,O
Stage,O
C,O
),O
.,O
 , 
In,O
the,O
right,O
colon,O
carcinoma,O
cases,O
the,O
rate,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
was,O
related,O
to,O
the,O
tumor,O
size,O
(,O
19,O
%,O
in,O
tumors,O
measuring,O
<,O
4,O
cm,O
,,O
and,O
34,O
%,O
in,O
tumors,O
measuring,O
>,O
4,O
cm,O
),O
.,O
 , 
No,O
correlation,O
between,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
and,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
was,O
detected,O
.,O
 , 
In,O
the,O
left,O
colon,O
carcinoma,O
cases,O
,,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
were,O
detected,O
in,O
41,O
%,O
of,O
tumors,O
and,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
in,O
14,O
%,O
;,O
neither,O
finding,O
was,O
related,O
to,O
the,O
tumor,O
size,O
.,O
 , 
Mutations,B-DNA_Mutation
of,O
the,O
hMLH1,B-Gene_protein
and,O
hMSH2,B-Gene_protein
mismatch,O
repair,O
genes,O
were,O
detected,O
in,O
7,O
of,O
24,O
cases,O
with,O
marked,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
#,O
#,O
CONCLUSIONS,O

,B-DNA_Mutation
Microsatellite,I-DNA_Mutation
instability,I-DNA_Mutation
is,O
prone,O
to,O
occur,O
in,O
sporadic,O
right,O
colon,O
carcinoma,O
during,O
tumor,O
growth,O
and,O
is,O
not,O
associated,O
significantly,O
with,O
mutations,B-DNA_Mutation
in,O
the,O
hMLH1,B-Gene_protein
and,O
hMSH2,B-Gene_protein
mismatch,O
repair,O
genes,O
or,O
in,O
the,O
p53,B-Gene_protein
gene,O
.,O
 , 
Concomitant,O
detection,O
of,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
and,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
in,O
right,O
colon,O
carcinoma,O
is,O
associated,O
with,O
the,O
presence,O
of,O
lymph,O
node,O
metastases,O
.,O

,O
 , 
#14966376
Genetic,O
analysis,O
of,O
the,O
APC,B-Gene_protein
gene,O
in,O
Taiwanese,O
familial,O
adenomatous,O
polyposis,O
.,O
 , 


,O
Colorectal,O
cancer,O
has,O
become,O
the,O
third,O
leading,O
cause,O
of,O
death,O
from,O
cancer,O
in,O
Taiwan,O
.,O
 , 
Familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
is,O
an,O
autosomal,O
dominant,O
inherited,O
disease,O
characterized,O
by,O
the,O
presence,O
of,O
multiple,O
adenomatous,O
polyps,O
in,O
the,O
colon,O
and,O
rectum,O
.,O
 , 
The,O
gene,O
responsible,O
for,O
FAP,O
(,B-Gene_protein
APC,I-Gene_protein
),I-Gene_protein
was,O
cloned,O
in,O
1991,O
.,O
 , 
Extensive,O
analyses,O
of,O
the,O
mutation,B-DNA_Mutation
spectra,O
in,O
FAP,O
kindreds,O
have,O
been,O
performed,O
in,O
different,O
countries,O
,,O
but,O
the,O
results,O
have,O
been,O
highly,O
variable,O
(,O
30,O
-,O
80,O
%,O
),O
.,O
 , 
In,O
this,O
study,O
,,O
we,O
used,O
denaturing,O
high,O
-,O
performance,O
liquid,O
chromatography,O
(,O
DHPLC,O
),O
followed,O
by,O
automatic,O
sequencing,O
in,O
an,O
effort,O
to,O
establish,O
the,O
mutation,B-DNA_Mutation
spectrum,O
of,O
APC,B-Gene_protein
from,O
DNA,O
of,O
peripheral,O
blood,O
cells,O
.,O
 , 
Among,O
the,O
6,O
FAP,O
probands,O
analyzed,O
,,O
mutations,B-DNA_Mutation
were,O
detected,O
in,O
3,O
(,O
50,O
%,O
),O
,,O
2,O
of,O
which,O
were,O
novel,O
.,O
 , 
The,O
first,O
novel,O
mutation,B-DNA_Mutation
was,O
at,O
codon,B-locus
2166,I-locus
,,I-locus
with,O
a,O
C,B-DNA_Mutation
to,I-DNA_Mutation
T,I-DNA_Mutation
transition,I-DNA_Mutation
,,I-DNA_Mutation
resulting,O
in,O
a,O
stop,O
codon,O
.,O
 , 
The,O
second,O
novel,O
mutation,B-DNA_Mutation
was,O
at,O
codon,B-locus
1971,I-locus
,,I-locus
with,O
a,O
C,B-DNA_Mutation
to,I-DNA_Mutation
G,I-DNA_Mutation
transversion,I-DNA_Mutation
,,I-DNA_Mutation
resulting,O
in,O
an,O
amino,O
acid,O
change,O
from,O
serine,B-Protein_Mutation
to,I-Protein_Mutation
cysteine,I-Protein_Mutation
.,I-Protein_Mutation
 , 
The,O
third,O
mutation,B-DNA_Mutation
involved,O
an,O
A,B-DNA_Mutation
insertion,I-DNA_Mutation
in,O
the,O
sequence,O
of,O
-AAAAAA-,O
at,O
codons,B-locus
1554,I-locus
-,I-locus
1556,I-locus
,,I-locus
which,O
created,O
a,O
downstream,O
stop,O
codon,O
(,B-locus
codon,I-locus
1558,I-locus
),I-locus
.,O
 , 
This,O
study,O
is,O
the,O
first,O
to,O
report,O
mutation,B-DNA_Mutation
analysis,O
in,O
Taiwanese,O
FAP,O
probands,O
.,O

,O
 , 
#16396368
[,O
Hereditary,O
non,O
polyposis,O
colon,O
cancer,O
--,O
basic,O
principle,O
and,O
ethical,O
considerations,O
],O
.,O
 , 


,O
HNPCC,O
is,O
a,O
hereditary,O
cancer,O
syndrome,O
of,O
several,O
organs,O
but,O
more,O
particularly,O
the,O
colon,O
and,O
the,O
uterus,O
.,O
 , 
It,O
is,O
characterized,O
by,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
related,O
to,O
mutations,B-DNA_Mutation
of,O
DNA,O
mismatch,O
repair,O
(,O
MMR,O
),O
genes,O
.,O
 , 
The,O
role,O
of,O
the,O
pathologist,O
in,O
the,O
detection,O
of,O
colorectal,O
cancer,O
with,O
MSI,B-DNA_Mutation
phenotype,O
is,O
important,O
.,O
 , 
Among,O
the,O
available,O
tests,O
to,O
detect,O
MSI,B-DNA_Mutation
,,I-DNA_Mutation
immunohistochemistry,O
appears,O
being,O
a,O
sensitive,O
,,O
specific,O
and,O
inexpensive,O
test,O
.,O
 , 
The,O
detection,O
of,O
HNPCC,O
syndrome,O
by,O
the,O
genetic,O
test,O
among,O
the,O
MSI,B-DNA_Mutation
cancers,O
implies,O
a,O
coordination,O
of,O
the,O
structures,O
of,O
health,O
and,O
requires,O
a,O
follow,O
-,O
up,O
of,O
the,O
patients,O
,,O
during,O
and,O
after,O
the,O
genetic,O
test,O
.,O
 , 
Ethical,O
dimension,O
related,O
to,O
these,O
hereditary,O
cancers,O
must,O
be,O
considered,O
without,O
constituting,O
a,O
brake,O
for,O
their,O
detection,O
.,O
 , 

,O
 , 
#12534642
Polymorphisms,B-DNA_Mutation
in,O
the,O
cytochrome,B-Gene_protein
P450,I-Gene_protein
CYP1A2,I-Gene_protein
gene,O
(,B-Gene_protein
CYP1A2,I-Gene_protein
),I-Gene_protein
in,O
colorectal,O
cancer,O
patients,O
and,O
controls,O
:,O
allele,O
frequencies,O
,,O
linkage,O
disequilibrium,O
and,O
influence,O
on,O
caffeine,O
metabolism,O
.,O
 , 



,O
#,O
#,O
AIMS,O

,O
Several,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNPs,I-DNA_Mutation
),I-DNA_Mutation
of,O
the,O
cytochrome,B-Gene_protein
P450,I-Gene_protein
enzyme,I-Gene_protein
1A2,I-Gene_protein
gene,O
(,B-Gene_protein
CYP1A2,I-Gene_protein
),I-Gene_protein
have,O
been,O
reported,O
.,O
 , 
Here,O
,,O
frequencies,O
,,O
linkage,O
disequilibrium,O
and,O
phenotypic,O
consequences,O
of,O
six,O
SNPs,O
are,O
described,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
From,O
genomic,O
DNA,O
,,O
114,O
British,O
Caucasians,O
(,O
49,O
colorectal,O
cancer,O
cases,O
and,O
65,O
controls,O
),O
were,O
genotyped,O
for,O
the,O
CYP1A2,B-Gene_protein
polymorphisms,B-DNA_Mutation
-3858G-->A,B-DNA_Mutation
(,O
allele,O
CYP1A2,B-DNA_Mutation
*,I-DNA_Mutation
1C,I-DNA_Mutation
),I-DNA_Mutation
,,O
-2464T-->delT,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1D,I-DNA_Mutation
),I-DNA_Mutation
,,O
-740T-->G,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1E,I-DNA_Mutation
and,I-DNA_Mutation
*,I-DNA_Mutation
1,I-DNA_Mutation
G,I-DNA_Mutation
),I-DNA_Mutation
,,O
-164A-->C,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1F,I-DNA_Mutation
),I-DNA_Mutation
,,O
63C-->G,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
2,I-DNA_Mutation
),I-DNA_Mutation
,,O
and,O
1545T-->C,B-DNA_Mutation
(,O
alleles,O
CYP1A2,B-DNA_Mutation
*,I-DNA_Mutation
1B,I-DNA_Mutation
,,I-DNA_Mutation
*,I-DNA_Mutation
1,I-DNA_Mutation
G,I-DNA_Mutation
,,I-DNA_Mutation
*,I-DNA_Mutation
1H,I-DNA_Mutation
and,I-DNA_Mutation
*,I-DNA_Mutation
3,I-DNA_Mutation
),I-DNA_Mutation
,,O
using,O
polymerase,O
chain,O
reaction,O
-,O
restriction,O
fragment,O
length,O
polymorphism,O
assays,O
.,O
 , 
All,O
patients,O
and,O
controls,O
were,O
phenotyped,O
for,O
CYP1A2,B-Gene_protein
by,O
h.p.l.c,O
.,O
 , 
analysis,O
of,O
urinary,O
caffeine,O
metabolites,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
In,O
114,O
samples,O
,,O
the,O
most,O
frequent,O
CYP1A2,B-Gene_protein
SNPs,B-DNA_Mutation
were,O
1545T-->C,B-DNA_Mutation
(,O
38.2,O
%,O
of,O
tested,O
chromosomes,O
),O
,,O
-164A-->C,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1F,I-DNA_Mutation
,,I-DNA_Mutation
33.3,O
%,O
),O
and,O
-2464T-->delT,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1D,I-DNA_Mutation
,,I-DNA_Mutation
4.82,O
%,O
),O
.,O
 , 
The,O
SNPs,B-DNA_Mutation
were,O
in,O
linkage,O
disequilibrium,O
:,O
the,O
most,O
frequent,O
constellations,O
were,O
found,O
to,O
be,O
-3858G/-2464T/-740T/-164A/63C/1545,B-DNA_Mutation
T,I-DNA_Mutation
(,O
61.8,O
%,O
),O
,,O
-3858G/-2464T/-740T/-164C/63C/1545C,B-DNA_Mutation
(,O
33.3,O
%,O
),O
,,O
and,O
-3858G/-2464delT/-740T/-164A/63C/1545C,B-DNA_Mutation
(,O
3.51,O
%,O
),O
,,O
with,O
no,O
significant,O
frequency,O
differences,O
between,O
cases,O
and,O
controls,O
.,O
 , 
In,O
the,O
phenotype,O
analysis,O
,,O
lower,O
caffeine,O
metabolic,O
ratios,O
were,O
detected,O
in,O
cases,O
than,O
in,O
controls,O
.,O
 , 
This,O
was,O
significant,O
in,O
smokers,O
(,O
n,O
=,O
14,O
,,O
P,O
=,O
0.020,O
),O
,,O
and,O
in,O
a,O
subgroup,O
of,O
15,O
matched,O
case,O
-,O
control,O
pairs,O
(,O
P,O
=,O
0.007,O
),O
,,O
but,O
it,O
was,O
not,O
significant,O
in,O
nonsmokers,O
(,O
n,O
=,O
100,O
,,O
P,O
=,O
0.39,O
),O
.,O
 , 
There,O
was,O
no,O
detectable,O
association,O
between,O
CYP1A2,B-Gene_protein
genotype,O
and,O
caffeine,O
phenotype,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
(,O
i,O
),O
CYP1A2,B-Gene_protein
polymorphisms,B-DNA_Mutation
are,O
in,O
linkage,O
disequilibrium,O
.,O
 , 
Therefore,O
,,O
only,O
-164A-->C,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1F,I-DNA_Mutation
),I-DNA_Mutation
and,O
-2464T-->delT,B-DNA_Mutation
(,B-DNA_Mutation
CYP1A2,I-DNA_Mutation
*,I-DNA_Mutation
1D,I-DNA_Mutation
),I-DNA_Mutation
need,O
to,O
be,O
analysed,O
in,O
the,O
routine,O
assessment,O
of,O
CYP1A2,B-Gene_protein
genotype,O
;,O
(,O
ii,O
),O
in,O
vivo,O
CYP1A2,B-Gene_protein
activity,O
is,O
lower,O
in,O
colorectal,O
cancer,O
patients,O
than,O
in,O
controls,O
,,O
and,O
(,O
iii,O
),O
CYP1A2,B-Gene_protein
genotype,O
had,O
no,O
effect,O
on,O
phenotype,O
(,O
based,O
on,O
the,O
caffeine,O
metabolite,O
ratio,O
),O
.,O
 , 
However,O
,,O
this,O
remains,O
to,O
be,O
confirmed,O
in,O
a,O
larger,O
study,O
.,O
 , 

,O
 , 
#8187091
Characteristics,O
of,O
somatic,O
mutation,B-DNA_Mutation
of,O
the,O
adenomatous,B-Gene_protein
polyposis,I-Gene_protein
coli,I-Gene_protein
gene,O
in,O
colorectal,O
tumors,O
.,O
 , 


,B-DNA_Mutation
Mutation,I-DNA_Mutation
of,O
the,O
adenomatous,B-Gene_protein
polyposis,I-Gene_protein
coli,I-Gene_protein
(,B-Gene_protein
APC,I-Gene_protein
),I-Gene_protein
gene,O
was,O
analyzed,O
in,O
500,O
colorectal,O
tumors,O
from,O
70,O
familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
and,O
102,O
non,O
-,O
FAP,O
patients,O
and,O
in,O
normal,O
tissues,O
from,O
119,O
FAP,O
patients,O
,,O
using,O
polymerase,O
chain,O
reaction,O
-,O
single,O
-,O
strand,O
conformation,O
polymorphism,O
and,O
direct,O
sequencing,O
methods,O
.,O
 , 
These,O
tumors,O
were,O
histopathologically,O
diagnosed,O
.,O
 , 
Sixty,O
-,O
eight,O
germ,O
line,O
mutations,B-DNA_Mutation
(,O
62,O
%,O
deletion,B-DNA_Mutation
,,I-DNA_Mutation
9,O
%,O
insertion,B-DNA_Mutation
,,I-DNA_Mutation
and,O
29,O
%,O
single,B-DNA_Mutation
-,I-DNA_Mutation
base,I-DNA_Mutation
substitution,I-DNA_Mutation
),I-DNA_Mutation
and,O
241,O
somatic,O
mutations,B-DNA_Mutation
(,O
56,O
%,O
deletion,B-DNA_Mutation
,,I-DNA_Mutation
12,O
%,O
insertion,B-DNA_Mutation
,,I-DNA_Mutation
and,O
32,O
%,O
single,B-DNA_Mutation
-,I-DNA_Mutation
base,I-DNA_Mutation
substitution,I-DNA_Mutation
),I-DNA_Mutation
were,O
detected,O
.,O
 , 
All,O
mutations,B-DNA_Mutation
formed,O
stop,O
codons,O
resulting,O
in,O
truncated,O
APC,B-Gene_protein
proteins,O
,,O
except,O
for,O
one,O
germ,O
line,O
mutation,O
.,O
 , 
Differences,O
were,O
found,O
between,O
somatic,O
and,O
germ,O
line,O
mutations,B-DNA_Mutation
,,I-DNA_Mutation
including,O
3,O
new,O
hot,O
spots,O
of,O
mutation,B-DNA_Mutation
at,O
codons,O
1378,B-locus
,,I-locus
1450,B-locus
,,I-locus
and,O
1487,B-locus
-,I-locus
1490,I-locus
,,I-locus
which,O
frequently,O
occurred,O
in,O
somatic,O
mutations,B-DNA_Mutation
but,O
not,O
in,O
germ,O
lines,O
.,O
 , 
The,O
frequency,O
of,O
mutation,B-DNA_Mutation
in,O
each,O
histopathological,O
type,O
of,O
FAP,O
tumor,O
was,O
53,O
%,O
in,O
moderate,O
adenoma,O
,,O
64,O
%,O
in,O
severe,O
adenoma,O
,,O
52,O
%,O
in,O
intramucosal,O
carcinoma,O
,,O
and,O
33,O
%,O
in,O
invasive,O
carcinoma,O
,,O
whereas,O
the,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
including,O
the,O
APC,B-Gene_protein
gene,O
increased,O
with,O
development,O
to,O
each,O
histopathological,O
type,O
.,O
 , 
A,O
similar,O
tendency,O
was,O
observed,O
in,O
non,O
-,O
FAP,O
tumors,O
.,O
 , 
Additionally,O
,,O
we,O
found,O
10,O
FAP,O
tumors,O
that,O
had,O
both,O
somatic,O
mutation,B-DNA_Mutation
and,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
.,I-DNA_Mutation
 , 
These,O
tumors,O
were,O
assumed,O
to,O
have,O
developed,O
from,O
moderate,O
adenomas,O
with,O
germ,O
line,O
and,O
somatic,O
mutations,B-DNA_Mutation
,,I-DNA_Mutation
followed,O
by,O
deletion,O
of,O
the,O
allele,O
with,O
germ,O
line,O
mutation,B-DNA_Mutation
.,I-DNA_Mutation
 , 
These,O
results,O
suggest,O
that,O
inactivation,O
of,O
the,O
APC,B-Gene_protein
gene,O
by,O
two,O
mutations,B-DNA_Mutation
is,O
involved,O
in,O
the,O
development,O
of,O
moderate,O
adenoma,O
,,O
and,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
of,O
the,O
APC,B-Gene_protein
gene,O
is,O
associated,O
with,O
further,O
development,O
to,O
carcinoma,O
.,O
 , 
It,O
was,O
also,O
observed,O
that,O
the,O
distribution,O
of,O
75,O
somatic,O
mutations,B-DNA_Mutation
from,O
one,O
FAP,O
patient,O
on,O
the,O
APC,B-Gene_protein
sequence,O
was,O
similar,O
to,O
the,O
distribution,O
of,O
159,O
somatic,O
mutations,B-DNA_Mutation
from,O
83,O
patients,O
with,O
FAP,O
and,O
non,O
-,O
FAP,O
,,O
which,O
suggests,O
that,O
the,O
position,O
of,O
somatic,O
mutation,B-DNA_Mutation
is,O
mostly,O
due,O
to,O
the,O
APC,B-Gene_protein
sequence,O
itself,O
.,O
 , 

,O
 , 
#15946795
GPX,B-Gene_protein
Pro198Leu,B-Protein_Mutation
and,O
OGG1,B-Gene_protein
Ser326Cys,B-Protein_Mutation
polymorphisms,B-DNA_Mutation
and,O
risk,O
of,O
development,O
of,O
colorectal,O
adenomas,O
and,O
colorectal,O
cancer,O
.,O
 , 


,O
Little,O
is,O
known,O
about,O
genetic,O
risk,O
factors,O
for,O
colorectal,O
cancer,O
.,O
 , 
We,O
assessed,O
the,O
association,O
between,O
polymorphisms,B-DNA_Mutation
in,O
two,O
genes,O
involved,O
in,O
DNA,O
repair,O
of,O
oxidative,O
stress,O
,,O
GPX,B-Gene_protein
and,O
OGG1,B-Gene_protein
,,I-Gene_protein
and,O
risk,O
of,O
colorectal,O
carcinoma,O
or,O
adenomas,O
.,O
 , 
We,O
studied,O
166,O
cases,O
with,O
adenocarcinoma,O
,,O
974,O
with,O
adenomas,O
and,O
397,O
controls,O
recruited,O
from,O
the,O
Norwegian,O
cohort,O
NORCCAP,O
.,O
 , 
No,O
associations,O
were,O
found,O
between,O
the,O
polymorphism,B-DNA_Mutation
GPX,B-Gene_protein
Pro198Leu,B-Protein_Mutation
and,O
risk,O
of,O
colorectal,O
adenomas,O
or,O
carcinomas,O
.,O
 , 
Carriers,O
of,O
the,O
variant,O
allele,O
OGG1,B-Gene_protein
Ser326Cys,B-Protein_Mutation
polymorphism,B-DNA_Mutation
had,O
a,O
lowered,O
risk,O
of,O
colorectal,O
cancer,O
,,O
OR=0.56,O
(,O
95,O
%,O
confidence,O
interval,O
0.33,O
-,O
0.95,O
),O
,,O
while,O
no,O
association,O
were,O
found,O
with,O
risk,O
of,O
adenomas,O
.,O
 , 
This,O
indicates,O
that,O
a,O
low,O
repair,O
capacity,O
of,O
oxidative,O
DNA,O
damage,O
may,O
not,O
be,O
a,O
risk,O
factor,O
for,O
development,O
of,O
colorectal,O
adenomas,O
or,O
carcinoma,O
.,O
 , 

,O
 , 
#23584879
Self,O
administered,O
screening,O
for,O
hereditary,O
cancers,O
in,O
conjunction,O
with,O
mammography,O
and,O
ultrasound,O
.,O
 , 


,O
We,O
evaluated,O
the,O
feasibility,O
of,O
an,O
automated,O
tablet,O
computer,O
application,O
providing,O
a,O
family,O
and,O
personal,O
history,O
based,O
cancer,O
risk,O
assessment,O
for,O
hereditary,O
breast,O
,,O
ovarian,O
,,O
endometrial,O
and,O
colorectal,O
cancers,O
.,O
 , 
1,002,O
women,O
presenting,O
for,O
screening,O
mammography,O
and,O
1,000,O
presenting,O
for,O
ultrasound,O
were,O
offered,O
screening,O
.,O
 , 
The,O
application,O
calculated,O
the,O
risk,O
of,O
BRCA,B-Gene_protein
mutations,B-DNA_Mutation
using,O
BRCAPRO,B-Gene_protein
,,O
Myriad,O
and,O
Tyrer,O
-,O
Cuzick,O
risk,O
assessment,O
models,O
.,O
 , 
Lifetime,O
risk,O
of,O
breast,O
and,O
ovarian,O
cancer,O
was,O
assessed,O
with,O
the,O
BRCAPRO,B-Gene_protein
,,O
Claus,O
and,O
Tyrer,O
-,O
Cuzick,O
models,O
.,O
 , 
Colorectal,O
and,O
endometrial,O
cancer,O
risk,O
was,O
calculated,O
via,O
the,O
MMRpro,O
model,O
.,O
 , 
Patients,O
were,O
identified,O
as,O
high,O
-,O
risk,O
based,O
on,O
thresholds,O
10,O
%,O
or,O
greater,O
risk,O
for,O
carrying,O
genetic,B-DNA_Mutation
mutations,I-DNA_Mutation
or,O
20,O
%,O
or,O
greater,O
lifetime,O
risk,O
of,O
breast,O
or,O
ovarian,O
cancer,O
.,O
 , 
The,O
percent,O
of,O
women,O
found,O
to,O
be,O
high,O
-,O
risk,O
by,O
a,O
single,O
risk,O
assessment,O
tool,O
ranged,O
from,O
0.5,O
to,O
5.3,O
%,O
.,O
 , 
Combining,O
assessment,O
tools,O
found,O
9.3,O
%,O
of,O
women,O
to,O
be,O
high,O
-,O
risk,O
.,O
 , 
The,O
risk,O
assessments,O
performed,O
similarly,O
for,O
the,O
mammography,O
and,O
ultrasound,O
cohorts,O
with,O
yields,O
(,O
combining,O
assessment,O
tools,O
),O
of,O
9.2,O
and,O
9.4,O
%,O
respectively,O
.,O
 , 
The,O
average,O
ages,O
of,O
all,O
the,O
high,O
-,O
risk,O
women,O
were,O
45.8,O
and,O
39.6,O
years,O
for,O
the,O
mammography,O
and,O
ultrasound,O
cohorts,O
respectively,O
.,O
 , 
Difficulties,O
encountered,O
included,O
a,O
need,O
for,O
software,O
upgrade,O
,,O
wireless,O
network,O
unreliability,O
and,O
hardware,O
theft,O
.,O
 , 
Automated,O
family,O
history,O
screening,O
can,O
identify,O
women,O
probably,O
at,O
high,O
-,O
risk,O
for,O
hereditary,O
cancers,O
efficiently,O
.,O
 , 
The,O
number,O
of,O
women,O
identified,O
is,O
increased,O
by,O
employing,O
multiple,O
risk,O
assessment,O
models,O
simultaneously,O
.,O
 , 
Surveying,O
women,O
in,O
conjunction,O
with,O
ultrasound,O
identified,O
women,O
at,O
increased,O
risk,O
as,O
effectively,O
and,O
at,O
a,O
younger,O
age,O
than,O
with,O
screening,O
mammography,O
.,O
 , 

,O
 , 
#14734469
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
is,O
frequently,O
present,O
in,O
sporadic,O
colorectal,O
cancer,O
with,O
methylated,B-DNA_modification
hMLH1,B-Gene_protein
,,I-Gene_protein
but,O
not,O
in,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
PURPOSE,O

,O
 , 
The,O
BRAF,B-Gene_protein
gene,O
encodes,O
a,O
serine,B-Gene_protein
/,I-Gene_protein
threonine,I-Gene_protein
kinase,I-Gene_protein
and,O
plays,O
an,O
important,O
role,O
in,O
the,O
mitogen,O
-,O
activated,O
protein,O
kinase,O
signaling,O
pathway,O
.,O
 , 
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
in,O
sporadic,O
colorectal,O
cancer,O
with,O
microsatellite,O
instability,O
(,O
MSI,O
),O
are,O
more,O
frequently,O
detected,O
than,O
those,O
in,O
microsatellite,O
stable,O
cancer,O
.,O
 , 
In,O
this,O
study,O
,,O
we,O
sought,O
to,O
compare,O
the,O
frequencies,O
of,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
in,O
sporadic,O
colorectal,O
cancer,O
with,O
MSI,O
with,O
those,O
in,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
.,O
 , 


,O
#,O
#,O
EXPERIMENTAL,O
DESIGN,O

,O
 , 
We,O
analyzed,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
in,O
26,O
colorectal,O
cancer,O
cell,O
lines,O
,,O
80,O
sporadic,O
colorectal,O
cancers,O
,,O
and,O
20,O
tumors,O
from,O
HNPCC,O
patients,O
by,O
DNA,O
sequencing,O
and,O
sequence,O
-,O
specific,O
PCR,O
.,O
 , 
The,O
methylation,B-DNA_modification
status,O
of,O
the,O
hMLH1,B-Gene_protein
gene,O
was,O
measured,O
by,O
either,O
sequencing,O
or,O
restriction,O
enzyme,O
digestion,O
after,O
NaHSO(3,O
),O
treatment,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
We,O
observed,O
a,O
strong,O
correlation,O
of,O
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
with,O
hMLH1,B-Gene_protein
promoter,O
methylation,B-DNA_modification
.,I-DNA_modification
 , 
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
were,O
present,O
in,O
13,O
of,O
15,O
(,O
87,O
%,O
),O
of,O
the,O
colorectal,O
cell,O
lines,O
and,O
cancers,O
with,O
methylated,B-DNA_modification
hMLH1,B-Gene_protein
,,I-Gene_protein
whereas,O
only,O
4,O
of,O
91,O
(,O
4,O
%,O
),O
of,O
the,O
cell,O
lines,O
and,O
cancers,O
with,O
unmethylated,O
hMLH1,B-Gene_protein
carried,O
the,O
mutations,B-DNA_Mutation
(,O
P,O
<,O
0.00001,O
),O
.,O
 , 
Sixteen,O
of,O
17,O
mutations,B-DNA_Mutation
were,O
at,O
residue,B-locus
599,I-locus
(,B-Protein_Mutation
V599E,I-Protein_Mutation
),I-Protein_Mutation
.,O
 , 
A,O
BRAF,B-Gene_protein
mutation,B-DNA_Mutation
was,O
also,O
identified,O
at,O
residue,B-locus
463,I-locus
(,B-Protein_Mutation
G463V,I-Protein_Mutation
),I-Protein_Mutation
in,O
one,O
cell,O
line,O
.,O
 , 
In,O
addition,O
,,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
were,O
not,O
found,O
in,O
any,O
cancers,O
or,O
cell,O
lines,O
with,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
In,O
20,O
MSI+,O
cancers,O
from,O
HNPCC,O
patients,O
,,O
however,O
,,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
were,O
not,O
detectable,O
,,O
including,O
a,O
subset,O
of,O
9,O
tumors,O
with,O
negative,O
hMLH1,B-Gene_protein
immunostaining,O
and,O
methylated,B-DNA_modification
hMLH1,B-Gene_protein
.,I-Gene_protein
 , 


,O
#,O
#,O
CONCLUSIONS,O

,B-Gene_protein
BRAF,I-Gene_protein
mutations,B-DNA_Mutation
are,O
frequently,O
present,O
in,O
sporadic,O
colorectal,O
cancer,O
with,O
methylated,B-DNA_modification
hMLH1,B-Gene_protein
,,I-Gene_protein
but,O
not,O
in,O
HNPCC,O
-,O
related,O
cancers,O
.,O
 , 
This,O
discrepancy,O
of,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
between,O
sporadic,O
MSI+,O
cancer,O
and,O
HNPCC,O
might,O
be,O
used,O
in,O
a,O
strategy,O
for,O
the,O
detection,O
of,O
HNPCC,O
families,O
.,O
 , 

,O
 , 
#6300869
Homogeneously,O
staining,O
chromosomal,O
regions,O
contain,O
amplified,O
copies,O
of,O
an,O
abundantly,O
expressed,O
cellular,O
oncogene,O
(,B-Gene_protein
c,I-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
),I-Gene_protein
in,O
malignant,O
neuroendocrine,O
cells,O
from,O
a,O
human,O
colon,O
carcinoma,O
.,O
 , 


,O
Two,O
human,O
neuroendocrine,O
tumor,O
cell,O
lines,O
derived,O
from,O
a,O
colon,O
carcinoma,O
contain,O
either,O
numerous,O
double,O
minute,O
chromosomes,O
(,O
COLO,O
320,O
DM,O
),O
or,O
a,O
homogeneously,O
staining,O
marker,O
chromosome,O
(,O
COLO,O
320,O
HSR,O
),O
.,O
 , 
We,O
found,O
amplification,O
and,O
enhanced,O
expression,O
of,O
the,O
cellular,O
oncogene,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
in,O
both,O
COLO,O
320,O
DM,O
and,O
HSR,O
cells,O
,,O
and,O
we,O
were,O
able,O
to,O
show,O
that,O
the,O
homogeneously,O
staining,O
regions,O
of,O
the,O
COLO,O
320,O
HSR,O
marker,O
chromosome,O
contain,O
amplified,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
.,I-Gene_protein
 , 
From,O
previous,O
and,O
present,O
karyotypes,O
,,O
it,O
appears,O
that,O
the,O
homogeneously,O
staining,O
regions,O
reside,O
on,O
a,O
distorted,O
X,O
chromosome,O
.,O
 , 
Therefore,O
,,O
amplification,O
of,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
has,O
been,O
accompanied,O
by,O
translocation,B-DNA_Mutation
of,O
the,O
gene,O
from,O
its,O
normal,O
position,O
on,O
chromosome,B-locus
8,I-locus
(,B-locus
8q24,I-locus
),I-locus
.,O
 , 
Because,O
double,O
minute,O
chromosomes,O
were,O
features,O
of,O
primary,O
cultures,O
from,O
the,O
original,O
tumor,O
,,O
it,O
seems,O
reasonable,O
to,O
suspect,O
that,O
amplification,O
of,O
c,B-Gene_protein
-,I-Gene_protein
myc,I-Gene_protein
may,O
have,O
contributed,O
to,O
tumorigenesis,O
.,O
 , 

,O
 , 
#20196079
Oncogenic,O
KRAS,B-Gene_protein
is,O
not,O
necessary,O
for,O
Wnt,O
signalling,O
activation,O
in,O
APC,B-Gene_protein
-,I-Gene_protein
associated,O
FAP,O
adenomas,O
.,O
 , 


,O
Recent,O
studies,O
have,O
suggested,O
that,O
APC,B-Gene_protein
loss,B-DNA_Mutation
alone,O
may,O
be,O
insufficient,O
to,O
promote,O
aberrant,O
Wnt,O
/,O
beta,O
-,O
catenin,O
signalling,O
.,O
 , 
Our,O
aim,O
was,O
to,O
comprehensively,O
characterize,O
Wnt,O
signalling,O
components,O
in,O
a,O
set,O
of,O
APC,B-Gene_protein
-,I-Gene_protein
associated,O
familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
tumours,O
.,O
 , 
Sixty,O
adenomas,O
from,O
six,O
FAP,O
patients,O
with,O
known,O
pathogenic,O
APC,B-Gene_protein
mutations,B-DNA_Mutation
were,O
included,O
.,O
 , 
Somatic,O
APC,B-Gene_protein
and,O
KRAS,B-Gene_protein
mutations,B-DNA_Mutation
,,I-DNA_Mutation
beta,O
-,O
catenin,O
immunostaining,O
,,O
and,O
qRT,O
-,O
PCR,O
of,O
APC,B-Gene_protein
,,I-Gene_protein
MYC,B-Gene_protein
,,I-Gene_protein
AXIN2,B-Gene_protein
and,O
SFRP1,B-Gene_protein
were,O
analysed,O
.,O
 , 
Array,O
-,O
comparative,O
genomic,O
hybridization,O
(,O
aCGH,O
),O
was,O
also,O
assessed,O
in,O
26,O
FAP,O
adenomas,O
and,O
24,O
paired,O
adenoma,O
-,O
carcinoma,O
samples,O
.,O
 , 
A,O
somatic,O
APC,B-Gene_protein
alteration,B-DNA_Mutation
was,O
present,O
in,O
15,O
adenomas,O
(,O
LOH,O
in,O
11,O
and,O
four,O
point,O
mutations,O
),O
.,O
 , 
KRAS,B-Gene_protein
mutations,B-DNA_Mutation
were,O
detected,O
in,O
10,O
%,O
of,O
the,O
cases,O
.,O
 , 
APC,B-Gene_protein
mRNA,O
was,O
overexpressed,O
in,O
adenomas,O
.,O
 , 
MYC,B-Gene_protein
and,O
AXIN2,B-Gene_protein
were,O
also,O
overexpressed,O
,,O
with,O
significant,O
intra,O
-,O
case,O
heterogeneity,O
.,O
 , 
Increased,O
cytoplasmic,O
and/or,O
nuclear,O
beta,O
-,O
catenin,O
staining,O
was,O
seen,O
in,O
94,O
%,O
and,O
80,O
%,O
of,O
the,O
adenomas,O
.,O
 , 
beta,O
-,O
Catenin,O
nuclear,O
staining,O
was,O
strongly,O
associated,O
with,O
MYC,B-Gene_protein
levels,O
(,O
p,O
value,O
0.03,O
),O
but,O
not,O
with,O
KRAS,B-Gene_protein
mutations,B-Mutation
.,I-Mutation
 , 
Copy,B-DNA_Mutation
number,I-DNA_Mutation
aberrations,I-DNA_Mutation
were,O
rare,O
.,O
 , 
However,O
,,O
the,O
recurrent,O
chromosome,O
changes,O
observed,O
more,O
frequently,O
contained,O
Wnt,O
pathway,O
genes,O
(,O
p,O
value,O
0.012,O
),O
.,O
 , 
Based,O
on,O
beta,O
-,O
catenin,O
staining,O
and,O
Wnt,O
pathway,O
target,O
genes,O
alterations,O
the,O
Wnt,O
pathway,O
appears,O
to,O
be,O
constitutively,O
activated,O
in,O
all,O
APC,B-Gene_protein
-,I-Gene_protein
FAP,O
tumours,O
,,O
with,O
alterations,O
occurring,O
both,O
upstream,O
and,O
downstream,O
of,O
APC,B-Gene_protein
.,I-Gene_protein
 , 
Wnt,O
aberrations,O
are,O
present,O
at,O
both,O
the,O
DNA,O
and,O
the,O
RNA,O
level,O
.,O
 , 
Somatic,O
profiling,O
of,O
APC,B-Gene_protein
-,I-Gene_protein
FAP,O
tumours,O
provides,O
new,O
insights,O
into,O
the,O
role,O
of,O
APC,B-Gene_protein
in,O
tumourigenesis,O
.,O
 , 

,O
 , 
#18550572
Differential,O
cancer,O
predisposition,O
in,O
Lynch,O
syndrome,O
:,O
insights,O
from,O
molecular,O
analysis,O
of,O
brain,O
and,O
urinary,O
tract,O
tumors,O
.,O
 , 


,O
Hereditary,O
non,O
-,O
polyposis,O
colorectal,O
carcinoma,O
(,O
Lynch,O
syndrome,O
),O
is,O
among,O
the,O
most,O
common,O
hereditary,O
cancers,O
in,O
man,O
and,O
a,O
model,O
of,O
cancers,O
arising,O
through,O
deficient,O
DNA,O
mismatch,O
repair,O
(,O
MMR,O
),O
.,O
 , 
Lynch,O
syndrome,O
patients,O
are,O
predisposed,O
to,O
different,O
cancers,O
in,O
a,O
non,O
-,O
random,O
fashion,O
,,O
the,O
basis,O
of,O
which,O
is,O
poorly,O
understood,O
.,O
 , 
We,O
addressed,O
this,O
issue,O
by,O
determining,O
the,O
molecular,O
profiles,O
for,O
different,O
tumors,O
from,O
a,O
nationwide,O
cohort,O
of,O
Lynch,O
syndrome,O
families,O
(,O
approximately,O
150,O
tumors,O
in,O
total,O
),O
.,O
 , 
We,O
focused,O
on,O
some,O
less,O
prevalent,O
cancers,O
,,O
affecting,O
the,O
brain,O
(,O
n,O
=,O
7,O
),O
and,O
urinary,O
tract,O
(,O
five,O
bladder,O
and,O
five,O
ureter,O
uroepithelial,O
cancers,O
and,O
four,O
kidney,O
adenocarcinomas,O
),O
,,O
and,O
compared,O
their,O
molecular,O
characteristics,O
to,O
those,O
of,O
the,O
most,O
common,O
cancers,O
,,O
colorectal,O
,,O
gastric,O
and,O
endometrial,O
adenocarcinomas,O
,,O
from,O
the,O
same,O
families,O
.,O
 , 
Despite,O
origin,O
from,O
verified,O
MMR,O
gene,O
mutation,B-DNA_Mutation
carriers,O
,,O
the,O
frequency,O
of,O
high,O
-,O
level,O
microsatellite,O
instability,O
in,O
tumors,O
varied,O
between,O
high,O
(,O
100,O
-,O
96,O
%,O
for,O
ureter,O
,,O
stomach,O
and,O
colon,O
),O
,,O
intermediate,O
(,O
63,O
-,O
60,O
%,O
for,O
endometrium,O
and,O
bladder,O
),O
and,O
low,O
(,O
25,O
-,O
0,O
%,O
for,O
kidney,O
and,O
brain,O
),O
.,O
 , 
In,O
contrast,O
to,O
gastrointestinal,O
and,O
endometrial,O
carcinomas,O
,,O
active,O
(,O
nuclear,O
),O
beta,B-Gene_protein
-,I-Gene_protein
catenin,I-Gene_protein
was,O
rare,O
and,O
KRAS,B-Gene_protein
mutations,B-DNA_Mutation
were,O
absent,O
in,O
brain,O
and,O
urological,O
tumors,O
.,O
 , 
Compared,O
with,O
other,O
tumors,O
,,O
frequent,O
stabilization,O
of,O
p53,B-Gene_protein
protein,O
characterized,O
urinary,O
tract,O
cancers,O
.,O
 , 
Promoter,O
methylation,B-DNA_modification
of,O
tumor,O
suppressor,O
genes,O
discriminated,O
the,O
tumors,O
in,O
an,O
organ,O
-,O
specific,O
manner,O
.,O
 , 
Our,O
findings,O
suggest,O
that,O
different,O
Lynch,O
syndrome,O
tumors,O
develop,O
along,O
different,O
routes,O
.,O
 , 
Uroepithelial,O
cancers,O
of,O
the,O
ureter,O
(,O
and,O
bladder,O
to,O
lesser,O
extent,O
),O
share,O
many,O
characteristics,O
of,O
MMR,O
deficiency,O
-,O
driven,O
tumorigenesis,O
,,O
whereas,O
brain,O
tumors,O
and,O
kidney,O
adenocarcinomas,O
follow,O
separate,O
pathways,O
.,O
 , 

,O
 , 
#20661832
Hydrophobic,O
bile,O
acid,O
-,O
induced,O
micronuclei,O
formation,O
,,O
mitotic,O
perturbations,O
,,O
and,O
decreases,O
in,O
spindle,O
checkpoint,O
proteins,O
:,O
relevance,O
to,O
genomic,O
instability,O
in,O
colon,O
carcinogenesis,O
.,O
 , 


,O
We,O
show,O
,,O
for,O
the,O
first,O
time,O
,,O
that,O
hydrophobic,O
bile,O
acids,O
cause,O
aberrations,O
of,O
the,O
mitotic,O
machinery,O
of,O
colon,O
cells,O
that,O
can,O
give,O
rise,O
to,O
aneuploidy,O
,,O
the,O
chromosomal,O
perturbations,O
common,O
in,O
colon,O
tumors,O
.,O
 , 
First,O
,,O
we,O
show,O
that,O
DOC,O
induces,O
a,O
statistically,O
significant,O
fourfold,O
increase,O
in,O
the,O
number,O
of,O
micronuclei,O
in,O
NCM-460,O
cells,O
(,O
a,O
noncancerous,O
colon,O
cell,O
line,O
),O
and,O
a,O
threefold,O
increase,O
in,O
the,O
number,O
of,O
micronuclei,O
in,O
binucleated,O
HT-29,O
colon,O
cancer,O
cells,O
using,O
the,O
cytokinesis,O
block,O
micronucleus,O
assay,O
.,O
 , 
Second,O
,,O
we,O
observed,O
mitotic,B-DNA_Mutation
aberrations,I-DNA_Mutation
after,O
DOC,O
treatment,O
,,O
including,O
improper,B-DNA_Mutation
alignment,I-DNA_Mutation
of,O
chromosomes,O
at,O
the,O
metaphase,O
plate,O
,,O
lagging,O
chromosomes,O
during,O
anaphase,O
,,O
anaphase,O
/,O
telophase,O
chromatin,O
bridges,O
,,O
multipolar,O
divisions,O
,,O
and,O
formation,O
of,O
polynucleated,O
cells,O
.,O
 , 
It,O
was,O
determined,O
that,O
there,O
was,O
a,O
statistically,O
significant,O
threefold,O
increase,O
in,O
the,O
number,O
of,O
aberrant,O
metaphases,O
after,O
short,O
-,O
term,O
and,O
long,O
-,O
term,O
exposure,O
of,O
HT-29,O
and,O
HCT-116,O
cells,O
,,O
respectively,O
.,O
 , 
Third,O
,,O
we,O
showed,O
with,O
Western,O
blots,O
and,O
immunohistochemistry,O
that,O
a,O
likely,O
basis,O
for,O
these,O
mitosis,O
-,O
related,O
perturbations,O
included,O
decreased,O
expression,O
of,O
the,O
spindle,O
checkpoint,O
proteins,O
,,O
Mad2,B-Gene_protein
,,I-Gene_protein
BubR1,B-Gene_protein
,,I-Gene_protein
and,O
securin,B-Gene_protein
.,I-Gene_protein
 , 
Fourth,O
,,O
results,O
of,O
DOC,O
treatment,O
on,O
nocodazole,O
-,O
challenged,O
cells,O
further,O
indicated,O
deficiencies,O
in,O
activation,O
of,O
the,O
spindle,O
assembly,O
checkpoint,O
.,O
 , 
This,O
study,O
provides,O
mechanisms,O
by,O
which,O
hydrophobic,O
bile,O
acids,O
can,O
induce,O
genomic,O
instability,O
in,O
colon,O
epithelial,O
cells,O
.,O
 , 

,O
 , 
#20646601
[,O
Significance,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
detection,O
in,O
colorectal,O
cancer,O
],O
.,O



,O
#,O
#,O
OBJECTIVE,O

,O
To,O
determine,O
the,O
mutation,B-DNA_Mutation
status,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
in,O
colorectal,O
cancer,O
and,O
analyze,O
the,O
associations,O
between,O
its,O
mutation,B-DNA_Mutation
status,O
and,O
clinicopathological,O
characteristics,O
in,O
colorectal,O
cancer,O
so,O
as,O
to,O
select,O
the,O
patients,O
likely,O
to,O
benefit,O
from,O
a,O
targeted,O
therapy,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
A,O
total,O
of,O
208,O
colorectal,O
cancer,O
tissue,O
samples,O
were,O
collected,O
from,O
September,O
2008,O
to,O
February,O
2009,O
.,O
 , 
DNA,O
was,O
extracted,O
with,O
a,O
genomic,O
DNA,O
miniprep,O
kit,O
.,O
 , 
Then,O
PCR,O
was,O
performed,O
with,O
the,O
designed,O
primers,O
and,O
the,O
product,O
directly,O
sequenced,O
by,O
the,O
Sanger,O
method,O
.,O
 , 
Then,O
the,O
associations,O
between,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutation,B-DNA_Mutation
status,O
and,O
clinicopathological,O
characteristics,O
in,O
colorectal,O
cancer,O
were,O
analyzed,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Of,O
208,O
cases,O
,,O
91,O
cases,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
mutation,B-DNA_Mutation
were,O
detected,O
.,O
 , 
The,O
12,B-locus
or,O
13,B-locus
codon,O
had,O
a,O
mutation,B-DNA_Mutation
rate,O
of,O
43.8,O
%,O
.,O
 , 
There,O
were,O
no,O
significant,O
differences,O
in,O
gender,O
,,O
tumor,O
location,O
,,O
histopathological,O
grading,O
and,O
Duke,O
's,O
stage,O
between,O
the,O
wild,O
and,O
mutated,O
groups,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
Detection,O
of,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
gene,O
status,O
in,O
colorectal,O
cancer,O
will,O
help,O
to,O
select,O
the,O
patients,O
likely,O
to,O
benefit,O
from,O
the,O
monoclonal,O
antibody,O
therapy,O
of,O
targeting,O
epidermal,O
growth,O
factor,O
receptor,O
.,O
 , 

,O
 , 
#11766074
Attenuated,O
familial,O
adenomatous,O
polyposis,O
associated,O
with,O
advanced,O
rectal,O
cancer,O
in,O
a,O
16,O
-,O
year,O
-,O
old,O
boy,O
:,O
report,O
of,O
a,O
case,O
.,O
 , 


,O
We,O
herein,O
present,O
a,O
case,O
of,O
attenuated,O
familial,O
adenomatous,O
polyposis,O
(,O
AFAP,O
),O
with,O
advanced,O
rectal,O
cancer,O
in,O
a,O
16,O
-,O
year,O
-,O
old,O
boy,O
.,O
 , 
His,O
mother,O
and,O
younger,O
brother,O
both,O
had,O
subcutaneous,O
soft,O
tissue,O
tumors,O
in,O
the,O
back,O
and,O
sparse,O
-,O
type,O
colorectal,O
polyposis,O
.,O
 , 
His,O
mother,O
also,O
had,O
dental,O
anomalies,O
and,O
gastric,O
fundic,O
gland,O
polyposis,O
.,O
 , 
The,O
patient,O
was,O
admitted,O
to,O
our,O
hospital,O
for,O
investigation,O
of,O
bloody,O
stools,O
.,O
 , 
Barium,O
enema,O
and,O
colonofiberscopy,O
revealed,O
advanced,O
rectal,O
cancer,O
and,O
sparse,O
(,O
<,O
50,O
),O
colorectal,O
polyps,O
.,O
 , 
He,O
also,O
had,O
dental,O
anomalies,O
,,O
a,O
subcutaneous,O
soft,O
tissue,O
tumor,O
in,O
the,O
back,O
,,O
and,O
gastric,O
fundic,O
gland,O
polyposis,O
as,O
extracolonic,O
manifestations,O
.,O
 , 
A,O
total,O
proctocolectomy,O
and,O
ileoanal,O
anastomosis,O
were,O
performed,O
,,O
and,O
histological,O
examination,O
of,O
the,O
resected,O
specimens,O
confirmed,O
moderately,O
differentiated,O
adenocarcinomas,O
of,O
the,O
rectum,O
with,O
metastases,O
to,O
the,O
regional,O
lymph,O
nodes,O
.,O
 , 
The,O
other,O
colorectal,O
polyps,O
were,O
tubular,O
adenomas,O
with,O
no,O
evidence,O
of,O
malignancy,O
.,O
 , 
Germline,O
mutations,B-DNA_Mutation
in,O
the,O
APC,B-Gene_protein
gene,O
were,O
observed,O
in,O
codons,B-locus
486,I-locus
,,I-locus
545,B-locus
,,I-locus
1493,B-locus
,,I-locus
and,O
1556,B-locus
.,I-locus
 , 
This,O
case,O
serves,O
to,O
demonstrate,O
that,O
a,O
total,O
proctocolectomy,O
with,O
ileoanal,O
anastomosis,O
should,O
be,O
the,O
procedure,O
of,O
choice,O
for,O
young,O
patients,O
found,O
to,O
have,O
advanced,O
rectal,O
cancer,O
associated,O
with,O
FAP,O
.,O
 , 

,O
 , 
#17389618
Twenty,O
-,O
four,O
non,B-DNA_Mutation
-,I-DNA_Mutation
synonymous,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
in,O
the,O
one,O
-,O
carbon,O
metabolic,O
pathway,O
and,O
risk,O
of,O
colorectal,O
adenoma,O
in,O
the,O
Nurses,O
',O
Health,O
Study,O
.,O
 , 


,O
Dietary,O
folate,O
and,O
alcohol,O
consumption,O
as,O
well,O
as,O
polymorphic,O
variants,O
in,O
one,O
-,O
carbon,O
metabolism,O
genes,O
may,O
modulate,O
risk,O
of,O
colorectal,O
adenoma,O
through,O
aberrant,O
DNA,O
methylation,B-DNA_modification
and,O
altered,O
nucleotide,O
synthesis,O
and,O
repair,O
.,O
 , 
We,O
assessed,O
the,O
association,O
of,O
24,O
non,B-DNA_Mutation
-,I-DNA_Mutation
synonymous,I-DNA_Mutation
single,I-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
nsSNPs,I-DNA_Mutation
),I-DNA_Mutation
in,O
13,O
genes,O
in,O
the,O
one,O
-,O
carbon,O
metabolism,O
pathway,O
and,O
risk,O
of,O
colorectal,O
adenoma,O
in,O
556,O
incident,O
cases,O
and,O
557,O
controls,O
nested,O
in,O
the,O
Nurses,O
',O
Health,O
Study,O
.,O
 , 
Most,O
of,O
the,O
SNPs,B-DNA_Mutation
were,O
not,O
associated,O
with,O
risk,O
of,O
colorectal,O
adenoma,O
.,O
 , 
We,O
did,O
,,O
however,O
,,O
observe,O
a,O
modest,O
increased,O
risk,O
among,O
carriers,O
of,O
the,O
transcobalamin,B-Gene_protein
(,B-Gene_protein
TCN,I-Gene_protein
),I-Gene_protein
II,O
259,B-Protein_Mutation
Pro,I-Protein_Mutation
/,I-Protein_Mutation
Arg,I-Protein_Mutation
+,I-Protein_Mutation
Arg,I-Protein_Mutation
/,I-Protein_Mutation
Arg,I-Protein_Mutation
variant,I-Protein_Mutation
(,O
odds,O
ratio,O
1.48,O
,,O
95,O
%,O
confidence,O
interval,O
1.09,O
-,O
2.02,O
),O
for,O
colorectal,O
adenoma,O
.,O
 , 
The,O
TCN,B-Gene_protein
II,I-Gene_protein
Pro259Arg,B-Protein_Mutation
polymorphism,O
may,O
affect,O
TCN,B-Gene_protein
binding,O
and,O
transport,O
of,O
vitamin,O
B(12,O
),O
and,O
thus,O
warrants,O
further,O
investigation,O
of,O
its,O
biological,O
function,O
.,O
 , 
In,O
addition,O
,,O
the,O
methionine,B-Gene_protein
synthase,I-Gene_protein
reductase,I-Gene_protein
(,B-Gene_protein
MTRR,I-Gene_protein
),I-Gene_protein
Arg415Cys,B-Protein_Mutation
and,O
MTRR,B-Gene_protein
Ser284Thr,B-Protein_Mutation
variant,O
carriers,O
,,O
also,O
in,O
the,O
vitamin,O
B(12,O
),O
pathway,O
,,O
have,O
suggestive,O
associations,O
with,O
advanced,O
colorectal,O
adenoma,O
(,O
defined,O
as,O
being,O
larger,O
than,O
1,O
cm,O
,,O
villous,O
,,O
tubular,O
-,O
villous,O
or,O
carcinoma,O
in,O
situ,O
histology,O
),O
.,O
 , 
We,O
observed,O
significant,O
evidence,O
for,O
departure,O
from,O
multiplicative,O
interaction,O
for,O
the,O
betaine,B-Gene_protein
-,I-Gene_protein
homocysteine,I-Gene_protein
methyltransferase,I-Gene_protein
(,B-Gene_protein
BHMT,I-Gene_protein
),I-Gene_protein
Arg239Gln,B-Protein_Mutation
with,O
dietary,O
methyl,O
status,O
(,O
based,O
on,O
intake,O
of,O
dietary,O
folate,O
,,O
methionine,O
and,O
alcohol,O
intake,O
),O
in,O
relation,O
to,O
colorectal,O
adenoma,O
;,O
no,O
such,O
interaction,O
was,O
observed,O
for,O
the,O
other,O
23,O
SNPs,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Further,O
investigation,O
is,O
required,O
to,O
validate,O
the,O
association,O
of,O
the,O
polymorphisms,B-DNA_Mutation
in,O
the,O
one,O
-,O
carbon,O
metabolic,O
genes,O
and,O
risk,O
of,O
colorectal,O
adenoma,O
.,O
 , 

,O
 , 
#7905818
Combined,O
use,O
of,O
molecular,O
and,O
biomarkers,O
for,O
presymptomatic,O
carrier,O
risk,O
assessment,O
in,O
familial,O
adenomatous,O
polyposis,O
:,O
implications,O
for,O
screening,O
guidelines,O
.,O
 , 


,O
Predictive,O
carrier,O
testing,O
for,O
the,O
inherited,O
disorder,O
of,O
familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
can,O
be,O
conducted,O
using,O
DNA,O
markers,O
linked,O
to,O
the,O
FAP,B-locus
locus,I-locus
.,I-locus
 , 
The,O
presence,O
of,O
characteristic,O
hypertrophic,O
retinal,O
lesions,O
has,O
been,O
advocated,O
as,O
useful,O
biomarkers,O
for,O
FAP,O
.,O
 , 
We,O
have,O
compared,O
molecular,O
linkage,O
and,O
retinal,O
screening,O
techniques,O
by,O
evaluating,O
the,O
presymptomatic,O
carrier,O
risk,O
of,O
40,O
at,O
-,O
risk,O
individuals,O
from,O
15,O
FAP,O
families,O
.,O
 , 
Linkage,O
analysis,O
was,O
informative,O
in,O
all,O
and,O
retinal,O
lesion,O
analysis,O
in,O
25,O
cases,O
.,O
 , 
For,O
informative,O
at,O
-,O
risk,O
population,O
,,O
predictive,O
diagnosis,O
by,O
both,O
techniques,O
was,O
completely,O
concordant,O
and,O
identified,O
15,O
members,O
at,O
",O
high,O
",O
and,O
10,O
at,O
",O
low,O
",O
risk,O
of,O
inheriting,O
FAP,O
.,O
 , 
Because,O
of,O
the,O
unique,O
advantages,O
offered,O
by,O
each,O
technique,O
,,O
a,O
strategy,O
integrating,O
both,O
techniques,O
will,O
increase,O
the,O
number,O
of,O
FAP,O
families,O
that,O
can,O
be,O
screened,O
presymptomatically,O
.,O
 , 
Identification,O
of,O
individuals,O
at,O
high,O
risk,O
of,O
polyposis,O
will,O
improve,O
their,O
clinical,O
surveillance,O
and,O
further,O
reduce,O
the,O
incidence,O
of,O
colorectal,O
cancer,O
in,O
FAP,O
families,O
.,O
 , 

,O
 , 
#20459617
Distinct,O
high,O
resolution,O
genome,O
profiles,O
of,O
early,O
onset,O
and,O
late,O
onset,O
colorectal,O
cancer,O
integrated,O
with,O
gene,O
expression,O
data,O
identify,O
candidate,O
susceptibility,O
loci,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Estimates,O
suggest,O
that,O
up,O
to,O
30,O
%,O
of,O
colorectal,O
cancers,O
(,O
CRC,O
),O
may,O
develop,O
due,O
to,O
an,O
increased,O
genetic,O
risk,O
.,O
 , 
The,O
mean,O
age,O
at,O
diagnosis,O
for,O
CRC,O
is,O
about,O
70,O
years,O
.,O
 , 
Time,O
of,O
disease,O
onset,O
20,O
years,O
younger,O
than,O
the,O
mean,O
age,O
is,O
assumed,O
to,O
be,O
indicative,O
of,O
genetic,O
susceptibility,O
.,O
 , 
We,O
have,O
compared,O
high,O
resolution,O
tumor,O
genome,O
copy,B-DNA_Mutation
number,I-DNA_Mutation
variation,I-DNA_Mutation
(,B-DNA_Mutation
CNV,I-DNA_Mutation
),I-DNA_Mutation
(,O
Roche,O
NimbleGen,O
,,O
385,O
000,O
oligo,O
CGH,O
array,O
),O
in,O
microsatellite,O
stable,O
(,O
MSS,O
),O
tumors,O
from,O
two,O
age,O
groups,O
,,O
including,O
23,O
young,O
at,O
onset,O
patients,O
without,O
known,O
hereditary,O
syndromes,O
and,O
with,O
a,O
median,O
age,O
of,O
44,O
years,O
(,O
range,O
:,O
28,O
-,O
53,O
),O
and,O
17,O
elderly,O
patients,O
with,O
median,O
age,O
79,O
years,O
(,O
range,O
:,O
69,O
-,O
87,O
),O
.,O
 , 
Our,O
aim,O
was,O
to,O
identify,O
differences,O
in,O
the,O
tumor,O
genomes,O
between,O
these,O
groups,O
and,O
pinpoint,O
potential,O
susceptibility,O
loci,O
.,O
 , 
Integration,O
analysis,O
of,O
CNV,B-DNA_Mutation
and,O
genome,O
wide,O
mRNA,O
expression,O
data,O
,,O
available,O
for,O
the,O
same,O
tumors,O
,,O
was,O
performed,O
to,O
identify,O
a,O
restricted,O
candidate,O
gene,O
list,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
total,O
fraction,O
of,O
the,O
genome,O
with,O
aberrant,B-DNA_Mutation
copy,I-DNA_Mutation
number,I-DNA_Mutation
,,I-DNA_Mutation
the,O
overall,O
genomic,O
profile,O
and,O
the,O
TP53,B-Gene_protein
mutation,B-DNA_Mutation
spectrum,O
were,O
similar,O
between,O
the,O
two,O
age,O
groups,O
.,O
 , 
However,O
,,O
both,O
the,O
number,O
of,O
chromosomal,B-DNA_Mutation
aberrations,I-DNA_Mutation
and,O
the,O
number,O
of,O
breakpoints,O
differed,O
significantly,O
between,O
the,O
groups,O
.,O
 , 
Gains,B-DNA_Mutation
of,O
2q35,B-locus
,,I-locus
10q21.3,B-locus
-,I-locus
22.1,I-locus
,,I-locus
10q22.3,B-locus
and,O
19q13.2,B-locus
-,I-locus
13.31,I-locus
and,O
losses,B-DNA_Mutation
from,O
1p31.3,B-locus
,,I-locus
1q21.1,B-locus
,,I-locus
2q21.2,B-locus
,,I-locus
4p16.1,B-locus
-,I-locus
q28.3,I-locus
,,I-locus
10p11.1,B-locus
and,O
19p12,B-locus
,,I-locus
positions,O
that,O
in,O
total,O
contain,O
more,O
than,O
500,O
genes,O
,,O
were,O
found,O
significantly,O
more,O
often,O
in,O
the,O
early,O
onset,O
group,O
as,O
compared,O
to,O
the,O
late,O
onset,O
group,O
.,O
 , 
Integration,O
analysis,O
revealed,O
a,O
covariation,O
of,O
DNA,O
copy,O
number,O
at,O
these,O
sites,O
and,O
mRNA,O
expression,O
for,O
107,O
of,O
the,O
genes,O
.,O
 , 
Seven,O
of,O
these,O
genes,O
,,O
CLC,B-Gene_protein
,,I-Gene_protein
EIF4E,B-Gene_protein
,,I-Gene_protein
LTBP4,B-Gene_protein
,,I-Gene_protein
PLA2G12A,B-Gene_protein
,,I-Gene_protein
PPAT,B-Gene_protein
,,I-Gene_protein
RG9MTD2,B-Gene_protein
,,I-Gene_protein
and,O
ZNF574,B-Gene_protein
,,I-Gene_protein
had,O
significantly,O
different,O
mRNA,O
expression,O
comparing,O
median,O
expression,O
levels,O
across,O
the,O
transcriptome,O
between,O
the,O
two,O
groups,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Ten,O
genomic,O
loci,O
,,O
containing,O
more,O
than,O
500,O
protein,O
coding,O
genes,O
,,O
are,O
identified,O
as,O
more,O
often,O
altered,O
in,O
tumors,O
from,O
early,O
onset,O
versus,O
late,O
onset,O
CRC,O
.,O
 , 
Integration,O
of,O
genome,O
and,O
transcriptome,O
data,O
identifies,O
seven,O
novel,O
candidate,O
genes,O
with,O
the,O
potential,O
to,O
identify,O
an,O
increased,O
risk,O
for,O
CRC,O
.,O
 , 

,O
 , 
#1916131
[,O
Immunochemical,O
evidence,O
of,O
a,O
mutated,B-Mutation
p53,B-Gene_protein
protein,O
expressed,O
in,O
human,O
colorectal,O
adenocarcinoma,O
],O
.,O
 , 


,O
Evidence,O
is,O
accumulating,O
that,O
the,O
p53,B-Gene_protein
anti,O
-,O
oncogene,O
is,O
a,O
key,O
gene,O
in,O
the,O
genesis,O
of,O
carcinoma,O
in,O
human,O
colon,O
and,O
rectum,O
.,O
 , 
Although,O
mutations,B-DNA_Mutation
of,O
the,O
p53,B-Gene_protein
gene,O
have,O
been,O
shown,O
to,O
be,O
frequent,O
,,O
the,O
protein,O
was,O
present,O
in,O
only,O
approximately,O
50,O
percent,O
of,O
specimens,O
examined,O
.,O
 , 
However,O
only,O
one,O
monoclonal,O
antibody,O
recognizing,O
an,O
epitope,O
present,O
on,O
wild,O
-,O
type,O
p53,B-Gene_protein
had,O
been,O
used,O
.,O
 , 
We,O
studied,O
the,O
p53,B-Gene_protein
expression,O
in,O
a,O
series,O
of,O
16,O
colorectal,O
carcinoma,O
specimens,O
using,O
3,O
different,O
monoclonal,O
antibodies,O
(,B-Gene_protein
pAb,I-Gene_protein
421,I-Gene_protein
,,I-Gene_protein
1801,B-Gene_protein
,,I-Gene_protein
240,B-Gene_protein
),I-Gene_protein
.,O
 , 
Specific,O
immunofluorescent,O
staining,O
was,O
quantified,O
by,O
dual,O
parameter,O
(,O
DNA,O
/,B-Gene_protein
p53,I-Gene_protein
),I-Gene_protein
flow,O
cytometry,O
.,O
 , 
Two,O
different,O
types,O
of,O
preparations,O
were,O
compared,O
in,O
order,O
to,O
verify,O
the,O
conservation,O
of,O
the,O
antigen,O
.,O
 , 
Nuclear,O
suspensions,O
prepared,O
from,O
frozen,O
tumor,O
fragments,O
were,O
shown,O
to,O
produce,O
results,O
equivalent,O
to,O
those,O
of,O
whole,O
cell,O
preparations,O
originating,O
from,O
fresh,O
surgical,O
specimens,O
.,O
 , 
The,O
p53,B-Gene_protein
protein,O
was,O
detected,O
in,O
9,O
of,O
the,O
16,O
cancers,O
with,O
pAb,B-Gene_protein
421,I-Gene_protein
and,O
240,B-Gene_protein
monoclonal,O
antibodies,O
(,O
8,O
of,O
which,O
were,O
also,O
positive,O
for,O
pAb,B-Gene_protein
1801,I-Gene_protein
antibody,O
),O
.,O
 , 
Four,O
additional,O
tumors,O
were,O
considered,O
positive,O
for,O
pAb,B-Gene_protein
240,I-Gene_protein
antibody,O
alone,O
.,O
 , 
Overall,O
,,O
13/16,O
cancer,O
specimens,O
were,O
shown,O
to,O
present,O
immunoreactivity,O
for,O
pAb,B-Gene_protein
240,I-Gene_protein
antibody,O
.,O
 , 
Topography,O
of,O
staining,O
was,O
investigated,O
by,O
immunohistochemistry,O
with,O
peroxidase,O
methods,O
.,O
 , 
Eight,O
cases,O
were,O
informative,O
,,O
6,O
of,O
which,O
presented,O
nuclear,O
staining,O
compatible,O
with,O
the,O
cytometry,O
results,O
.,O
 , 
There,O
was,O
one,O
discordant,O
case,O
i.e.,O
pAb,B-Gene_protein
240,I-Gene_protein
antibody,O
being,O
positive,O
on,O
cytometry,O
and,O
entirely,O
negative,O
on,O
immunohistochemistry,O
.,O
 , 
This,O
small,O
series,O
allowed,O
us,O
to,O
show,O
that,O
81,O
percent,O
of,O
tumor,O
samples,O
stained,O
with,O
monoclonal,O
antibody,O
pAb,B-Gene_protein
240,I-Gene_protein
,,I-Gene_protein
considered,O
to,O
be,O
specific,O
to,O
mutated,B-Mutation
protein,O
,,O
and,O
that,O
some,O
tumors,O
express,O
a,O
p53,B-Gene_protein
protein,O
which,O
is,O
not,O
detected,O
with,O
terminal,O
sequence,O
-,O
specific,O
antibodies,O
.,O
 , 

,O
 , 
#17096342
MDM2,B-Gene_protein
SNP309,B-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
G,I-DNA_Mutation
alone,O
or,O
in,O
combination,O
with,O
the,O
TP53,B-Gene_protein
R72P,B-Protein_Mutation
polymorphism,B-DNA_Mutation
does,O
not,O
appear,O
to,O
influence,O
disease,O
expression,O
and,O
age,O
of,O
diagnosis,O
of,O
colorectal,O
cancer,O
in,O
HNPCC,O
patients,O
.,O
 , 


,O
Disease,O
expression,O
in,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
can,O
not,O
be,O
readily,O
explained,O
by,O
mutation,B-Mutation
site,O
in,O
the,O
respective,O
DNA,O
mismatch,O
repair,O
genes,O
associated,O
with,O
this,O
disorder,O
.,O
 , 
One,O
explanation,O
is,O
the,O
role,O
of,O
modifying,O
genes,O
that,O
can,O
either,O
promote,O
or,O
prevent,O
disease,O
development,O
on,O
a,O
background,O
of,O
increased,O
risk,O
.,O
 , 
Two,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
in,O
MDM2,B-Gene_protein
and,O
TP53,B-Gene_protein
have,O
been,O
shown,O
to,O
be,O
associated,O
with,O
younger,O
ages,O
of,O
disease,O
onset,O
in,O
HNPCC,O
(,B-Gene_protein
TP53,I-Gene_protein
),I-Gene_protein
and,O
Li,O
-,O
Fraumeni,O
syndrome,O
(,B-Gene_protein
MDM2,I-Gene_protein
),I-Gene_protein
.,O
 , 
In,O
this,O
study,O
220,O
HNPCC,O
patients,O
were,O
examined,O
,,O
from,O
Australia,O
and,O
Poland,O
,,O
all,O
characterized,O
at,O
the,O
molecular,O
level,O
to,O
determine,O
the,O
frequency,O
of,O
the,O
MDM2,B-Gene_protein
SNP309,B-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
G,I-DNA_Mutation
and,O
to,O
assess,O
its,O
influence,O
on,O
disease,O
expression,O
.,O
 , 
The,O
results,O
were,O
then,O
pooled,O
with,O
the,O
results,O
of,O
a,O
previous,O
study,O
to,O
assess,O
the,O
combined,O
influence,O
of,O
the,O
MDM2,B-Gene_protein
SNP309,B-DNA_Mutation
T,I-DNA_Mutation
>,I-DNA_Mutation
G,I-DNA_Mutation
and,O
TP53,B-Gene_protein
SNP,B-DNA_Mutation
R72P.,B-Protein_Mutation
 , 
A,O
significant,O
difference,O
was,O
observed,O
between,O
CRC,O
patients,O
and,O
unaffected,O
MMR,B-Gene_protein
gene,O
mutation,B-DNA_Mutation
carriers,O
over,O
the,O
age,O
of,O
45,O
years,O
(,O
p,O
=,O
0.01,O
),O
.,O
 , 
The,O
unaffected,O
MMR,B-Gene_protein
gene,O
mutation,B-DNA_Mutation
carriers,O
over,O
the,O
age,O
of,O
45,O
years,O
who,O
carry,O
the,O
G,O
allele,O
have,O
a,O
reduced,O
risk,O
of,O
developing,O
CRC,O
.,O
 , 
The,O
results,O
indicate,O
that,O
the,O
MDM2,B-Gene_protein
SNP309,B-DNA_Mutation
,,I-DNA_Mutation
alone,O
or,O
in,O
combination,O
with,O
TP53,B-Gene_protein
R72P,B-Protein_Mutation
,,I-Protein_Mutation
does,O
not,O
influence,O
age,O
of,O
diagnosis,O
of,O
CRC,O
in,O
individuals,O
with,O
HNPCC,O
.,O
 , 
In,O
conclusion,O
,,O
the,O
data,O
indicates,O
the,O
G,O
allele,O
of,O
MDM2,B-Gene_protein
SNP309,B-DNA_Mutation
might,O
have,O
a,O
protective,O
effect,O
on,O
disease,O
development,O
in,O
HNPCC,O
patients,O
and,O
that,O
age,O
of,O
diagnosis,O
of,O
CRC,O
is,O
not,O
associated,O
with,O
MDM2,B-Gene_protein
SNP309,B-DNA_Mutation
or,O
TP53,B-Gene_protein
R72P,B-Protein_Mutation
either,O
as,O
single,O
SNPs,B-DNA_Mutation
or,O
combined,O
.,O
 , 

,O
 , 
#25421761
[,O
Application,O
of,O
molecular,O
targeted,O
agents,O
in,O
comprehensive,O
treatment,O
of,O
gastrointestinal,O
cancer,O
],O
.,O
 , 


,O
Targeted,O
agents,O
increase,O
response,O
rates,O
and,O
improved,O
overall,O
survival,O
in,O
treatment,O
of,O
metastatic,O
gastrointestinal,O
cancer,O
.,O
 , 
Therefore,O
,,O
physicians,O
pay,O
more,O
attention,O
to,O
the,O
role,O
of,O
targeted,O
agents,O
in,O
treatment,O
of,O
local,O
advanced,O
gastrointestinal,O
cancer,O
.,O
 , 
The,O
clinical,O
trials,O
are,O
ongoing,O
to,O
evaluate,O
the,O
efficacy,O
of,O
Trastuzumab,O
in,O
neoadjuvant,O
treatment,O
of,O
local,O
advanced,O
gastric,O
cancer,O
with,O
HER-2,B-Gene_protein
gene,O
over,O
expression,O
.,O
 , 
Many,O
studies,O
reported,O
Cetuximab,O
plus,O
chemotherapy,O
as,O
a,O
conversion,O
treatment,O
improve,O
R0,O
resection,O
rates,O
and,O
prolonged,O
overall,O
survival,O
of,O
the,O
patients,O
with,O
potentially,O
resectable,O
colorectal,O
cancer,O
liver,O
metastasis,O
with,O
wild,O
type,O
KRAS,B-Gene_protein
gene,O
status,O
.,O
 , 
A,O
phase,O
III,O
(,O
clinical,O
trial,O
is,O
assessing,O
the,O
conversion,O
efficacy,O
of,O
Bevacizumab,O
in,O
unresectable,O
disease,O
with,O
KRAS,B-Gene_protein
gene,O
mutation,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Current,O
evidence,O
showed,O
that,O
neoadjuvant,O
therapy,O
of,O
targeted,O
agents,O
did,O
not,O
prolong,O
survival,O
of,O
patients,O
with,O
resectable,O
liver,O
metastasis,O
.,O
 , 
However,O
,,O
this,O
is,O
controversial,O
.,O
 , 
In,O
neoadjuvant,O
therapy,O
of,O
local,O
advanced,O
rectal,O
cancer,O
,,O
Cetuximab,O
did,O
not,O
improve,O
the,O
rates,O
of,O
pathological,O
complete,O
response,O
in,O
most,O
of,O
the,O
phase,O
II,O
(,O
trials,O
.,O
 , 
Furthermore,O
,,O
there,O
are,O
no,O
phase,O
III,O
(,O
trials,O
to,O
assess,O
the,O
role,O
of,O
Bevacizumab,O
.,O
 , 
Compared,O
to,O
chemotherapy,O
alone,O
for,O
metastatic,O
cancer,O
,,O
it,O
is,O
more,O
important,O
to,O
evaluate,O
the,O
interaction,O
and,O
synergistic,O
action,O
of,O
targeted,O
agents,O
,,O
cytotoxic,O
drugs,O
,,O
surgery,O
and,O
radiation,O
,,O
to,O
make,O
a,O
scientific,O
multidisciplinary,O
model,O
in,O
comprehensive,O
treatment,O
of,O
local,O
advanced,O
cancer,O
.,O
 , 

,O
 , 
#20198339
Bile,O
acid,O
regulates,O
MUC2,B-Gene_protein
transcription,O
in,O
colon,O
cancer,O
cells,O
via,O
positive,O
EGFR,B-Gene_protein
/,B-Gene_protein
PKC,I-Gene_protein
/,I-Gene_protein
Ras,I-Gene_protein
/,B-Gene_protein
ERK,I-Gene_protein
/,I-Gene_protein
CREB,I-Gene_protein
,,I-Gene_protein
PI3K,B-Gene_protein
/,I-Gene_protein
Akt,I-Gene_protein
/,I-Gene_protein
IkappaB,I-Gene_protein
/,I-Gene_protein
NF,I-Gene_protein
-,I-Gene_protein
kappaB,I-Gene_protein
and,O
p38,B-Gene_protein
/,I-Gene_protein
MSK1,I-Gene_protein
/,B-Gene_protein
CREB,I-Gene_protein
pathways,O
and,O
negative,O
JNK,B-Gene_protein
/,B-Gene_protein
c,I-Gene_protein
-,I-Gene_protein
Jun,I-Gene_protein
/,I-Gene_protein
AP-1,I-Gene_protein
pathway,O
.,O
 , 


,B-Gene_protein
MUC2,I-Gene_protein
is,O
a,O
major,O
secretory,O
mucin,O
normally,O
expressed,O
by,O
goblet,O
cells,O
of,O
the,O
intestine,O
,,O
but,O
is,O
aberrantly,O
expressed,O
in,O
colonic,O
neoplasia,O
.,O
 , 
Bile,O
acids,O
have,O
been,O
implicated,O
in,O
colorectal,O
carcinogenesis,O
and,O
,,O
therefore,O
,,O
we,O
sought,O
to,O
determine,O
the,O
effects,O
of,O
bile,O
acids,O
on,O
MUC2,B-Gene_protein
expression,O
and,O
regulation,O
in,O
colon,O
cancer,O
cells,O
.,O
 , 
Since,O
deoxycholic,O
acid,O
(,O
DCA,O
),O
,,O
a,O
secondary,O
bile,O
acid,O
,,O
has,O
been,O
reported,O
to,O
be,O
a,O
potent,O
mucin,O
secretagogue,O
and,O
tumor,O
promoter,O
,,O
DCA,O
-,O
treated,O
HM3,O
colon,O
cancer,O
cells,O
were,O
analyzed,O
using,O
promoter,O
-,O
reporter,O
assays,O
of,O
the,O
5,O
',O
flanking,O
region,O
of,O
the,O
MUC2,B-Gene_protein
gene,O
.,O
 , 
Chemical,O
inhibitors,O
,,O
mutant,O
reporter,O
constructs,O
and,O
EMSA,O
showed,O
that,O
DCA,O
upregulates,O
MUC2,B-Gene_protein
transcription,O
via,O
multiple,O
pathways,O
involving,O
activation,O
of,O
EGFR,B-Gene_protein
/,B-Gene_protein
PKC,I-Gene_protein
/,I-Gene_protein
Ras,I-Gene_protein
/,B-Gene_protein
Raf-1,I-Gene_protein
/,I-Gene_protein
MEK1,I-Gene_protein
/,B-Gene_protein
ERK,I-Gene_protein
/,I-Gene_protein
CREB,I-Gene_protein
,,I-Gene_protein
PI3,B-Gene_protein
/,I-Gene_protein
Akt,I-Gene_protein
/,I-Gene_protein
IkappaB,I-Gene_protein
/,B-Gene_protein
NF,I-Gene_protein
-,I-Gene_protein
kappaB,I-Gene_protein
and,O
p38,B-Gene_protein
/,B-Gene_protein
MSK1,I-Gene_protein
/,I-Gene_protein
CREB,I-Gene_protein
while,O
DCA,O
induced,O
MUC2,B-Gene_protein
transcription,O
is,O
inhibited,O
by,O
JNK,B-Gene_protein
/,I-Gene_protein
c,I-Gene_protein
-,I-Gene_protein
Jun,I-Gene_protein
/,B-Gene_protein
AP-1,I-Gene_protein
pathway,O
.,O
 , 
These,O
results,O
provide,O
new,O
insight,O
into,O
the,O
complex,O
molecular,O
mechanisms,O
involved,O
in,O
the,O
regulation,O
of,O
mucin,O
gene,O
by,O
bile,O
acids,O
in,O
colon,O
cancer,O
cells,O
that,O
may,O
contribute,O
to,O
further,O
elucidation,O
of,O
colorectal,O
carcinogenesis,O
.,O
 , 

,O
 , 
#22895193
Recurrent,O
R,B-Gene_protein
-,I-Gene_protein
spondin,I-Gene_protein
fusions,B-DNA_Mutation
in,O
colon,O
cancer,O
.,O
 , 


,O
Identifying,O
and,O
understanding,O
changes,O
in,O
cancer,O
genomes,O
is,O
essential,O
for,O
the,O
development,O
of,O
targeted,O
therapeutics,O
.,O
 , 
Here,O
we,O
analyse,O
systematically,O
more,O
than,O
70,O
pairs,O
of,O
primary,O
human,O
colon,O
tumours,O
by,O
applying,O
next,O
-,O
generation,O
sequencing,O
to,O
characterize,O
their,O
exomes,O
,,O
transcriptomes,O
and,O
copy,B-DNA_Mutation
-,I-DNA_Mutation
number,I-DNA_Mutation
alterations,I-DNA_Mutation
.,I-DNA_Mutation
 , 
We,O
have,O
identified,O
36,303,O
protein,O
-,O
altering,O
somatic,B-DNA_Mutation
changes,I-DNA_Mutation
that,O
include,O
several,O
new,O
recurrent,O
mutations,B-DNA_Mutation
in,O
the,O
Wnt,O
pathway,O
gene,O
TCF7L2,B-Gene_protein
,,I-Gene_protein
chromatin,O
-,O
remodelling,O
genes,O
such,O
as,O
TET2,B-Gene_protein
and,O
TET3,B-Gene_protein
and,O
receptor,O
tyrosine,O
kinases,O
including,O
ERBB3,B-Gene_protein
.,I-Gene_protein
 , 
Our,O
analysis,O
for,O
significantly,O
mutated,O
cancer,O
genes,O
identified,O
23,O
candidates,O
,,O
including,O
the,O
cell,O
cycle,O
checkpoint,O
kinase,O
ATM,B-Gene_protein
.,I-Gene_protein
 , 
Copy,O
-,O
number,O
and,O
RNA,O
-,O
seq,O
data,O
analysis,O
identified,O
amplifications,O
and,O
corresponding,O
overexpression,O
of,O
IGF2,B-Gene_protein
in,O
a,O
subset,O
of,O
colon,O
tumours,O
.,O
 , 
Furthermore,O
,,O
using,O
RNA,O
-,O
seq,O
data,O
we,O
identified,O
multiple,B-RNA
fusion,I-RNA
transcripts,I-RNA
including,O
recurrent,B-DNA_Mutation
gene,I-DNA_Mutation
fusions,I-DNA_Mutation
involving,O
R,B-Gene_protein
-,I-Gene_protein
spondin,I-Gene_protein
family,O
members,O
RSPO2,B-Gene_protein
and,O
RSPO3,B-Gene_protein
that,O
together,O
occur,O
in,O
10,O
%,O
of,O
colon,O
tumours,O
.,O
 , 
The,O
RSPO,B-Gene_protein
fusions,B-DNA_Mutation
were,O
mutually,O
exclusive,O
with,O
APC,B-Gene_protein
mutations,B-DNA_Mutation
,,I-DNA_Mutation
indicating,O
that,O
they,O
probably,O
have,O
a,O
role,O
in,O
the,O
activation,O
of,O
Wnt,O
signalling,O
and,O
tumorigenesis,O
.,O
 , 
Consistent,O
with,O
this,O
we,O
show,O
that,O
the,O
RSPO,B-Gene_protein
fusion,B-DNA_Mutation
proteins,O
were,O
capable,O
of,O
potentiating,O
Wnt,O
signalling,O
.,O
 , 
The,O
R,B-Gene_protein
-,I-Gene_protein
spondin,I-Gene_protein
gene,B-DNA_Mutation
fusions,I-DNA_Mutation
and,O
several,O
other,O
gene,O
mutations,B-DNA_Mutation
identified,O
in,O
this,O
study,O
provide,O
new,O
potential,O
opportunities,O
for,O
therapeutic,O
intervention,O
in,O
colon,O
cancer,O
.,O
 , 

,O
 , 
#23132392
Somatic,O
MED12,B-Gene_protein
mutations,B-Mutation
in,O
uterine,O
leiomyosarcoma,O
and,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Mediator,O
complex,O
participates,O
in,O
transcriptional,O
regulation,O
by,O
connecting,O
regulatory,O
DNA,O
sequences,O
to,O
the,O
RNA,O
polymerase,O
II,O
initiation,O
complex,O
.,O
 , 
Recently,O
,,O
we,O
discovered,O
through,O
exome,O
sequencing,O
that,O
as,O
many,O
as,O
70,O
%,O
of,O
uterine,O
leiomyomas,O
harbour,O
specific,O
mutations,B-Mutation
in,O
exon,B-locus
2,I-locus
of,O
mediator,B-Gene_protein
complex,I-Gene_protein
subunit,I-Gene_protein
12,I-Gene_protein
(,B-Gene_protein
MED12,I-Gene_protein
),I-Gene_protein
.,O
 , 
In,O
this,O
work,O
,,O
we,O
examined,O
the,O
role,O
of,O
MED12,B-Gene_protein
exon,B-locus
2,I-locus
mutations,B-Mutation
in,O
other,O
tumour,O
types,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
The,O
frequency,O
of,O
MED12,B-Gene_protein
exon,B-locus
2,I-locus
mutations,B-Mutation
was,O
analysed,O
in,O
altogether,O
1158,O
tumours,O
by,O
direct,O
sequencing,O
.,O
 , 
The,O
tumour,O
spectrum,O
included,O
mesenchymal,O
tumours,O
(,O
extrauterine,O
leiomyomas,O
,,O
endometrial,O
polyps,O
,,O
lipomas,O
,,O
uterine,O
leiomyosarcomas,O
,,O
other,O
sarcomas,O
,,O
gastro,O
-,O
intestinal,O
stromal,O
tumours,O
),O
,,O
hormone,O
-,O
dependent,O
tumours,O
(,O
breast,O
and,O
ovarian,O
cancers,O
),O
,,O
haematological,O
malignancies,O
(,O
acute,O
myeloid,O
leukaemias,O
,,O
acute,O
lymphoid,O
leukaemias,O
,,O
myeloproliferative,O
neoplasms,O
),O
,,O
and,O
tumours,O
associated,O
with,O
abnormal,O
Wnt,O
-,O
signalling,O
(,O
colorectal,O
cancers,O
(,O
CRC,O
),O
),O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Five,O
somatic,B-DNA_Mutation
alterations,I-DNA_Mutation
were,O
observed,O
:,O
three,O
in,O
uterine,O
leiomyosarcomas,O
(,O
3/41,O
,,O
7,O
%,O
;,O
Gly44Ser,B-Protein_Mutation
,,I-Protein_Mutation
Ala38_Leu39ins7,B-Protein_Mutation
,,I-Protein_Mutation
Glu35_Leu36delinsVal,B-Protein_Mutation
),I-Protein_Mutation
,,O
and,O
two,O
in,O
CRC,O
(,O
2/392,O
,,O
0.5,O
%,O
;,O
Gly44Cys,B-Protein_Mutation
,,I-Protein_Mutation
Ala67Val,B-Protein_Mutation
),I-Protein_Mutation
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
Somatic,O
MED12,B-Gene_protein
exon,B-locus
2,I-locus
mutations,B-DNA_Mutation
were,O
observed,O
in,O
uterine,O
leiomyosarcomas,O
,,O
suggesting,O
that,O
a,O
subgroup,O
of,O
these,O
malignant,O
tumours,O
may,O
develop,O
from,O
a,O
leiomyoma,O
precursor,O
.,O
 , 
Mutations,B-DNA_Mutation
in,O
CRC,O
samples,O
indicate,O
that,O
MED12,B-Gene_protein
may,O
,,O
albeit,O
rarely,O
,,O
contribute,O
to,O
CRC,O
tumorigenesis,O
.,O
 , 

,O
 , 
#16924054
An,O
illustrative,O
case,O
of,O
Muir,O
-,O
Torre,O
syndrome,O
:,O
contribution,O
of,O
immunohistochemical,O
analysis,O
in,O
identifying,O
indicator,O
sebaceous,O
lesions,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Muir,O
-,O
Torre,O
syndrome,O
(,O
MTS,O
),O
is,O
an,O
autosomal,O
dominant,O
genodermatosis,O
characterized,O
by,O
the,O
association,O
of,O
at,O
least,O
1,O
cutaneous,O
sebaceous,O
tumor,O
and,O
1,O
internal,O
malignancy,O
,,O
often,O
arising,O
in,O
the,O
gastrointestinal,O
tract,O
.,O
 , 
It,O
is,O
secondary,O
to,O
germline,O
mutations,B-DNA_Mutation
in,O
DNA,O
mismatch,O
repair,O
genes,O
,,O
mainly,O
MLH-1,B-Gene_protein
and,O
MSH-2,B-Gene_protein
.,I-Gene_protein
 , 


,O
#,O
#,O
OBSERVATIONS,O

,O
We,O
report,O
the,O
case,O
of,O
a,O
54,O
-,O
year,O
-,O
old,O
man,O
with,O
a,O
2,O
-,O
year,O
history,O
of,O
skin,O
-,O
colored,O
papules,O
clinically,O
reminiscent,O
of,O
large,O
sebaceous,O
hyperplasias,O
on,O
the,O
nose,O
and,O
back,O
,,O
but,O
histologically,O
diagnosed,O
as,O
sebaceous,O
adenomas,O
and,O
epitheliomas,O
.,O
 , 
His,O
family,O
history,O
was,O
positive,O
for,O
colon,O
cancer,O
in,O
the,O
mother,O
and,O
2,O
brothers,O
.,O
 , 
A,O
colonoscopy,O
done,O
during,O
the,O
hospitalization,O
revealed,O
2,O
sessile,O
polyps,O
in,O
the,O
left,O
colon,O
,,O
both,O
showing,O
a,O
low,O
-,O
grade,O
dysplasia,O
on,O
the,O
biopsy,O
specimen,O
.,O
 , 
Immunohistochemical,O
staining,O
performed,O
on,O
the,O
cutaneous,O
and,O
colic,O
biopsy,O
specimens,O
revealed,O
a,O
lack,O
of,O
expression,O
of,O
MSH-2,B-Gene_protein
and,O
MSH-6,B-Gene_protein
.,I-Gene_protein
 , 
Genetic,O
testing,O
revealed,O
microsatellite,O
instability,O
in,O
the,O
colon,O
and,O
cutaneous,O
tumors,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
The,O
immunohistochemical,O
testing,O
for,O
MSH-2,B-Gene_protein
,,I-Gene_protein
MSH-6,B-Gene_protein
,,I-Gene_protein
and,O
MLH-1,B-Gene_protein
is,O
useful,O
for,O
rapid,O
identification,O
of,O
an,O
underlying,O
mismatch,O
repair,O
defect,O
and,O
early,O
diagnosis,O
of,O
MTS,O
.,O

,O
 , 
